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1 Glycopeptides and glycoproteins 
 
Glycoproteins are fundamental to many important biological processes including fertilisation, 
immune defence, viral replication, parasitic infection, cell growth, cell-cell adhesion, degradation 
of blood clots, inflammation and protein folding, stability and solubility.1 The carbohydrate 
moiety of a glycoprotein may participate directly in recognition events, but it may also modify 
the properties of the protein. The large size of the carbohydrates is probably the most significant 
factor in modifying the properties of the proteins to which they are attached. Glycoproteins and 
glycolipids are major components of the outer surface of mammalian cells. Oligosaccharide 
structures change dramatically during development, and it has been shown that specific sets of 
oligosaccharides are expressed at distinct stages of differentiation. Furthermore, alterations in 
cell surface oligosaccharides are associated with various pathological conditions including 
malignant transformation. 
At each glycosylation site on a protein, there can be a set of glycosylated structures. This has led 
to the concept of a glycoprotein being defined as a set of glycoforms which all have the same 
amino acids but differ in the sequence or position of the attached sugars. It is the populations in 
this set of glycoforms that change under a variety of conditions such as disease. 
There is no single function for oligosaccharides. Perhaps their major function is to serve as 
recognition markers. Additionally, oligosaccharides can modify the intrinsic properties of 
proteins to which they are attached by altering the stability, protease resistance, or quaternary 
structure. The large size of oligosaccharides may allow them to cover functionally important 
areas of proteins, to modulate the interactions of glycoconjugates with other molecules, and to 
affect the rate of processes which involve conformational changes. Glycosylation is highly 
sensitive to alterations in cellular function, and abnormal glycosylation is diagnostic of a number 
of disease states including rheumatoid arthritis and cancer. The control of glycosylation by the 
cell affords, in principle, a means of putting the same recognition markers on quite different 
proteins without having to code the information into the DNA of that protein. Site-specific 
glycosylation of a protein also suggests that the 3D structure of the protein plays a role in 
determining the extent and type of its own glycosylation. 
More than 50 % of proteins in humans are glycosylated. Also less complex species such bacteria 
as E. coli have this modification machinery. In mammals, the saccharide residues found in 
proteins are covalently linked to the protein backbone either N- (via asparagine) or O-
glycosidically (via serine, threonine, tyrosine or hydroxylysine).  
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1.1 N-Linked glycoproteins 
 
To be glycosylated, an asparagine residue must form part of the tripeptide Asn-Xaa-Ser/Thr 
(where Xaa is any amino acid other than proline), although the presence of this sequon is not in 
itself sufficient to ensure glycosylation. 
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Figure 1. Classification of N-linked oligosaccharides  
 
Some rules have emerged with respect to the factors which control the attachment of 
oligosaccharides to potential glycosylation sites and the subsequent enzymatic modifications of 
the glycan chains. While the potential oligosaccharide processing pathways available to a 
nascent protein are dictated by the cell in which it is expressed, its final glycosylation pattern is 
also the result of constraints imposed by the 3D structure of the individual protein.  
All N-linked glycans contain the pentasaccharide Manα1-6-(Manα1-3)-Manβ1-4-GlcNAcβ1-4-
GlcNAc as a common core. On the basis of the structure and the location of glycan residues 
added to the trimannosyl core, N-linked oligosaccharides can be classified into four main 
subgroups:2 high mannose-type (a), complex-type (b), hybrid-type (c), and poly-N-
acetyllactosamine-type (d) (Figure 1). High mannose-type glycans (a) contain only α-mannosyl 
residues attached to the trimannosyl core. Complex-type glycans (b) contain no mannose 
residues other than those in the trimannosyl core, but have branches with N-acetylglucosamine 
residues at their reducing termini attached to the core. The number of branches normally ranges 
from two (biantennary) to four (tetraantennary), but a pentaantennary structure has been reported 
in hen ovomuvoid.2b While various monosaccharides can be found in the antennae, the presence 
or absence of fucose and a bisecting GlcNAc residue on the core contributes to the enormous 
structural variation of complex-type glycans. The hybrid-type N-glycans (c) have the 
characteristic features of both complex-type and high mannose-type glycans. The fourth group is 
the poly-N-acetyllactosamine N-glycans containing repeating units of (Galβ1-4-GlcNAcβ1-3-) 
attached to the core. These repeats are not necessarily uniformly distributed on the different 
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antennae and the lactosamine repeat may also be branched. Poly-N-acetyllactosamine extensions 
are most frequently found in tetraantennary glycans.3 
Although the same glycosylation machinery is available to all the proteins which are translated 
in a particular cell and use the secretory pathway, it has been estimated that between 10 % and 
30 % of potential glycosylation sites are not occupied.4 Moreover site analysis has shown that 
the distribution of different classes of N-linked oligosaccharide structures is frequently specific 
for each site on a protein. The 3D structure of the individual protein clearly has a role in 
determining the type and extent of its glycosylation. A number of mechanisms may be involved. 
These include the following: 
1) The position of the glycosylation site in the protein. N-Linked sites at the exposed turns of β-
pleated sheets, which are sometimes close to proline residues, are normally occupied while those 
near the C-terminus are more often vacant. 
2) Access to the glycosylation site on the developing oligosaccharide. This may be sterically 
hindered by the local protein structure or by protein folding which may compete with the 
initiation of N-glycosylation. 
3) Interaction of the developing oligosaccharide with the protein surface. This may result in a 
glycan conformation which may alter the accessibility to specific glycosyltransferases or 
glycosidases. 
4) Interaction of the glycosyl enzymes with the protein structure. This can lead to site-specific 
processing. 
5) Glycosylation at one site in a multiglycosylated protein. This may sterically hinder events at a 
second site on the same molecule. 
6) The interaction of protein subunits to form oligomers. This may prevent glycosylation or 
restrict the glycoforms at individual sites. 
 
1.2 Biosynthesis of N-linked glycoproteins 
 
Many enzymes and proteins are involved in the posttranslational modification of proteins. Their 
effects often fundamentally alter protein function. Posttranslational modifications create a 
dynamic combinatorial library of properties that can rapidly respond to systemic stimuli, starting 
from one basic protein scaffold. N-linked protein glycosylation is the most widespread and 
complex posttranslational modification of secretory proteins in eukaryotes. The dynamic 
complexity of these modifications is often difficult to elucidate in the laboratory. Working out 
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the role of each protein component (sometimes very minor but important) requires abundant 
sources and extensive purification. Furthermore, to continue to precisely exploit the power of 
proteins in therapeutics requires the creation of pure protein drugs (most today are sold as 
mixtures). A better understanding of the mechanism by which modifications are formed coupled 
with methods for creating artificial posttranslational modification mimics may provide a solution 
to both of these problems. Chemical probes and inhibitors of glycoprocessing enzymes are 
especially useful in this context.5  
Aberrant glycosylation occurs in essentially all types of experimental and human cancers, as has 
been observed for over 40 years, and many glycosyl epitopes constitute tumour-associated 
antigens.6 A long-standing debate is whether aberrant glycosylation is a result or a cause of 
cancer. Many recent studies indicate that some, if not all, aberrant glycosylation is a result of 
initial oncogenic transformation, as well as a key event in induction of invasion and metastasis. 
Glycosylation promoting or inhibiting tumour cell invasion and metastasis is of crucial 
importance in current cancer research. Glycosylation appears to be considered “in the shade” of 
more popular topics such as oncogenes and antioncogenes, apoptosis, angiogenesis, growth 
factor receptors, integrin and caderin function, etc., despite the fact that aberrant glycosylation 
profoundly affects all of these processes.  
 
1.3 N-Linked glycopeptides with different linkage 
 
It is now well appreciated that the modification of proteins with carbohydrates plays a very 
important role in many biological events. For example, the carbohydrate moieties of 
glycoproteins can be involved in cell-cell communication, immune response, cell adhesion, 
intracellular targeting, protease resistance, and many other processes.7 The carbohydrates can 
also impact several physicochemical properties of proteins including hydration, hydrophilicity, 
and conformational stability.8 Additionally, because N-linked glycosylation occurs 
cotranslationally during biosynthesis on the ribosome, the attachment of the carbohydrates may 
affect the protein folding pathway. Detailed studies of the impact of carbohydrates on 
glycoprotein structure have been limited due to the flexibility of the carbohydrates, which 
complicates crystallographic analyses. 
Imperiali and co-workers have recently demonstrated by NMR and Molecular Dynamics studies 
that the stereochemistry of the carbohydrate-peptide linkage has critical and unique 
conformational effects on the glycopeptide structure.9 The two N-linked glycopeptides A and B 
shown in Figure 2 were employed for these conformational studies. 
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Figure 2. Structure of glycopeptides A and B 9 
 
The NMR studies revealed that the stereochemistry at the anomeric center of the N-linked 
carbohydrate dramatically affects the backbone conformation of the glycopeptide, and, indeed, 
only the β-linked glycopeptide adopts a compact β-turn conformation, while the conformation of 
the α-glycopeptide is more similar to that of the unglycosylated peptide, featuring an Asx-turn 
structure (Figure 3).  
 
 
 
Figure 3. Structure of Asx and Type I β-turn 
 
The conformational consequences of the stereochemistry of the anomeric center in the 
carbohydrate-peptide linkage reported, provide valuable information for the design of 
neoglycopeptides and glycopeptide mimetics that may be useful as therapeutic agents. 
Nephritogenoside (structure represented in Figure 4) is a glycopeptide isolated as a minor 
component in the basement membrane of normal animals. This substance is able to induce 
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glomerulonephritis in homologous animals. The peptide portion is directly and α-N-
glycosidically bound to the trisaccharide portion (Glcα1-6-Glcβ1-6-Glcα1-Asn) via the N-
terminal amino acid Asn. Nephritogenoside represents the first and so far only example, among 
natural compounds, of a carbohydrate-peptide linkage having a direct α-N-glycosidic linkage.10 
 
 
 
Figure 4. The structure of nephritogenoside 
 
1.4 Neo-glycoconjugates and glycopeptide mimics 
 
The data described so far show how glycoproteins and glycolipids play a central role in human 
health and disease. N-Glycosyl amides are currently under intense scrutiny as potential effectors 
of carbohydrate-binding proteins.11 Their mimetics therefore, are interesting candidates to 
develop drugs and biological probes, useful to clarify the biological roles of these molecules. A 
major synthetic effort is under way to synthesize so-called “neo-glycoconjugates” where a sugar 
ring is connected through a N atom to a carbon chain, often to a natural amino acid, using an 
unnatural linkage. 
For instance, Dondoni and co-workers have introduced 1,2,3-triazolo-linked conjugates, 
exemplified by the structures shown in Figure 5 (1,6)-α-D-oligomannoses (triazolomannoses, 
Figure 5).12,13 The choice of mannose as the sugar fragment in these oligomers was suggested by 
their potential use as mimetics of the manno-oligosaccharide family members which constitute 
the essential substructure of mycobacteria lipoglycans.  
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Figure 5. Structures of triazolomannoses synthesized by the Dondoni group12, 13 
 
High stability can be foreseen for these oligomers owing to the resistance of anomeric carbon-
carbon bond and triazole ring toward chemical and enzymatic degradation.14 On the other hand, 
triazole rings can participate in hydrogen bonding and dipole interactions, thereby favoring 
molecular recognition process and improving solubility. In particular these features were 
designed as inhibitors of Mycobacterium tuberculosis cell-wall biosynthesis. 
Glycosyl ureas are found in nature as structural unit of glycocinnamoylspermidine antibiotics.15, 
16
 They have been used as stable N-linked-glycopeptide mimics,17 for the synthesis of polyvalent 
glycoconjugates18 and for the development of antidiabetic agents and aminoglycoside 
antibiotics.19, 20 However, only a few methods for the synthesis of glycosyl ureas have been 
reported,21, 22, 23, 24, 25 and in particular, the stereoselective synthesis of α-glycosyl ureas (Figure 
6) is still limited.17b, 21d, 26, 27 
 
 
 
Figure 6. α-glycosyl ureas described from our laboratory (ref. 26) 
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As seen above, natural N-linked glycopeptides are almost invariably β-linked,10 hence, it is 
plausible that the unnatural, α-linked isomers may be stable to hydrolytic enzymes and may be 
used for in vivo applications. For these reasons stereoselective synthesis of neo-glycoconjugates 
in the “unnatural” α N-linked configuration is of great interest as a means of designing 
glycopeptide mimics with altered metabolic stability and virtually unexplored physico-chemical 
properties.  Our laboratory has been actively exploring the synthesis and biological applications 
of such unnatural glycoconjugate. 
A small group of α-fucosyl amides (structure represented in Figure 7) have been tested for their 
affinity for the carbohydrate recognition domain (CRD) of DC-SIGN 28 and for the PA-II 
lectin.29 DC-SIGN is a dendritic cell receptor with mannose and fucose specificities, which has 
been implicated in the onset of HIV infection. It was brought to the attention of the scientific 
community by the group of van Kooyk, who reported that HIV-1 targets DC-SIGN but escapes 
degradation in lytic compartments, and thus uses DCs as a Trojan horse to invade the host 
organism.30 After this discovery, it was shown by several groups that many pathogens are 
recognized by DC-SIGN; this indicates that this lectin could participate in some way during the 
corresponding infection process.31 Furthermore, as the detailed molecular mechanisms by which 
this receptor operates are not known, effective modulators of DC-SIGN are needed to help 
clarify the different biological processes in which it can be involved. Compound A in Figure 7 
was the first reported fucose-based glycomimetics to interact with DC-SIGN with an affinity 
similar to that of the natural DC-SIGN fucose-based ligand, the Lewis-x trisaccharide.28 
PA-II lectin is a fucose selective lectin from Pseudomonas aeruginosa, involved in the formation 
and stabilization of microbial biofilms.32  This soluble bacterial lectin binds with an unusually 
strong micromolar affinity to L-fucose in a tight binding site which requires two Ca2+ ions.33 
Compounds B-F in Figure 7 were found to bind to the lectin in the micromolar range.29  
Collectively the compounds shown in Figure 7 constitute proof of principle that a α-glycosyl 
amides can perform as effective mimics of α-fucosides also in high affinity, tight binding 
proteins such as PA-II lectin.  
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Figure 7. Small library of α-fucosyl amides with affinity for DC-SIGN CRD (A)  28 or for PA-II 
lectin (B-F) 29 
 
 
1.5 Traceless Staudinger ligation of glycosyl azides: stereoselective synthesis of 
glycosyl amides 
 
The most widely employed method for the synthesis of glycosyl amides is the condensation of 
protected or unprotected glycosylamines 34, 35 with carboxylic acid derivatives. Several examples 
of the reduction of glycosyl azides by catalytic hydrogenation followed by acylation of the 
resulting glycosylamines have been reported.36, 37, 38 Because glycosylamines rapidly equilibrate 
to the most stable β-anomer, all the approaches that make use of isolated amine intermediates 
afford β-glycosyl amides. An alternative methodology attempts to avoid anomeric equilibration 
by reducing glycosyl azides in the presence of acylating agents.39, 40, 41, 42, 43 
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The group of Györgydeàk investigated in detail the stereochemical course of the reduction-
acylation of glycosyl azides by the Staudinger reaction 44 to establish whether α- and β-glycosyl 
amides can be derived in a stereoselective fashion from the corresponding azides.45 
The Staudinger reduction of glycosyl azides affords aza-ylide intermediates (also called 
iminophosphoranes; Scheme 1), which can be trapped by acylating agents to give 
configurationally stable acylamino phosphonium salts that, in turn, yield the corresponding 
amides upon quenching. However, like glycosylamines, the Staudinger’s aza-ylides are also 
subject to anomeric isomerization, which is biased toward the β-anomers. Thus, the synthesis of 
β-glycosyl amides can be easily achieved in this process, but in most cases, anomerization 
remains a significant problem during the synthesis of α-glycosyl amides. 
 
 
 
Scheme 1. Mechanism of the Staudinger reduction-acylation of the glycosyl azides 
 
Only a handful of methods have been reported to afford α-glycosyl amides, most of which 
require two steps and have been described for a limited number of substrates.46, 47, 48 
Two main synthetic approaches are available for the synthesis of α-glycosyl amides, one, 
reported by DeShong and coworkers48 starts from α or β-glucopyranosyl azides 1 and 2 by 
treatment with PPh3 in refluxing 1,2-dichloroethane gave oxazoline 3 (Scheme 2). Formation of 
oxazoline 3 from either azides can be explained by the mechanism shown in Scheme 1 involving 
α/β anomerization of the intermediate iminophosphorane 4 and 5.49, 50 Oxazoline formation from 
4 cannot occur due to strain in the resulting product. Accordingly, epimerization followed by 
cyclization gives exclusively α-oxazoline 3. 
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Scheme 2. Mechanism for the formation of isoxazoline 3 
 
Acylation of oxazoline 3 (formed in situ) with a thiopyridyl ester in the presence of CuCl2.2H2O 
gave exclusively the α-glucopyranosyl amide 6 in a highly stereoselective process (Scheme 3). 
 
 
 
Sceme 3. Coupling reaction of glucopyranosyl isoxazoline 3 
 
The second method, developed primarily by our group, 47 is based on the traceless Staudinger 
ligation of glycosyl azides, using functionalized phosphines 9 (Figure 4) described originally by 
Bertozzi 51 and Kiessling.52 
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The traceless Staudinger ligation of azides employs a Staudinger-like protocol, such as the one 
described in Scheme 1, but the phosphines used are modified to include an acylating agent, 
which in 9 is a phenolic ester. Thus, in principle, the reaction allows for reduction of the starting 
azide and fast intramolecular trapping of the reduction intermediates, resulting in the direct 
formation of an amide link. We have shown that, in many instances this prevents epimerization 
and allows retention of configuration at the anomeric carbon. 47 
In 2006 our laboratory reported that the traceless Staudinger ligation of O-benzyl-α-glucosyl 
azide 8 with diphenylphosphanyl-phenyl esters 9 in polar aprotic solvents yields α-glucosyl 
amides with good yields and selectivity (Scheme 4, path A). The phosphines employed, which 
are stable to air, allow the fast intramolecular trapping of the reduction intermediates affording 
direct formation of the amide link and preventing anomerisation. However, the process depends 
critically on the nature of the sugar protecting groups: the same phosphines react with tetra-O-
acetyl-α-glucosyl azides 2 in non-stereoconservative fashion and afford β-glucosyl amides 
(Scheme 4, path B). The dependence of the ligation stereochemistry on the nature of the sugar 
protecting group appeared to be related to the electron-withdrawing effect of the acetates,53, 54 
which may reduce the rate of the acylation step and favor the anomerization. This effect enforces 
the use of benzyl ethers as protecting groups in the synthesis of α-glycosyl azides. The method 
could be applied to O-benzyl glycosyl azides in the fuco, gluco, and galacto series to afford the 
corresponding α-glycosyl amides with good yields and stereoselectivities for a range of acyl 
chains, how many alkyl and alkenyl groups, both linear and branched, and amino acids with 
various functional groups. 47d 
More recently, we have developed a protocol for ligation of  unprotected α and β glucosyl azides 
with the same phosphines 9 (Scheme 4, path A). We were able to identify conditions that 
allowed a clean and stereoconservative reaction to occur in good to moderate yields, affording α 
or β glucosylamides depending on the configuration of the starting azide.55 Ligation of the 
unprotected α- and β-glucosyl azides 7 and 10 was particularly remarkable because in both case 
it occurred stereoconservatively and allowed simple isolation from the phosphane oxide by-
product by water extraction.  
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Scheme 4. Traceless Staudinger ligation of glycosyl azides with functionalized phosphine 9. 
 
The overall picture emerging from previous studies on the traceless Staudinger ligation of 
glycosyl azides are summarized in Scheme 4. β-glycosyl azides can be transformed into the 
corresponding amides with retention of configuration, irrespective of the nature of the hydroxyl 
protecting group R (Figure 4, eq 3, R = Bn, Ac, H). On the contrary, the ligation of  α-glycosyl 
azides depends critically on the nature of R: benzyl ethers and free hydroxyl groups allow the 
reaction to occur with retention of configuration (Figure 4, eq 1), whereas acetates enforce 
inversion of configuration at the anomeric center and formation of the corresponding β-amide 
(Figure 4, eq 2). 
Phosphines 9 are air stable reagents that can be easily synthesized and purified by flash 
chromatography, which gives a significant advantage over other ligation reagents, and their 
application in the stereoselective synthesis of glycosyl amides should be particularly useful. 
The process described, however, left various synthetic problems unresolved. The reactivity of α-
glycosyl azides was uniformely low, and the corresponding amides were obtained generally in 
modest yields. Moreover, the yields of the ligation appeared to depend critically also on the 
nature of the acyl group to be transferred and were specially disappointing for the transfer of 
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amino acids to α-azides. Thus, in order to further explore the reactivity and stereoselectivity of 
ligation in the synthesis of α-glycosyl amides, different acyl phosphines were prepared, trying to 
vary the basicity of the P atom and the nature of the phenyl ester leaving group. 
 
1.6 Aim of the work and plan of the thesis 
 
Our efforts have been initially directed to addressing the issues mentioned above in order to 
develop more general methods for the stereoselective ligation of unprotected glycosyl azides and 
to improve the yields of the more difficult ligation reactions.  
The first two chapters of the thesis are dedicated to describe the synthesis of the starting material 
used, i.e. the glycosyl azides (Chapter 2) and the functionalized phosphines (Chapter 3). 
Initial results were achieved by screening a set of different phosphines and using as a common 
substrate α-glucosyl azide 7. The methods and results are described in Chapter 4. These studies 
allowed to select appropriate reagents and reaction conditions which led to consistently good 
yields and stereoselectivity in the ligation of α- and β-glycosyl azides and aminoacids (Chapter 
5). 
Side-reactions encountered during these initial studies drew our attention to a previously 
unknown class of compounds, represented by glycofuranosyl amides. In Chapter 6 we describe 
how these molecules can be selectively synthesized and report preliminary data concerning their 
biological activity as antibacterial agents.  
Finally in Chapter 7 we recapitulate the main mechanistic and stereochemical information 
collected throughout these studies and use it to formulate a comprehensive mechanistic picture of 
the traceless Staudinger ligation of unprotected glycosyl azides. 
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In order to develop a stereoselective Staudinger ligation for the synthesis of α-glycosyl amides, 
it was decided to employ the procedure based on the reduction-acylation of the corresponding α-
glycosyl azides. Our methods to achieve a stereoselective synthesis of α-glycosyl amides are 
described in Chapters 4-6. Before that, the stereoselective procedures employed for the synthesis 
of α-glycosyl azides are described in the following sections. 
 
2.1 Stereoselective synthesis of α-glycosyl azides 
 
Generally, 1,2-trans glycosyl azides can be synthesised using trimethylsilyl azide. Trimethylsilyl 
azide is an excellent azide donor and enables direct conversion, under Lewis acid catalysis, of 
acylated (mainly acetylated) monosaccharides. The high stereoselectivity observed in these 
reactions is due to intermediate formation of acyloxonium ions whose ring opening by the azide 
reactant yields 1,2-trans products (β-azide for glucosyl and galactosyl derivatives and α-azide 
for mannosyl derivatives).1 2-acetamido-3,4,6-tri-O-acetyl glucosamine represents an exception 
because no reaction occurs treating the acetate with trimethylsilyl azide. In this case, the 1,2-
trans azide is synthesised starting from the corresponding α-chloride. 2 
1,2-cis Azides of peracetylated substrates must be prepared by SN2 nucleophilic substitution 
from the corresponding β-halides.3 
Monosaccharides acylated at position C1 and bearing a non-participating group in position C2 
mainly give 1,2-cis azides upon reaction with trimethylsilyl azide under Lewis acid-catalysed 
conditions. In this case, α/β mixtures are obtained (as in the case of tetra-O-benzyl-glucose and 
galactose) because the azido group can act as a leaving group.∗ 
Recently, one procedure has been developed for the one-pot transformation of unprotected 
monosaccharides into peracetylated β-glycosyl azides under phase-transfer catalysis conditions, 
                                                 
∗
 This effect was observed during our attempt to synthesise the 2,3,4,6-tetra-O-acetyl-α-glucosyl azide 2 from the 
corresponding β-DISAL (methyl dinitrosalicylate, 2-hydroxy-3,5-dinitrobenzoate) donor. Either using sodium azide 
with tetrabutylammonium iodide or tetrabutylammonium azide in CH2Cl2, β to α equilibration was observed in 
during the reaction: the 2,4-dinitro phenoxide is a stronger nucleophile than the azide and the epimerisation of the 
starting material occurred without formation of the corresponding azide. 
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in the presence of HBr/AcOH (30%), sodium azide and tetrabutylammonium hydrogen sulphate 
(Scheme 3).4 
In 2009 Shoda and coworkers showed the direct synthesis of various glycosyl azides via an 
intermolecular nucleophilic attack of the azide ion on the anomeric center of an unprotected 
sugar 12 mediated by 2-chloro-1,3 dimethylimidazolinium chloride in aqueous solution (Scheme 
1).5  
 
 
 
Scheme 1. Direct synthesis of glycosyl azides by using DCM 
 
The reactions proceed through a reactive intermediate formed by preferential attack of the 
anomeric hydroxyl group towards 2-chloro-1,3 dimethylimidazolinium chloride, based on the 
fact that the pKa values of hemiacetal anomeric hydroxy groups are much lower than those of 
other hydroxy groups and water.6 
Several methods for the direct azidation of unprotected carbohydrates have been reported in the 
literature, for example using PPh3/NaN37 or under Mitsunobu conditions,8 but both these 
methodologies presented low stereoselectivity on the anomeric carbon. 
 
2.2 1,2-trans-per-O-Acetyl glycopyranosyl azides  
 
2.2.1 Glucose, Fucose and Galactose 
 
The per-O-acetyl-β-glucosyl, fucosyl and galactosyl azides 1, 13 and 14 were synthesised by 
treating the per-O-acetylated sugars 15, 16 and 17 with trimethylsilyl azide and tin tetrachloride 
employing the general procedure described by Paulsen (Scheme 2).1, 3 
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Scheme 2. Stereoselective synthesis of per-O-acetyl-β-glycosyl azides 2, 13 and 14 1, 3 
 
Alternatively 2,3,4,6-tetra-O-acetyl-β-galactosyl azide 13 has also been prepared directly from 
the free sugar 19 with a one-pot phase-transfer methodology (Scheme 3).4 
 
 
 
Scheme 3. Stereoselective synthesis of 2,3,4,6-tetra-O-acetyl-β-galactosyl azide 13 4 
 
Use of a stoichiometric quantity of acetic anhydride in the presence of HBr/AcOH (30%) gives 
per-O-acetylated galactosyl bromide 20; subsequent azidolysis of the acetyl-bromo-D-galactose 
formed in situ was carried out by treatment with sodium azide and tetrabutylammonium 
hydrogen sulphate under phase-transfer catalysis conditions in CH2Cl2 at to room temperature 
and afforded 2,3,4,6-tetra-O-acetyl-β-galactosyl azide 13 in excellent yield without further 
purification. 
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2.2.2 Glucosamine  
 
The β-azide of the peracetylated glucosamine 21 cannot be synthesised by simple treatment of 
the 
corresponding anomeric acetate with trimethylsilyl azide and tin tetrachloride as in the case of 
tetra-O-acetyl glucose. 
Thus, the β-azide was prepared from the corresponding α-chloride 22 with sodium azide and 
tetrabutylammonium hydrogensulfate in CH2Cl2 and saturated NaHCO3.9 The α-chloride 22 was 
previously obtained from commercial N-acetylglucosamine hydrochloride in a one-pot procedure 
which employs acetyl chloride and a catalytic amount of dry MeOH (Scheme 4).2 
 
 
 
Scheme 4. Stereoselective synthesis 3,4,6-tri-O-acetyl -2-N-acetyl-2-deoxy-β-D-glucopyranosyl 
azide 21 2, 9 
 
Nitz and co-worker10 showed (Scheme 5) that unprotected N-acetylglucosamine condensed with 
p-toluenesulfonylhydrazine give N’-glucosyltoluenesulfohydrazides (GSHs), which can be 
activated with tetrabutylamoniumchloride, lutidine and then transformed to glucosyl azide 42 by 
treatment with NaN3. 
 
 
Scheme 5. Formation of glycosyl azide 42 
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2.2.3 Arabinopyranose and Ribopyranose 
 
Treatments of commercial available free L-arabinopyranose 24 and D-ribofuranose 25 with 
excess of acetic anhydride and pyridine at room temperature for 24 h afforded the conversion of 
the free sugar into the corresponding 1,2,3,5-tetra-O-acetyl-β-L-arabinopyranose 26 11 and 
1,2,3,5-tetra-O-acetyl-β-D-ribopyranose 2711, 12 as the predominant products (Scheme 6). 
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Scheme 6. Synthesis of 1,2,3,5-tetra-O-acetyl-β-L-arabinopyranose 26 11 and 1,2,3,5-tetra-O-
acetyl-β-D-ribopyranose 27 11, 12 
 
 
The corresponding 1,2-trans glycosyl azides were prepared following the procedure of Paulsen.1, 
3
 Treating 1,2,3,5-tetra-O-acetyl-β-L-arabinopyranose 26 with trimethylsilyl azide and tin 
tetrachloride the β-azide 28 was obtained.  
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Scheme 7. Stereoselective synthesis of 1,2,3-tri-O-acetyl-β-L-arabinopyranosyl azide 28 and 
1,2,3-tri-O-acetyl-β-D-ribopyranosyl azide 29 
 
The β configuration of 28 was supported by NOESY contact H1-H3, J1,2 = 8 Hz and a low value 
of the chemical shift C4 = 67.8 ppm, which confirms the pyranose structure. Similarly 1,2,3,5-
tetra-O-acetyl-β-D-ribopyranose 27 reacted with trimethylsilyl azide in the presence of tin 
tetrachloride (Scheme 7)1, 3 to give β-azide 29. 
 
2.3 1,2-cis-per-O-Acetyl glycopyranosyl azides  
 
2.3.1 Glucose, Galactose and Arabinopyranose 
 
The 2,3,4,6-tetra-O-acetyl α-glucosyl azide 2 was prepared from the corresponding β-chloride 
30 13 with trimethylsilyl azide and tetrabutylammonium fluoride (Scheme 8).14,15  
 
 
 
Scheme 8. Stereoselective synthesis of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl azide 2 14 
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The β-chloride 30 can be obtained because of the neighbouring group participation. The 
following mechanism was suggested by the authors: the electrophilic aluminium atom 
coordinates to the ether oxygen of the anomeric acetoxy group and the resulting change in 
polarity, assisted by electron displacement from the acetoxy group in position C2, cause the 
transfer of this group from the anomeric position to the aluminium. Complete separation of 
AlCl3OAc- to afford the free ion II (which might exist in mesomeric forms) is unlikely, although 
an ion pair may be transiently formed. More probably, transfer of the chlorine from aluminium to 
the anomeric position within the reaction complex I is practically synchronous with fission of 
C1-acetoxy bond. The primary products are the β-chloride III and aluminium dichloride acetate 
(Scheme 9). 
 
 
 
 
Scheme 9. Mechanism of the formation of the β-chloride 30 13 
 
 
The same procedure can also been used for the synthesis of the 2,3,4,6-tetra-O-acetyl-α-D-
galactopyranosyl azide 3116 from 16 (Scheme 10) and of the 2,3,5-tri-O-acetyl-α-L-
arabinopyranosyl azide 32 from 26 (Scheme 10). 
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Scheme 10. Stereoselective synthesis of 2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl azide 31 
and 2,3,5-tri-O-acetyl-α-L-arabinopyranosyl azide 32 14 
 
The structure of 32 was established on the basis of the chemical shift of the C4 carbon at 68.7 
ppm, which is consistent with the pyranose form and of the J1,2 = 3.6 Hz consistent with a cis 
configuration of C1-C2. 
 
2.4 1,2-trans-per-O-Acetyl glycofuranosyl azides  
 
2.4.1 Galactofuranose 
 
The conversion of free galactopyranose 19 into 1,2,3,5,6-penta-O-acetyl-β-galactofuranose 35 
was obtained by treating the free hexose sugar with excess of acetic anhydride and pyridine at 
high temperature (100°C), for the first step of the reaction (Scheme 11).17 Most probably, at high 
temperature pyranose-furanose equilibration is facilitated and Ac2O treatment traps the furanose 
form. Isolation of 1,2,3,5,6-penta-O-acetyl-β-galactofuranose 35 from the reaction mixture, 
containing the other three epimers of galactose, required several steps of crystallization (Figure 
1). 
 
Scheme 11. Stereoselective synthesis of 1,2,3,5,6-penta-O-acetyl-β-galactofuranose 35 17 
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Figure 1. 1H-NMR (CDCl3) spectra of anomeric proton of four epimers of peracetyl-galactose. 
 
 
The process was assisted by 1H-NMR analysis (CDCl3), which allowed clear identification of the 
four isomers formed (Figure 1). 
When the reaction mixture was quenched into ice-water, we observed the precipitation of penta-
O-acetyl-β-D-galactopyranose 16 characterized in the 1H-NMR spectra (CDCl3) by a doublet at 
5.68 ppm (J1-2 = 8.4 Hz). Then the solution was extracted with AcOEt, to give an orange oil. A 
second portion of penta-O-acetyl-β-D-galactopyranose 16 was obtained from the oil, after 
dissolution in MeOH and water at low temperature (4°C overnight). Finally, treatment of the 
residue with isopropanol and water at room temperature afforded pure penta-O-acetyl-β-D-
galactofuranose 35 in 37 % yield (Figure 2). 17 
The compound is characterized in the 1H-NMR (Figure 1) by a broad singlet of the anomeric 
proton at 6.17 ppm and its 1H-NMR spectra (Figure 2) coincided with the literature data for 33.18  
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Figure 2. 1H-NMR (CDCl3) spectra of 1,2,3,5,6-penta-O-acetyl-β-D-galactofuranose 33 
 
The 2,3,5,6-tetra-O-acetyl-β-galactofuranosyl azide 36 was then synthesised with good yield and 
total stereocontrol using trimethylsilyl azide and thin tetrachloride employing the general 
procedure described by Paulsen (Scheme 12).1, 3 
 
 
Scheme 12. Stereoselective synthesis of 2,3,5,6-tetra-O-acetyl-β-galactofuranosyl azide 36 and 
of β-galactofuranosyl azides 37 
 
Zemplen’s deacetylation (Scheme 12), which afforded the unprotected galactofuranosyl azide 
37. The anomeric configuration of 36 was established after NOE difference experiments on 37 
showed a clear correlation between protons H1 and H3 (Figure 3), and also the chemical shift of 
C4 in 37 at 84.2 ppm is diagnostic for the furanose form. 
OAc
H OAc
AcO HO
AcO
AcO
H
H
 
1,2,3,5,6-penta-O-acetyl-β-D-galactofuranose 
1H-NMR (400 MHz, CDCl3, 25°C) 
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Figure 3. 1H-NMR (D2O) spectra of β-D-galactofuranosyl azide 37 
 
 
2.4.2 Arabinofuranose and Ribofuranose 
 
The synthesis of 40 and 41, from the commercial available 38 19 and 39 was performed using the 
procedure described by Stimac and Kobe 20 under Paulsen’s conditions. The reaction afforded 
high yields and an optimal stereoselectivity for the synthesis of β-D-ribofuranosyl azide 41 20 
from 39. The structure of 41 was confirmed by NOESY correlation between H1-H4 and high 
value of C4 79.2 ppm. The 2,3,5-tri-O-acetyl-α-L-arabinofuranosyl azide 40 was obtained from 
38 in high yield, but required an additional purification step by flash chromatography or re-
crystallization from hexane, to eliminate the little amount of 2,3,5-tri-O-acetyl-β-L-
arabinofuranose 28 formed during the reaction. The anomeric configuration of 40 was 
characterized by NOESY correlation between H1-H5. 
 
 
 
 
 
β-D-galactofuranosyl azide 
1H-NMR (400 MHz, D2O, 25°C) 
 
H1 
 
H2 
H3 
Chapter 2 
 34 
O
OAc
AcO
OAc
N3
CH2Cl2, r.t., 24 h
TMSN3, SnCl4
OAc
AcO OAc
H HO
AcO
AcO H
H OAcO
AcO
OAc
CH2Cl2, r.t., 24 h
TMSN3, SnCl4
AcO H
H OAcO
AcO
N3
+
N3
AcO OAc
H HO
AcO
38 40 28
39 41
 
 
Scheme 13. Synthesis of 2,3,5-tri-O-acetyl-α-L-arabinofuranosyl azide 40 and 2,3,5-tri-O-
acetyl-β-D-ribofuranosyl azide 41 20 
 
 
2.5 Unprotected glycosyl azides 
 
2.5.1 General procedure for the deprotection of peracetylated glycosyl azides 
 
The deprotection of all acetylated glycosyl azides was performed with the Zemplen’s procedure 
(a solution of NaOMe in dry methanol was added, at room temperature and under nitrogen, to a 
solution of peracetylated glycosyl azide in dry MeOH). This method afforded unprotected 
glycosyl azides without further purifications (Scheme 13). 
 
 
Scheme 13. Deacetylation of per-acetylated glycosyl azides 
 
In the same way all the azides collected in Figure 4 were prepared and used without further 
purification. The synthesis of the a-galactofuranosyl azides 46 is described in Chapter 6. Unless 
otherwise stated all the sugar belong to the D-series. 
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Figure 4. Unprotected glycosyl azides used in this thesis 
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2.6 Experimental Section 
 
Solvents were dried by standard procedures: dichloromethane, and methanol were dried over 
calcium hydride; hexane and tetrahydrofuran were dried over sodium; pyridine were dried over 
activated molecular sieves. Reactions requiring anhydrous conditions were performed under 
nitrogen. 1H and 13C-NMR spectra were recorded at 400 MHz on a Bruker AVANCE-400 
instrument. Chemical shifts δ for 1H and 13C are expressed in ppm relative to internal Me4Si as 
standard. Signals were abbreviated as s, singlet; bs broad singlet; d, doublet; t, triplet; q, quartet; 
m, multiplet. Mass spectra were obtained with a Bruker ion-trap Esquire 3000 apparatus (ESI 
ionization). Optical rotations [α]D were measured in a cell of 1 dm pathlength and 1 ml capacity 
with a Perkin-Elmer 241 polarimeter. Thin layer chromatography (TLC) was carried out with 
precoated Merck F254 silica gel plates. Flash chromatography (FC) was carried out with 
Macherey-Nagel silica gel 60 (230-400 mesh). 
 
Synthesis of 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl azide (1) 
 
 
 
Trimethylsilyl azide (238 µL, 1.79 mmol, 1.4 eq) and tin tetrachloride (45 µL, 0.384 mmol, 0.3 
eq) were added, at room temperature and under nitrogen, to a solution of 1,2,3,4,6-penta-O-
acetyl-D-glucopyranose 15 (500 mg, 1.28 mmol, 1 eq) in dry CH2Cl2 (2.56 mL, 0.5 M). The 
reaction mixture was stirred at room temperature and the reaction was monitored by TLC (60:40 
hexane/AcOEt). After 24 h CH2Cl2 was added and the solution was washed with saturated 
Na2CO3 and then with water. The organic layer was dried over Na2SO4, filtered and evaporated 
under reduced pressure. The product was purified by flash chromatography using 60:40 
hexane/AcOEt as the eluent. Quantitative yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.20 (dd, J2,3 = J3,4 = 9.5 Hz, 1H, H-3), 5.08 (dd, J3,4 = 
J4,5 = 9.5 Hz, 1H, H-4), 4.94 (dd, J1,2 = 8.9 Hz, J2,3 = 9.5 Hz, 1H, H-2), 4.63 (d, J1,2 = 8.9 Hz, 1H, 
H-1), 4.26 (dd, J5,6 = 4.7 Hz, J6,6’ = 12.5 Hz, 1H, H-6), 4.15 (dd, J5,6’ = 2.3 Hz, J6,6’ = 12.5 Hz, 
1H, H-6’), 3.78 (m, 1H, H-5), 2.08, 2.06, 2.01, 1.99 (4s, 12H, 4xOAc). 
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Synthesis of 2,3,4-tri-O-acetyl-β-D-fucosyl azide (14) 
 
 
 
Trimethylsilyl azide (1.4 eq) and tin tetrachloride (0.3 eq) were added, at room temperature and 
under nitrogen, to a solution of 1,2,3,4-tetra-O-acetyl-D-fucose 17 (1 eq) in dry CH2Cl2 (0.5 M). 
The reaction mixture was stirred at room temperature and the reaction was monitored by TLC 
(60:40 hexane/AcOEt). After 24 h CH2Cl2 was added and the solution was washed with saturated 
Na2CO3 and then with water. The organic layer was dried over Na2SO4, filtered and evaporated 
under reduced pressure. The product was purified by flash chromatography using 60:40 
hexane/AcOEt as the eluent. (α/β ratio 10:90).Yield = 85 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.30 (dd, J3,4 = 3.6 Hz, J4,5 = 0.8 Hz, 1H, H-4), 5.18 (t, 
J1,2 = 8.8 Hz, J2,3 = 10.4 Hz, 1H, H-2), 5.06 (dd, J2,3 = 10.4 Hz, J3,4 = 3.6 Hz, 1H, H-3), 4.60 (d, 
J1,2 = 8.8 Hz, 1H, H-1), 3.94 (dq, J4,5 = 0.8 Hz, J5,6 = 6.4 Hz, 1H, H-5), 2.22, 2.12, 2.02 (3s, 9H, 
3xOAc), 1.28 (d, J5,6 = 6.4 Hz, 3H, H-6). 
 
Synthesis of 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl azide (13) 
 
 
 
Procedure A 
 
Trimethylsilyl azide (472 µL, 3.58 mmol, 1.4 eq) and tin tetrachloride (90 µL, 0.768 mmol, 0.3 
eq) were added, at room temperature and under nitrogen, to a solution of 1,2,3,4,6-penta-O-
acetyl-D-galactopyranose 16 (1 g, 2.56 mmol, 1 eq) in dry CH2Cl2 (6.12 mL, 0.5 M). The 
reaction mixture was stirred at room temperature and the reaction was monitored by TLC (60:40 
hexane/AcOEt). After 24 h CH2Cl2 was added and the solution was washed with saturated 
Na2CO3 and then with water. The organic layer was dried over Na2SO4, filtered and evaporated 
under reduced pressure. The product was purified by flash chromatography using 60:40 
hexane/AcOEt as the eluent. Quantitative yield. 
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Procedure B 
 
A suspension of D-galactose (1.8 g, 10.0 mmol, 1 eq) in acetic anhydride (4.82 mL, 51.0 mmol, 
1.02 eq) was placed in an ice bath with continuous stirring. HBr/AcOH (30%, 2.7 mL, 10.0 
mmol, 1 eq) was added in one portion to the cold suspension of the reaction mixture. An 
exothermic reaction started immediately and the reaction mixture was allowed to stir at room 
temperature until a clear solution was obtained (approx. 15 min.). The reaction mixture was 
cooled to 0°C, additional HBr/AcOH (30%, 5.4 mL, 20.0 mmol, 2 eq) was added slowly, and 
stirring was continued for 2 h at room temperature. After completion of the reaction (monitored 
by TLC; hexane/AcOEt 50:50), solvents were removed under reduced pressure and coevaporated 
with toluene. Sodium azide (1.3g, 20 mmol), tetrabutylammonium hydrogen sulfate (TBAHS) 
(510 mg, 1.5 mmol) and aq. Na2CO3 (1 M, 70 mL) were added successively to a solution of the 
crude mass in CH2Cl2 (50mL) and the two phase reaction mixture was allowed to stir vigorously 
for another 1.5 h. The reaction mixture was diluted with CH2Cl2 (50mL). The organic layer was 
separated and washed with water, dried (Na2SO4), and concentrated under reduced pressure. The 
product was purified by flash chromatography using 65:35 hexane/AcOEt as the eluent. Yield.= 
85 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.42 (dd, J3,4 = 3.2 Hz, J4,5 = 1.2 Hz, 1H, H-4), 5.16 (q, 
J1,2 = 8.4 Hz, J2,3 = 10.4 Hz, 1H, H-2), 5.03 (dd, J2,3 = 10.4 Hz, J3,4 = 3.2 Hz, 1H, H-3), 4.59 (d, 
J1,2 = 8.4 Hz, 1H, H-1), 4.20-4.12 (m, 2H, H-6, H-6’), 4.01 (dt, J4,5 = 1.2 Hz, 1H, H-5), 2.16, 
2.10, 2.07, 1.98 (4s, 12H, 4xOAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.6, 170.3, 170.2, 
169.6, 88.5 (C-1), 73.1 (C-5), 70.9 (C-3), 68.3 (C-2), 67.1 (C-4), 61.4 (C-6), 20.9-20.7 (4xOAc). 
 
Synthesis of 3,4,6-tri-O-acetyl-2-N-acetyl-2-deoxy-α-D-glucopyranosyl chloride (22) 
 
O
AcHN
AcO
AcO
OAc
Cl
 
 
A suspension of N-acetylglucosamine hydrochloride 23 (510 mg, 2.3 mmol, 1 eq) in acetyl 
chloride (37.7 ml) was prepared at room temperature. The solution was cooled to 0 °C and dry 
MeOH (500 µL) was added. After 24 h the starting material was completely consumed. The 
solution was stirred at room temperature for 20 days (TLC: AcOEt). The solvent was evaporated 
under reduced pressure. The crude product was used without further purification. 
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1H-NMR (400 MHz, CDCl3, 25°C): δ = 6.20 (d, J1,2 = 3.6 Hz, 1H, H-1), 5.89 (d, J2-NH = 7.3 Hz, 
1H, NH), 5.34 (dd, J2,3 = J3,4 = 9.5 Hz, 1H, H-3), 5.23 (dd, J3,4 = J4,5 = 9.5 Hz, 1H, H-4), 4.55 (m, 
1H, H-2), 4.32-4.25 (m, 2H, H-5, H-6), 4.14 (m, 1H, H-6’), 2.11, 2.06 (2), 1.99 (4s, 12H, 
4xOAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 171.4, 170.5, 170.1, 169.1, 93.6, 70.9, 70.1, 
66.9, 61.2, 53.5, 23.1, 20.7, 20.5. 
 
Synthesis of 3,4,6-tri-O-acetyl -2-N-acetyl-2-deoxy-β-D-glucopyranosyl azide (21) 
 
 
 
Procedure A 
 
A solution of 3,4,6-tri-O-acetyl-2-N-acetyl-2-deoxy-α-D-glucopyranosyl chloride 22 (25.6 mg, 
0.07 mmol, 1 eq) containing sodium azide (13.4 mg, 0.21 mmol, 3 eq) and tetrabutylammonium 
hydrogensulfate (23.8 mg, 0.07 mmol, 1 eq) in CH2Cl2 (256 µL) was prepared at room 
temperature. Saturated NaHCO3 (256 µL) was added and the mixture was stirred vigorously for 
1 h; the reaction was monitored by TLC (AcOEt). The mixture was diluted with AcOEt and 
washed with water, saturated NaHCO3 and brine. The organic layer was dried over Na2SO4, 
filtered and the solvent was evaporated under reduced pressure. Yield.= 91 % 
 
Procedure B 
 
At room temperature and under nitrogen, a solution of 3,4,6-tri-O-acetyl-2-N-acetyl-2-deoxy-α-
D-glucopyranosyl chloride 22 (18.7 mg, 0.051 mmol, 1 eq) containing sodium azide (10.0 mg, 
0.153 mmol, 3 eq) in dry dimethylformamide (510 µL) was prepared. The mixture was heated to 
70 °C and stirred for 3 h. The reaction was monitored by TLC (AcOEt). The solvent was then 
evaporated under reduced pressure. The residue was taken up with AcOEt and washed with 
water. The organic layer was dried over Na2SO4, filtered and the solvent was evaporated under 
reduced pressure. Yield = 90 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.86 (d, J2-NH = 8.8 Hz, 1H, NH), 5.27 (dd, J2,3 = J3,4 = 
9.8 Hz, 1H, H-3), 5.11 (dd, J3,4 = J4,5 = 9.8 Hz, 1H, H-4), 4.79 (d, J1,2 = 9.2 Hz, 1H, H-1), 4.28 
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(dd, J5,6 = 4.7 Hz, J6,6’ = 12.4 Hz, 1H, H-6), 3.75 (dd, J5,6’ = 1.5 Hz, J6,6’ = 12.4 Hz, 1H, H-6’), 
3.94 (m, 1H, H-2), 4.32-3.82 (m, 1H, H-5), 2.11, 2.05, 2.04, 1.99 (4s, 12H, 4xOAc). 
13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.9, 170.7, 170.5, 169.3, 88.4, 73.9, 72.2, 68.1, 61.9, 
54.2, 23.2, 20.7, 20.6, 20.5. 
 
General procedure for the synthesis of 1,2,3,5-tetra-O-acetyl-β-L-arabinopyranose (26) and 
1,2,3,5-tetra-O-acetyl-β-D-ribopyranose (27) 
 
Acetic anhydride (10 eq) and a catalytic amount of N,N-dimethylaminopyridine were added, at 
room temperature, to a solution of substrate (1 eq) in pyridine dried on molecular sieves (0.1 M). 
The solution was stirred for 24 h and then was concentrated in vacuo. The residue was dissolved 
in AcOEt and washed with aqueous 5 % HCl, aqueous 5 % NaHCO3 and water. The organic 
layer was dried over Na2SO4 and concentrated to give the product in quantitative yield. The 
crude product was used without further purification. 
 
General procedure for the synthesis of 2,3,5-tri-O-acetyl-β-L-arabinopyranosyl azide (28) 
and 2,3,5-tri-O-acetyl-β-D-ribopyranosyl azide (29) 
 
Trimethylsilyl azide (1.4 eq) and tin tetrachloride (0.3 eq) were added, at room temperature and 
under nitrogen, to a solution of substrate 26 or 27 (1 eq) in dry CH2Cl2 (0.5 M). The reaction 
mixture was stirred at room temperature and the reaction was monitored by TLC (60:40 
hexane/AcOEt). After 24 h CH2Cl2 was added and the solution was washed with saturated 
Na2CO3 and then with water. The organic layer was dried over Na2SO4, filtered and evaporated 
under reduced pressure.  
 
2,3,4-tri-O-acetyl-β-L-arabinopyranosyl azide (28) 
 
 
 
The compound was purified by flash chromatography (hexane/acetone 80:20) yield = 75 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.29 (ddd, J3,4 = 3.6 Hz, J4,5 = 1.6 Hz, J4,5’ = 2.8 Hz, 1H, 
H-4), 5.15 (dd, J1,2= 8 Hz, J2,3 = 9.6 Hz, 1H, H-2), 5.05 (dd, J2,3 = 9.6 Hz, J3,4 = 3.6 Hz, 1H, H-3), 
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4.58 (d, J1,2= 8 Hz, 1H, H-1), 4.11 (dd, J4,5 = 2.8 Hz, J5,5’ = 13.2 Hz, 1H, H-5), 3.73 (dd, J4,5’ = 
1.6 Hz, J5,5’ = 13.2 Hz, 1H, H-5’), 2.16, 2.09, 2.02 (3s, 9H, 3xOAc). 13C-NMR (100 MHz, 
CDCl3, 25°C): δ = 170.4, 170.2, 169.6, 88.7 (C-1), 70.4 (C-3), 68.6 (C-2), 67.8 (C-4), 65.8 (C-5), 
21.1-20.8 (3xOAc). NOESY (400 MHz, CDCl3, 25°C): contact between H-1/H-3. ESI-MS: m/z 
324.1 (M+Na ). 
 
 
 
 
2,3,4-tri-O-acetyl-β-D-ribopyranosyl azide (29) 
 
 
 
The compound was purified by flash chromatography (hexane/acetone 80:20) yield = 65 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.48 (t, J2,3 = 3.2 Hz, 1H, H-3), 5.15-5.06 (m, 2H, H-1, 
H-4), 4.86 (dd, J1,2 = 6.4 Hz, J2,3 = 3.2 Hz, 1H, H-2), 4.07 (dd, J4,5’ = 4 Hz, J5,5’ = 12 Hz,1H, H-5), 
3.85 (dd, J4,5’ = 3.2 Hz, J5,5’ = 12 Hz, 1H, H-5’), 2.11, 2.08, 2.06 (3s, 9H, 3xOAc). ESI-MS: m/z 
324.1 (M+Na ). 
 
 
2,3,4-tri-O-acetyl-β-L-arabinopyranosyl azide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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Synthesis of 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl chloride (30) 
 
 
 
Aluminium trichloride (85.4 mg, 0.64 mmol, 0.5 eq) was added, at room temperature and under 
argon, to a solution of 1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose 15 (500 mg, 1.28 mmol, 1 
eq) in dry CH2Cl2 (2.56 mL, 0.5 M). Aluminium trichloride gradually disappeared and was 
replaced by a fine white precipitate. After 2 h, the mixture was filtered into a large volume (50 
mL) of dry hexane. The resulting white precipitate was filtered on celite and washed with dry 
CH2Cl2 (2.5 mL) and 60:40 hexane/AcOEt (50 mL). The solvent was evaporated under reduced 
pressure and the crude product was used without further purification. 
 
Synthesis of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl azide (2) 
 
 
 
2,3,4-tri-O-acetyl-β-L-ribopyranosyl azide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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At room temperature and under nitrogen, trimethylsilyl azide (108 µL, 0.820 mmol, 1.4 eq) and 
tetrabutylammonium fluoride (1 M in THF, 820 µL, 1.4 eq) were added to a solution of 2,3,4,6-
tetra-O-acetyl-β-D-glucopyranosyl chloride 30 (215 mg, 0.586 mmol, 1 eq) in dry THF (8.2 mL, 
0.1 M). The solution was heated to 65 °C and stirred for 30 h. The reaction was monitored by 
TLC (60:40 hexane/AcOEt). The solvent was evaporated under reduced pressure and the crude 
was purified by flash chromatography using 65:35 hexane/AcOEt as the eluent.  
Yield = 69 % (over 2 steps), α/β ratio 89:11 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.62 (d, J1,2 = 4.3 Hz, 1H, H-1), 5.40 (dd, J2,3 = 10 Hz, 
J3,4 = 9.8 Hz, 1H, H-3), 5.06 (dd, J3,4 = J4,5 = 9.8 Hz, 1H, H-4), 4.96 (dd, J1,2 = 4.3 Hz, J2,3 = 10 
Hz, 1H, H-2), 4.29 (dd, J5,6 = 4.7 Hz, J6,6’ = 12.4 Hz, 1H, H-6), 4.19-4.12 (m, 2H, H-5 and H-6’), 
2.11, 2.10, 2.05, 2.03 (4s, 12H, 4xOAc). 
13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.5, 169.9, 169.4, 86.2 (C-1), 70.1 (C-5), 69.6 (C-4), 
69.5 (C-2), 67.9 (C-3), 61.5 (C-6), 20.6, 20.6, 20.5, 20.5 (4xOAc). 
 
Synthesis of 2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl azide (31) 
 
 
 
See procedure for the synthesis of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl azide 2. The 
compound was purified by flash chromatography (hexane/AcOEt 60:40) Yield = 62 % (over 2 
steps), α/β ratio 75:25 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.65 (d, J1,2 = 3.6 Hz, 1H, H-1), 5.45 (dd, J3,4 = 3 Hz, 
J4,5 = 1.2 Hz, 1H, H-4), 5.24 (dd, J2,3 = 10.8 Hz, J3,4 = 3 Hz, 1H, H-3), 5.19 (dd, J1,2 = 3.6 Hz, J2,3 
= 10.8 Hz, 1H, H-2), 4.35 (dt, J4,5 = 1.2 Hz, 1H, H-5), 4.15-4.07 (m, 2H, H-6, H-6’), 2.14, 2.10, 
2.06, 1.99 (4s, 12H, 4xOAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.5, 170.3, 170.1, 
169.9, 86.9 (C-1), 68.7 (C-5), 67.8 (C-4), 67.5 (C-2), 67.4 (C-3), 61.6 (C-6), 21.2, 20.8, 20.7 
(4xOAc). 
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2,3,4-tri-O-acetyl-α-L-arabinopyranosyl azide (32) 
 
 
 
See procedure for the synthesis of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl azide 2. The 
compound was purified by flash chromatography (hexane/AcOEt 70:30). 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.59 (d, J1,2 = 3.2 Hz, 1H, H-1), 5.33 (q, J4,5 = 1.4 Hz, 
J4,5’ = 2.4 Hz, 1H, H-4), 5.27-5.20 (m, 2H, H-2, H-3), 4.08 (dd, J4,5 = 1.4 Hz, J5,5’ = 13 Hz, 1H, 
H-5), 3.80 (dd, J4,5’ = 2.4 Hz, J5,5’ = 13 Hz, 1H, H-5’), 2.14, 2.11, 2.02 (3xOAc). 13C-NMR (100 
MHz, CDCl3, 25°C): δ = 170.4, 170.3, 170, 87.4 (C-1), 68.7 (C-4), 68, 67.1, 62.7 (C-5), 21.1-
20.8 (3xOAc). 
 
 
 
 
 
 
2,3,4-tri-O-acetyl-α-L-arabino-pyranosyl azide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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2,3,4-tri-O-acetyl-α-D-fucosyl azide (18) 
 
 
 
Obtained as by-prodouct from  the synthesis of the β-fucosyl azide. Yield = 10% 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.59 (d, J1,2 = 4 Hz, 1H, H-1), 5.29 (dd, J3,4 = 3.2 Hz, 
J4,5 = 1.2 Hz, 1H, H-4), 5.24 (dd, J2,3 = 10.8 Hz, J3,4 = 3.2 Hz, 1H, H-3), 5.18 (dd, J1,2 = 4 Hz, J2,3 
= 10.8 Hz, 1H, H-2), 4.27 (q, J5,6 = 6.4 Hz, 1H, H-5), 2.15, 2.01, 1.98 (3s, 9H, 3xOAc), 1.17 (d, 
J5,6 = 6.4 Hz, 3H, H-6). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.6, 170.4, 170, 87.2 (C-1), 
70.8 (C-4), 67.8, 67.7, 67.1 (C-5), 20.9-20.8 (3xOAc), 16.1 (C-6). 
 
 
 
 
Synthesis of 1,2,3,5,6-penta-O-acetyl-β-D-galactofuranose (35). 
 
 
 
2,3,4-tri-O-acetyl-α-D-fucopyranosyl azide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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D-Galactose (10g, 5,5 mmol, 1 eq) was heated with pyridine (150 mL) for 1 h at 100°C. The 
temperature was lowered to 60°C, and acetic anhydride (33.12 mL, 35.2 mmol, 6.4 eq) was 
added dropwise. The mixture was kept for 1.5 h at 60°C, and, after 24 h at room temperature, it 
was quenched into ice-water (precipitation of penta-O-acetyl-β-D-galactopyranose). The solution 
was extracted with AcOEt (2x250 mL) and washed with aqueous 5 % HCl, aqueous 5 % 
NaHCO3 and water. The organic layer was dried over Na2SO4, filtered and evaporate under 
reduced pressure to give an orange oil. The oil was dissolved in MeOH, then water was added 
until the cloud point was reached. The solution was cooling at 4°C overnight, and the resulting 
white solid was filtered (penta-O-acetyl-β-D-galactopyranose); the solvent was evaporated under 
reduced pressure, the oil was dissolved in isopropanol, then water was added until the cloud 
point was reached, and the resulting white solid was filtered: yield = 36 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 6.18 (s, 1H, H-1), 5.36 (m, 1H, H-5), 5.18 (s, 1H, H-4), 
5.08 (d, J = 5.6 Hz, 1H), 4.38-4.31 (m, 2H, H-6), 4.24-4.19 (m, 1H, H-6’), 2.12-2.03 (m, 15H, 
5xOAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.7, 170.2, 169.9, 169.6, 169.2, 99.3 (C-1), 
82.3, 80.7 (C-4), 76.5, 69.4 (C-5), 62.7 (C-6), 21.1-20.8 (5xOAc). 
 
 
 
 
 
 
OAc
H OAc
AcO HO
AcO
AcO
H
H
 
1,2,3,5,6-penta-O-acetyl-β-D-galactofuranose 
1H-NMR (400 MHz, CDCl3, 25°C) 
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Synthesis of 2,3,5,6-tetra-O-acetyl-β-D-galactofuranosyl azide (36). 
 
 
 
Trimethylsilyl azide (154 µL, 1.16 mmol, 1.4 eq) and tin tetrachloride (29.1 µL, 0.25 mmol, 0.3 
eq) were added, at room temperature and under nitrogen, to a solution of 1,2,3,4,6-penta-O-
acetyl-D-galactofuranose 33 (324 mg, 0.83 mmol, 1 eq) in dry CH2Cl2 (3.3 mL, 0.5 M). The 
reaction mixture was stirred at room temperature and the reaction was monitored by TLC (60:40 
hexane/AcOEt). After 24 h CH2Cl2 was added and the solution was washed with saturated 
Na2CO3 and then with water. The organic layer was dried over Na2SO4, filtered and evaporated 
under reduced pressure. The product was purified by flash chromatography using 60:40 
hexane/AcOEt as the eluent. Yield = 90 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.42 (s, 1H, H-1), 5.40-5.35 (m, 1H, H-5), 5.05 (dd, J2,3 
= 5.2 Hz, J3,4 = 2.8 Hz, 1H, H-3), 4.95 (t, J3,4 = 2.8 Hz, 1H, H-4), 4.39-4.32 (m, 2H, H-2, H-6), 
4.19 (dd, J5,6’ = 6.8 Hz, J6,6’ = 11.6 Hz, 1H, H-6’), 2.16, 2.14, 2.12, 2.06 (4s, 12H, 4xOAc). 13C-
NMR (100 MHz, CDCl3, 25°C): δ = 170.6, 170.1, 169.9, 169.7, 94.3 (C-1), 82.2 (C-2), 81.1 (C-
4), 76.5 (C-3), 69.4 (C-5), 62.5 (C-6), 20.9-20.7 (4xOAc). ESI-MS: m/z 396.2 (M+Na ). 
 
 
 
 
 
N3
H OAc
AcO HO
AcO
AcO
H
H
 
2,3,5,6-tetra-O-acetyl-β-D-galactofuranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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2,3,5-tri-O-acetyl-α-L-arabinofuranosyl azide (40) 
 
 
 
See procedure for the synthesis of 2,3,5,6-tetra-O-acetyl-β-D-galactofuranosyl azide 36. The 
compound was purified by flash chromatography (hexane/acetone 80:20 or crystallization in 
hexane) Yield = 80 %  
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.45 (s, 1H, H-1), 5.02 (dd, J = 2.8 Hz, J = 1.2 Hz, 1H, 
H-3), 4.99 (s, 1H, H-2), 4.45-4.38 (m, 2H, H-4, H-5), 4.27-4.20 (m, 1H, H-5’), 2.13, 2.12, 2.10 
(3s, 9H, 3xOAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.7, 170.2, 169.7, 94.5 (C-1), 82.6 
(C-4), 78.3 (C-3), 81.1 (C-2), 77.1 (C-3), 63.2 (C-5), 21-20.9 (3xOAc). 
 
 
 
 
 
 
 
N3
AcO H
H OAcO
AcO
 
2,3,5-tri-O-acetyl-α-L-arabinofuranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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Synthesis of 2,3,5-tri-O-acetyl-β-D-ribofuranosyl azide (41) 
 
 
 
See procedure for the synthesis of 2,3,5,6-tetra-O-acetyl-β-D-galactofuranosyl azide 36. The 
compound was purified by flash chromatography (hexane/acetone 80:20) Yield = 94 %  
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.35 (d, J1,2 = 2.0 Hz, 1H, H-1), 5.32 (dd, J2,3 = 4.8 Hz, 
J3,4 = 6.8 Hz, 1H, H-3), 5.13 (dd, J1,2 = 2 Hz, J2,3 = 4.8 Hz, 1H, H-2), 4.41 (dd, J4,5 = 3.2 Hz, J5,5’ 
= 12 Hz, 1H, H-5), 4.35 (ddd, J3,4 = 6.8, Hz, J4,5 = 3.2 Hz, J4,5’ = 4.4 Hz, 1H, H-4), 4.14 (dd, J4,5’ 
= 4.4 Hz, J5,5’ = 12 Hz, 1H, H-5’),2.12, 2.11, 2.07 (3s, 9H, 3xOAc). 13C-NMR (100 MHz, CDCl3, 
25°C): δ = 170.7, 169.7, 169.5, 92.8 (C-1), 79.5 (C-4), 74.6 (C-2), 70.6 (C-3), 63.2 (C-5), 20.8, 
20.7, 20.6 (3xOAc). NOESY (400 MHz, CDCl3, 25°C): contact between H-1/H-4. 
 
 
 
 
General procedure for the deprotection of peracetylated glycosyl azides. 
 
A solution of NaOMe 0.1M in dry methanol (0.5 eq) was added, at room temperature and under 
nitrogen, to a solution of peracetylated glycosyl azides (1eq) in dry MeOH
 
(0.1 M). The mixture 
2,3,5-tri-O-acetyl-β-D-ribofuranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
 
N3
AcO OAc
H HO
AcO
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was stirred at room temperature. After 45 minutes TLC monitoring (eluents: hexane/AcOEt 
50:50 and CHCl3:MeOH 80:20) showed total consumption of the starting material, the acid resin 
Amberlyst IRA 120 H+ was added. The mixture was stirred for 30 minutes (pH = 3). The resin 
was filtered and washed with MeOH, the solvent was removed under reduced pressure. The 
product, isolated in quantitative yield, was used without further purification.  
 
β-D-glucopyranosyl azide (10) 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 4.48 (d, J1,2 = 8.8 Hz, 1H, H-1), 3.87 (dd, J5,6 = 2 Hz, 
J6,6’ = 12 Hz, 1H, H-6), 3.67 (dd, J5,6’ = 5.6 Hz, J6,6’ = 12 Hz, 1H, H-6’), 3.38-3.31 (m, 2H, H-3, 
H-5), 3.30-3.25 (m, 1H, H-4), 3.13 (t, J1,2 = 8.8 Hz, 1H, H-2). 13C-NMR (100 MHz, CD3OD, 
25°C): δ = 92.2 (C-1), 80.3 (C-5), 78.3 (C-3), 74.9 (C-2), 71.3 (C-4), 62.7 (C-6). 
 
β-D-fucosyl azide (50) 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 4.41 (d, J1,2 = 8 Hz, 1H, H-1), 3.73 (q, J5,6 = 6.4 Hz, 
1H, H-5), 3.64 (d, J4,5 = 1.6 Hz, 1H, H-4), 3.47-3.41 (m, 2H, H-2, H-3), 1.29 (d, J5,6 = 6.4 Hz, 
3H, H-6). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 92.5 (C-1), 75.3, 74.4 (C-5), 73 (C-4), 71.9, 
16.9 (C-6). 
 
β-D-galactopyranosyl azide (43) 
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1H-NMR (400 MHz, CD3OD, 25°C): δ = 4.42 (d, J1,2 = 8 Hz, 1H, H-1), 3.86 (dd, J4,5 = 2 Hz, 1H, 
H-4), 3.77 (dd, J5,6 = 6.4 Hz, J6,6’ = 11.6 Hz, 1H, H-6), 3.70 (dd, J5,6’ = 5.2 Hz, J6,6’ = 11.6 Hz, 
1H, H-6’), 3.61 (dt, J4,5 = 2 Hz, J5,6 = 6.4 Hz, J5,6’ = 5.2 Hz, 1H, H-5), 3.52-3.46 (m, 2H, H-2, H-
3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 92.8 (C-1), 79 (C-5), 75.1, 72.1, 70.4 (C-4), 62.6 
(C-6). 
 
2-N-acetyl-2-deoxy-β-D-glucopyranosyl azide (42) 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 4.48 (d, J1,2 = 9.2 Hz, 1H, H-1), 3.88 (dd, J5,6 = 1.6 Hz, 
J6,6’ = 12 Hz, 1H, H-6), 3.72-3.64 (m, 2H, H-2, H-6), 3.45 (t, J = 10 Hz, 1H, H-3), 3.37-3.32 (m, 
2H, H-4, H-5), 1.98 (s, 3H, OAc). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 173.9, 90.3 (C-1), 
80.5 (C-5), 75.9 (C-3), 71.8 (C-4), 62.8 (C-6), 56.9 (C-2), 23 (CH3). 
 
 
 
 
 
 
 
 
2-N-acetyl-2-deoxy-β-D-glucopyranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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β-L-arabinopyranosyl azide (48) 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 4.44 (t, J1,2 = 8 Hz, 1H, H-1), 3.95 (dd, J4,5 = 2.4 Hz, 
J5,5’ = 12.4 Hz, 1H, H-5), 3.88 (d, J4,5’ = 1.6 Hz, 1H, H-4), 3.67 (dd, J4,5’ = 1.6 Hz, J5,5’ = 12.4 Hz, 
1H, H-5’), 3.59-3.54 (m, 2H, H-2, H-3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 92.8 (C-1), 
74.5, 72.1, 70 (C-4), 69.7 (C-5). 
 
 
 
 
β-D-ribopyranosyl azide (45) 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.04 (d, J1,2 = 6 Hz, 1H, H-1), 3.99 (t, J = 2.4 Hz, 1H, 
H-4), 3.93-3.79 (m, 3H, H-3, H-5, H-5’), 3.48 (dd, J1,2 = 6 Hz, J = 2.8 Hz, 1H, H-2). 13C-NMR 
(100 MHz, CD3OD, 25°C): δ = 90.8 (C-1), 72.2 (C-2), 70 (C-4), 69.4 (C-3), 66.5 (C-5). 
 
 
 
β-L-arabinopyranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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α-D-glucopyranosyl azide (7) 
 
O
HO
HO
HO
OH
N3
 
 
1H-NMR (400 MHz, D2O, 25°C): δ = 5.46 (d, J1,2 = 4 Hz, 1H, H-1), 3.81 (dd, J6,6’ = 12 Hz, J5,6 = 
5.5 Hz, 1H, H-6), 3.72 (m, 1H, H-6’), 3.68 (t, J = 5.2 Hz, J3,4 = 12 Hz, J4,5 = 9.6 Hz, 1H, H-4), 
3.58 (dd, J = 4 Hz, J4,5 = 9.6 Hz, J5,6 = 5.5 Hz, 1H, H-5), 3.51 (t, J1,2 = 4 Hz, J2,3 = 18.4 Hz, 1H, 
H-2), 3.33 (t, J2,3 = 18.4 Hz, J3,4 = 5.2 Hz, 1H, H-3). 
13C-NMR (100 MHz, D2O, 25°C): δ = 89.2 (C-1), 73.8 (C-4), 72.7 (C-5), 70.7 (C-2), 69.2 (C-3), 
60.5 (C-6). 
 
α-D-galactopyranosyl azide (47) 
 
O
HO
HO
HO OH
N3
 
 
1H-NMR (400 MHz, D2O, 25°C): δ = 5.48 (d, J1,2 = 4.4 Hz, 1H, H-1), 3.99 (t, J = 6 Hz, 1H, H-5), 
3.90 (d, J
 
= 3.2 Hz, 1H, H-4), 3.84 (d, J1,2 = 4.4 Hz, J2,3 = 10.2 Hz, 1H, H-2), 3.71-3.64 (m, 3H, 
 
β-D-ribopyranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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H-3, H-6, H-6’). 13C-NMR (100 MHz, D2O, 25°C): δ = 89.4 (C-1), 73.1 (C-5), 69.2 (C-3), 69 
(C-4), 67.6 (C-2), 61.2 (C-6). 
 
α-L-arabinopyranosyl azide (51) 
 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.32 (d, J1,2 = 4 Hz, 1H, H-1), 4.02-3.93 (m, 3H, H-2, 
H-5), 3.81-3.77 (m, 2H, H-5’). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 91.5 (C-1), 70.9, 70.5, 
69.5, 66.4 (C-5). 
 
 
 
 
α-D-fucosyl azide (44) 
 
 
 
 
α-L-arabinopyranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.32 (d, J1,2 = 4.4 Hz, 1H, H-1), 4.03 (q, J5,6 = 6.8 Hz, 
1H, H-5), 3.86 (dd, J1,2 = 4.4 Hz, J2,3 = 10 Hz, 1H, H-2), 3.66 (d, J3,4 = 3.2 Hz, 1H, H-4), 3.62 
(dd, J2,3 = 10 Hz, J3,4 = 3.2 Hz, 1H, H-3), 1.24 (d, J5,6 = 6.8 Hz, 3H, H-6). 13C-NMR (100 MHz, 
CD3OD, 25°C): δ = 92.4 (C-1), 73.4 (C-4), 71.5 (C-3), 70.2 (C-5), 69.5 (C-2), 16.8 (C-6). 
 
 
 
 
β-D-galactofuranosyl azide (37) 
 
 
 
1H-NMR (400 MHz, D2O, 25°C): δ = 5.31 (d, J1,2 = 2.8 Hz, 1H, H-1), 4.06 (ABX system, part A 
dd, J2,3 = 4 Hz, J3,4 = 10 Hz 1H, H-3), 4.01 (ABX system, part B, dd, J3,4 = 10.4 Hz, J4,5 = 4.4 Hz, 
1H, H-4), 3.94 (ABX system, part X, dd, J1,2 = 2.8 Hz, J2,3 = 3.6 Hz, 1H, H-2), 3.80-3.73 (ddd, 
J4,5 = 4.4 Hz, J5,6’ = 7.2 Hz, J5,6 = 4.8 Hz, 1H, H-5), 3.64 (dd, J5,6 = 4.8 Hz, J6,6’ = 11.6 Hz, 1H, H-
6), 3.57 (dd, J5,6’ = 7.2 Hz, J6,6’ = 11.6 Hz, 1H, H-6’). 13C-NMR (100 MHz, D2O, 25°C): δ = 95.3 
(C-1), 84.2 (C-4), 80.6 (C-2), 76.4 (C-3), 70.7 (C-5), 62.6 (C-6). [α]D25 = -153 (c 1, MeOH). 
NOESY (400 MHz, D2O, 25°C): contact between H-1/H-3. 
 
 
 
α-D-fucopyranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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α-L-arabinofuranosyl azide (49) 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.25 (d, J1,2 = 2 Hz, 1H, H-1), 4.11 (ddd, J3,4 = 5.6 Hz, 
J4,5 = 3.6 Hz, J4,5’ = 5.2 Hz, 1H, H-4), 3.99 (dd, J2,3 = 3.6 Hz, J3,4 = 5.6 Hz, 1H, H-3), 3.93 (dd, 
J1,2 = 2 Hz, J2,3 = 3.6 Hz, 1H, H-2), 3.80 (dd, J4,5 = 3.6 Hz, J5,5’ = 12 Hz, 1H, H-5), 3.70 (dd, J4,5’ 
= 5.2 Hz, J5,5’ = 12 Hz, 1H, H-5’). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 97.9 (C-1), 87.8 (C-
4), 83.2 (C-2), 78.4 (C-3), 63 (C-5). 
 
 
β-D-galactofuranosyl azide 
1H-NMR (400 MHz, D2O, 25°C) 
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β-D-ribofuranosyl azide (53) 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.19 (d, J1,2 = 1.6 Hz, 1H, H-1), 4.04 (dd, J2,3 = 4.8 Hz, 
J3,4 = 6.8 Hz, 1H, H-3), 3.97 (ddd, J3,4 = 6.8 Hz, J4,5 = 3.2 Hz, J4,5’ = 6 Hz, 1H, H-4), 3.81 (dd, J1,2 
= 1.6 Hz, J2,3 = 4.8 Hz, 1H, H-2), 3.76 (dd, J4,5 = 3.2 Hz, J5,5’ = 12 Hz, 1H, H-5), 3.60 (dd, J4,5’ = 
6 Hz, J5,5’ = 12 Hz, 1H, H-5’). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 96.7 (C-1), 85.7 (C-4), 
76.6 (C-2), 72.2 (C-3), 63.8 (C-5). 
 
 
 
α-L-arabinofuranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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β-D-ribofuranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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In order to develop a stereoselective Staudinger ligation for the synthesis of glycosyl amides, it 
was decided to employ the procedure based on the Staudinger reduction-acylation process of the 
corresponding glycosyl azides. Our methods to achieve a stereoselective synthesis of glycosyl 
amides with traceless Staudinger ligation are described in Chapters 4-6. Before that, the 
procedures employed for the synthesis of phosphines are described in the following sections. 
 
3.1 Synthesised phosphines 
 
The traceless Staudinger ligation affords one approach to the synthesis of unnatural α-glycosyl 
amides, starting from the corresponding α-azides, because it allows for reduction of the starting 
material and immediate trapping of the Staudinger aza-ylide intermediate in an intramolecular 
fashion, thus resulting in the direct formation of an amide link. Fast, intramolecular acylation of 
the anomeric nitrogen can in many cases prevent epimerisation and give retention of 
configuration at the anomeric carbon. In 2006 1 and 2008 2 our laboratory has reported that the 
traceless Staudinger ligation of α-glycosyl azides 2, 7 and 8 with diphenylphosphanyl-phenyl 
esters 9 in polar aprotic solvents yields α-glycosyl amides with good yields and selectivity 
(Scheme 1). 
O
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7 R = H
8 R = Bn
1 R = Ac
10 R = H
11 R = Bn
 
 
Scheme 1. Traceless Staudinger ligation of glycosyl azides with functionalized phosphine 1, 2 
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The steric course of the reaction is controlled both by configuration of the starting azide and by 
the presence and nature of protecting groups on the pyranose ring. In fact, the O-acetyl azide 2 
allows full inversion of the anomeric center and yields the β-amide only. The phosphines 9 
employed are air stable and can be easily isolated and purified by flash chromatography. 
The process described, however, left various synthetic problems unresolved. The reactivity of α-
glycosyl azides was uniformely low, and the corresponding amides were obtained generally in 
modest yields. Moreover, the yields of the ligation appeared to depend critically also on the 
nature of the acyl group to be transferred and were specially disappointing for the transfer of 
amino acids to α-azides. Thus, in order to further explore the reactivity and stereoselectivity of 
ligation in the synthesis of α-glycosyl amides, different acyl phosphines were prepared, trying to 
vary the basicity of the P atom and the nature of the phenyl ester leaving group. 
 
3.2 Synthesis of diphenylphosphanyl-phenyl esters 
 
Phosphines 9 had been obtained in the course of a previous thesis3 starting from o-
diphenylphosphinophenol 57. This was prepared in three steps starting from phenol and using a 
procedure introduced by Rauchfuss with small modifications.4 Firstly, the hydroxyl group was 
protected as the methoxymethyl ether:5 the presence of the MOM-ether both protects and 
activates the phenol ring. Secondly, the diphenylphosphino group was attached by ortho 
lithiation of the ether 55 (BuLi, hexane, TMEDA) followed by reaction with 
chlorodiphenylphosphine (Ph2PCl). Finally, the hydroxyl group was deprotected with HCl in 
MeOH to afford 57 (Scheme 2). 
 
 
 
Scheme 2. Synthesis of o-diphenylphosphinophenyl ester 57 
 
Interestingly Luo et al. found that treatment of other methoxymethyl-protected phenols bearing 
phosphine groups with HCl led to phosphonium salts because of the basicity of the phosphine 
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moiety.6 As the authors noted, in the previously reported preparation of 57, a base-neutralisation 
step was omitted but the crude product was sublimed, which is consistent with known loss of 
HCl from phosphonium salts at elevated temperatures. In fact, 57 in our hands exhibited a single 
31P resonance at δ = -26.6 ppm, whereas omission of the base-neutralisation step led to the 
hydrochloride salt 58 with a 31P resonance at + 21.6 ppm (Figure 1).7  
 
 
 
Figure 1. 31P resonance of hydrochloride salt of o-diphenylphosphinophenol 58 (up) and o-
diphenylphosphinophenol 57 (down) 
 
o-Diphenylphosphinophenol 57 was then acylated to give the corresponding functionalised 
phosphines which were used for the Staudinger ligation reactions. 
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3.3 Synthesis of the diphenyl- and dialkyl-phosphanylphenols 
 
Following a similar approach, in the course of this thesis a group of other functionalized 
diphenyl- and dialkyl-phosphanylphenols was prepared. This include the diphenylphosphanyl-4- 
methoxyphenol 59 (Figure 2),8 diphenylphosphanyl-4-fluorophenol 608 and several novel 
phoshines (61, 62, 63 and 64 Figure 2) with various substituents at phosphorus and characterized 
by an electronpoor phenol ring.  
 
 
 
Figure 2. Set of diphenylphosphanyl-phenols (59 to 64) synthesized in this work 
 
The diphenylphosphanyl-4-methoxyphenol 59 (Scheme 3) is a known compound:8 it was 
prepared following exactly the same procedure described for 57 (Scheme 3) 3,4 and the analytical 
data were consistent with the reported structure. 
 
 
Scheme 3. Synthesis of the diphenylphosphanyl-4-methoxyphenol 59 
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For the synthesis of 60-62 the required fluorinated-methoxymethyl phenyl ethers 68-70 (Scheme 
4) were synthesised as usual by the reaction of phenols 71-73 with sodium hydride followed by 
treatment with chloromethyl methyl ether (MOM-Cl) (Scheme 4).4 Metalation and reaction with 
the appropriate chlorophosphine (Scheme 4) was performed according to Fink8, using diethyl 
ether rather than hexane, in the absence of TMEDA and at low temperature -50°C, probably to 
avoid ortho metalation respect to the flourus atom.9 Finally, HCl deprotection afforded the 
required phosphines 60, 61 and 62. 
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F F F
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F3C CF3 F3C CF3 CF3 F3C CF3
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NaH, MOM-Cl
0°C to r.t., DMF Ph2PCl, -50°C to r.t.
n-BuLi, Et2O dry MeOH
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MeOH
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Scheme 4. Synthesis of fluorinated-o-diphenylphosphinophenol  
 
Similarly, Fink 8 metalation of fluorinated-methoxymethyl phenyl ether 68 followed by reaction 
with commercially available chlorodicyclohexylphosphine or chlorodicyclopentylphosphine, 
gave the methoxymethyl o-dicyclohexylphosphinophenyl ether 77 and methoxymethyl o-
dicyclopentylphosphinophenyl ether 78 (Scheme 5), which were deprotected with HCl, as usual, 
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to yield 79 and 80. Both these phosphines are air stable and can be easily isolated and purified by 
flash chromatography. 
 
 
 
Scheme 5. Synthesis of the dialkyl-phosphanylphenols 79 and 80 
 
3.4 Acylation of the phosphanylphenols 
 
The phosphanylphenols described above were acylated with standard methods, which vary 
depending on the nature of the acyl chain employed. In general, the corresponding acyl chlorides 
were used, when commercially available. Benzoates were obtained from benzoic anhydride. 
Condensing agents (DCC or EDC) were employed for amino acids. 
All the compounds prepared are collected in Table 1, where the method of acylation is indicated. 
All other details are reported in the experimental section of this chapter. 
 
Table 1. O-acylphosphanylphenols prepared 
 
Compound 
Starting 
phosphanylphenol 
R-C=O 
Acylation 
method 
Y 
(%) 
PPh2
O CH3
O
         
81a 
57 CH3CO 
Ac2O, 
Pyridine, 
DMAP 
Quant 
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PPh2
O
O
 
81b 
57 CH3(CH2)3CO RCOCl/TEA 96 % 
PPh2
O
O
 
81c 
57 (CH3)2CHCH2CO RCOCl/TEA 97 % 
PPh2
O
O
   
81d 
57 (CH3)2CHCO RCOCl/TEA 87 % 
PPh2
O
O
 
81e 
57 (CH3)2C=CHCO RCOCl/TEA 84 % 
PPh2
O
O
13
 
81f 
57 CH3(CH2)14CO RCOCl/TEA 85 % 
PPh2
O
O
6
 
81g 
57 CH3(CH2)6CO 
RCOOH/DCC 
DMAP 
90 % 
PPh2
O
O
 
81h 
57 citronellic acid   
RCOOH/DCC 
DMAP 
75 % 
PPh2
O Ph
O
   
81i 
57 PhCO 
(PhCO)2O, 
Pyridine, 
DMAP 
Quant 
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PPh2
O
O
COOMe
NHCbz
 
81j 
57 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
85 % 
PPh2
O
O
NHCbz
COOMe
 
81k 
57 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
75 % 
PPh2
O
O
NHCbz
 
81l 
57 
 
RCOOH/DCC 
DMAP 
82 % 
PPh2
O CH3
O
MeO
 
82a 
59 CH3CO 
Ac2O, 
Pyridine, 
DMAP 
Quant 
PPh2
O
O
MeO
 
82b 
59 CH3(CH2)3CO RCOCl/TEA 87 % 
PPh2
O
O
MeO
 
82c 
59 (CH3)3CCO RCOCl/TEA 83 % 
PPh2
O
O
MeO
 
82d 
59 (CH3)2CHCO RCOCl/TEA 82 % 
PPh2
O
O
MeO
 
82e 
59 (CH3)2C=CHCO RCOCl/TEA 84 % 
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PPh2
O
O
COOMe
NHCbz
MeO
82j 
59 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
75 % 
PPh2
O CH3
O
F
 
83a 
60 CH3CO 
Ac2O, 
Pyridine, 
DMAP 
Quant 
PPh2
O
O
F
 
83b 
60 CH3(CH2)3CO RCOCl/TEA 95 % 
PPh2
O
O
F
 
83e 
60 (CH3)2C=CHCO RCOCl/TEA 91 % 
PPh2
O
O
COOMe
NHCbz
F
 
83j 
60 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
85 % 
PPh2
O
O
NHCbz
COOMe
F
83k 
60 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
85 % 
PPh2
O
O
NHCbz
F
 
83l 
60 
 
RCOOH/DCC 
DMAP 
92 % 
PPh2
O
O
NHCbz
F
 
83m 
60 
 
RCOOH/DCC 
DMAP 
90 % 
Chapter 3 
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PPh2
O
O
F
Boc
N
 
83l 
60 
 
RCOOH/DCC 
DMAP 
94 % 
PPh2
O
O
COOMe
NHCbz
F3C
84j 
61 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
90 % 
PPh2
O
O
CF3
F3C COOMe
NHCbz
85k 
62 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
95 % 
P(cyclohexil)2
O
O
COOMe
NHCbz
F
 
86j 
79 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
80 % 
P(cyclopentyl)2
O
O
COOMe
NHCbz
F
 
87j 
80 
 
RCOOH/EDC, 
DIPEA, 
DMAP 
80 % 
 
 
3.5 Synthesis of diphenylphosphinothiol ester 
 
The Staudinger ligation has also been proposed for the ligation of peptides en route to the total 
chemical synthesis of proteins.10 (Diphenylphosphino)methanethiol is the most efficacious of 
known reagents, in this case providing high isolated yields for equimolar couplings in which a 
glycine residue is at the nascent junction. 
This reagent has been used in the orthogonal assembly of a protein,11 site-specific 
immobilization 
of peptides and proteins to a surface,12, 13 and synthesis of glycopeptides.14 We prepared it to test 
it in the ligation of α-glycosyl azides. The diphenylphosphinothiol ester 91 was synthesised by 
treating the chloromethylphosphonic dichloride 88 with 4-methoxyphenylmagnesium bromide 
Chapter 3 
 71 
and potassium thioacetate to give phosphine oxide 88. Thus the desired compound 91 was 
prepared for reduction with trichlorosilane from corresponding oxide 89 (Scheme 6).10 
 
 
 
Scheme 6. Synthesis of phosphinothioester 91 
 
Also in this case, the diphenylphosphinothiol ester 91 was functionalized with valeroyl chloride 
to give phosphine 92 (Scheme 7). 
 
 
 
Scheme 7. Synthesis of phosphine 92 
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3.6 Experimental Section 
 
Solvents were dried by standard procedures: dichloromethane, methanol, N,N-
diisopropylethylamine and triethylamine were dried over calcium hydride; N,N-
dimethylformamide, N,N,N’,N’-tetramethylethylenediamine, diethyl ether, chloroform and 
pyridine were dried over activated molecular sieves. Reactions requiring anhydrous conditions 
were performed under nitrogen. 1H, 13C and 31P-NMR spectra were recorded at 400 MHz on a 
Bruker AVANCE-400 instrument. Chemical shifts (δ) for 1H and 13C spectra are expressed in 
ppm relative to internal Me4Si as standard. Chemical shifts (δ) for 31P are expressed in ppm 
relative to internal H3PO4 as standard. Signals were abbreviated as s, singlet; bs, broad singlet; d, 
doublet; t, triplet; q, quartet; m, multiplet. Mass spectra were obtained with a Bruker ion-trap 
Esquire 3000 apparatus (ESI ionization). Thin layer chromatography (TLC) was carried out with 
pre-coated Merck F254 silica gel plates. Flash chromatography (FC) was carried out with 
Macherey-Nagel silica gel 60 (230-400 mesh).  
 
Synthesis of methoxymethyl phenyl ether (55)  
 
O O
 
 
At 0 °C and with stirring, phenol 54 (5 g, 53.1 mmol, 1 eq) was added to a slurry of NaH (3.19 g, 
79.7 mmol, 1.5 eq 60 % in oil) in dimethylformamide (26.5 mL, 2 M). After 30 minutes, 
chloromethyl methyl ether (6.05 mL, 79.7 mmol, 1.5 eq) was added, then the temperature was 
allowed to warm up to room temperature. The mixture was stirred and the reaction was 
monitored by TLC (8:2 hexane/AcOEt). After 30 minutes, water (106 mL) was added. The 
product was exctracted with hexane (3 x 52 mL). The organic layer was dried over Na2SO4 and 
concentrated. Yield = 74 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.38-7.31 (m, 11H, Ph), 7.13 (m, 1H), 6.93 (m, 1H), 
6.72 (m, 1H), 5.19 (s, 2H, CH2O), 3.49 (s, 3H, OCH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 
158.6, 136.9, 134.4, 134.0, 133.7, 130.4, 128.9, 128.7, 128.5, 122.2, 113.6, 113.6, 94.3, 56.1. 
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Synthesis of methoxymethyl-4-methoxyphenyl ether (66)  
 
O O
MeO
 
 
At 0 °C and with stirring, phenol 65 (2.98 g, 24 mmol, 1 eq) was added to a slurry of NaH (90.9 
mg, 36 mmol, 1.5 eq) in dimethylformamide (12 mL, 2 M). After 30 minutes, chloromethyl 
methyl ether (2.72 mL, 36 mmol, 1.5 eq) was added, then the temperature was allowed to warm 
up to room temperature. The mixture was stirred and the reaction was monitored by TLC (80:20 
hexane/AcOEt). After 30 minutes, water (60 mL) was added. The product was exctracted with 
hexane (3 x 25 mL). The organic layer was dried over Na2SO4 and concentrated. yield = 94 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.01 (dd, J = 2.4 Hz, J = 7.2 Hz, 2H, ArH), 6.85 (dd, J = 
2 Hz, J = 6.8 Hz, 2H, ArH), 5.13 (s, 2H, CH2O), 3.78 (s, 3H, OCH3), 3.49 (s, 3H, CH3). 
 
General procedure for the synthesis of the methoxymethyl-fluorinated phenyl ether  
 
At 0 °C and with stirring, fluorinated phenol 71, 72 and 73 (1 eq) was added to a slurry of NaH 
(1.5 eq) in dimethylformamide (2 M). After 30 minutes, chloromethyl methyl ether (1.5 eq) was 
added, then the temperature was allowed to warm up to room temperature. The mixture was 
stirred and the reaction was monitored by TLC (80:20 hexane/AcOEt). After 30 minutes, water 
was added. The product was exctracted with hexane (3 x 50 mL). The organic layer was dried 
over Na2SO4 and concentrated. 
 
4-fluorophenyl methoxymethyl ether (68) 
 
O O
F
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.04-6.98 (m, 4H, Ph), 5.16 (s, 2H, CH2O), 3.51 (s, 3H, 
OCH3). Yield = 94 %. 
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4-trifuoromethylphenyl methoxymethyl ether (69) 
 
O O
F3C
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.54 (d, J = 8 Hz, 2H, ArH), 7.10 (d, J = 8 Hz, 2H, 
ArH), 5.22 (s, 2H, CH2O), 3.48 (s, 3H, OCH3). Yield = 96 %. 
 
3,5-ditrifuoromethylphenyl methoxymethyl ether (70) 
 
O OF3C
CF3
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.52 (s, 1H, ArH), 7.49 (s, 2H, ArH), 5.26 (s, 2H, 
CH2O), 3.50 (s, 3H, OCH3). Yield = 93 %. 
 
Synthesis of methoxymethyl o-diphenylphosphinophenyl ether (56) 
 
PPh2
O O
 
 
A solution containing 1.6 M n-BuLi (10 mL, 16 mmol, 1.1 eq) and N,N,N’,N’-
tetramethylendiamine (2.24 mL, 14.9 mmol, 1.03 eq) in dry hexane was added, under nitrogen, 
to an ice-cooled solution of methoxymethyl phenyl ether 55 (2 g, 14.5 mmol, 1 eq) in dry hexane 
(final concentration: 0.5 M). The temperature was allowed to warm up to room temperature. The 
solution became yellow and a pale precipitate formed after 1.5 h. The solution was cooled in ice 
and chlorodiphenylphosphine (2.74 mL, 14.5 mmol eq) was added slowly. The resultant solution 
was stirred for 16 h at room temperature and the solvent evaporated in vacuo. The residue was 
diluted with Et2O and washed with 1 M aqueous Na2HPO4. The organic layer was dried over 
Na2SO4 and concentrated to give a white solid. The solid was dissolved in MeOH. After cooling 
for 30 minutes, the crystals were collected and recrystallized from CH2Cl2-MeOH; yield = 61 %.  
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1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.38-7.31 (m, 11H, Ph), 7.13 (m, 1H), 6.93 (m, 1H), 
6.72 (m, 1H), 5.06 (s, 2H, CH2O), 3.16 (s, 3H, OCH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 
158.6, 136.9, 134.4, 134.0, 133.7, 130.4, 128.9, 128.7, 128.5, 122.2, 113.6, 113.6, 94.3, 56.1. 31P-
NMR (161 MHz, CDCl3, 25°C): δ = - 14.8.ppm  
 
Synthesis of methoxymethyl 2-(diphenylphosphino)-4-methoxyphenyl ether (67) 
 
PPh2
O O
MeO
 
 
A solution containing 1.6 M n-BuLi (8.1 mL, 13 mmol, 1.05 eq) and N,N,N’,N’-
tetramethylendiamine (1.74 mL, 12.2 mmol, 1.01 eq) in dry hexane was added, under nitrogen, 
to an ice-cooled solution of methoxymethyl phenyl ether 66 (2.02 g, 12 mmol, 1 eq) in dry 
hexane (final concentration: 0.5 M). The temperature was allowed to warm up to room 
temperature. The solution became yellow and a pale precipitate formed after 1.5 h. The solution 
was cooled in ice and chlorodiphenylphosphine (2.19 mL, 12 mmol, 1 eq) was added slowly. 
The resultant solution was stirred for 16 h at room temperature and the solvent evaporated in 
vacuo. The residue was diluted with DCM and washed with 1 M aqueous NaH2PO4. The organic 
layer was dried over Na2SO4 and concentrated to give a orange oil. The oil was dissolved in 
MeOH. After cooling for over-night, the white crystals were collected and dried in vacuo; yield 
= 61 %.  
1H-NMR (400 MHz, C6D6, 25°C): δ = 7.50-7.40 (m, 4H, Ph), 7.10 (dd, J = 8.9 Hz, J = 3.1 Hz, 
1H, H-6), 7.07-7.01 (m, 6H, Ph), 6.71 (dd, J = 8.9, J = 3.1 Hz, 1H, H-5), 6.60 (dd, J = 4.5 Hz, J 
= 3.1 Hz, 1H, H-3), 4.78 (s, 2H, CH2O), 3.18 (s, 3H, OCH3),3.04 (s, 3H, OCH3). 13C-NMR (100 
MHz, C6D6, 25°C): δ = 156.0, 154.4, 138.3, 135.1, 129.6, 129.5, 129.4, 128.5, 120.3, 116.2, 
115.7, 95.7, 56.3, 55.6. 31P-NMR (161 MHz, C6D6, 25°C): δ = - 14.1 ppm  
 
General procedure for the synthesis of the 2-(diphenylphosphanyl)-fuorinated-phenyl 
methoxymethyl ether 
 
A solution of n-BuLi in hexane (1.6 M, 1.1 eq) was added dropwise with stirring to a solution of 
methoxymethyl-fluorinated phenol 68, 69 and 70 (1 eq) in diethyl ether at -50°C and then 
allowed to warm to room temperature. After 3 h the solution was cooled again to -50°C, a 
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solution of chlorodiphenylphosphane (1.05 eq) in diethyl ether was added dropwise, and the 
suspension was stirred overnight at room temperature. The precipitate was removed, the solvent 
was replaced by dichloromethane, and methanol was added. At 0°C white crystals separated and 
dried in vacuo. 
 
2-(Diphenylphosphanyl)-4-fuorophenyl methoxymethyl ether (74) 
 
O O
F
PPh2
 
 
1H-NMR (400 MHz, C6D6, 25°C): δ = 7.40-7.32 (m, 4H, Ph), 7.05-7.00 (m,6H, Ph), 6.91-6.84 
(m, 1H, H-6), 6.78-6.70 (m, 2H, H-2, H-3), 4.65 (s, 2H, OCH2) 2.94 (s, 3H, OCH3). 13C-NMR 
(100 MHz, C6D6, 25°C): δ = 158.5, 155.4, 136.8, 134.4, 130.3, 129.1, 128.8, 120.4, 116.5, 115.3, 
94.7, 55.7. 31P-NMR (161 MHz, C6D6, 25°C): δ = -14.6 ppm. Yield = 47 % 
 
2-(Diphenylphosphanyl)-4-trifuoromethylphenyl methoxymethyl ether (75) 
 
O O
F3C
PPh2
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.54 (m, 1H), 7.36-7.7.27 (m, 10H, Ph), 7.16 (dd, J = 4 
Hz, J = 8.8 Hz, 1H, Ar-H), 6.93 (t, J = 3.2 Hz, 1H), 5.11 (s, 1H, CH2O), 3.15 (s, 3H, OCH3). 31P-
NMR (161 MHz, CDCl3, 25°C): δ = -14.4 ppm [ oxide 31P = + 26.8 ppm]. Yield = 34 %. 
 
2-(Diphenylphosphanyl)-3,5-ditrifuoromethylphenyl methoxymethyl ether (76) 
 
O O
PPh2
F3C
CF3
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1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.52-7.7.28 (m, 12H, Ph), 4.71(s, 1H, CH2O), 2.96 (s, 
3H, OCH3). Yield = 46 % 
 
Synthesis of the 2-(dicyclohexylphosphanyl)-4-fluorophenyl methoxymethyl ether (77) 
 
O O
F
P(cyclohexyl)2
 
 
A solution of n-BuLi in hexane 1.6 M, (8.27 mL, 13.2 mmol, 1.05 eq) was added dropwise with 
stirring to a solution of 4-fluorophenyl methoxymethyl ether 68 (1.97 g, 12.6 mmol, 1 eq) in 
diethyl ether at -50°C and then allowed to warm to room temperature. After 3 h the solution was 
cooled again to -50°C, a solution of chlorodicyclohexylphosphane (3.02 g, 12.6 mmol, 1 eq) in 
diethyl ether was added dropwise, and the suspension was stirred overnight at room temperature. 
The precipitate was removed, then the solvent was evaporated giving a yellow oil. The crude 
product was purified by flash chromatography using 90:10 hexane/AcOEt as eluent to afford 77 
in 61 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.13-7.07 (m, 2H, ArH), 7.02-6.92 (m, 1H, ArH), 5.18 
(s, 2H, CH2O), 3.52 (s, 3H, CH3), 2.01-1.53 (m, 14H, Cyhex), 1.41-1.13 (m, 8H, Cyhex). 31P-
NMR (161 MHz, CDCl3, 25°C): δ = - 8.6 ppm [ oxide 31P = + 48.9 ppm]. 
 
Synthesis of the 2-(dicyclopentylphosphanyl)-4-fluorophenyl methoxymethyl ether (78) 
 
O O
F
P(cyclopentyl)2
 
 
A solution of n-BuLi in hexane (2.13 mL, 3.41 mmol, 1.1 eq) was added dropwise with stirring 
to a solution of 4-fluorophenyl methoxymethyl ether 68 (506.4 mg, 3.24 mmol, 1 eq) in diethyl 
ether at -50°C and then allowed to warm to room temperature. After 3 h the solution was cooled 
again to -50°C, a solution of chlorodicyclopentylphosphane (639 µL, 3.24 mmol, 1.05 eq) in 
diethyl ether was added dropwise, and the suspension was stirred overnight at room temperature. 
The precipitate was removed and the crude without further purification was used in the 
deprotection step.  
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1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.20-7.02 (m, 2H), 7.01-6.91 (m, 1H), 5.22 (s, 2H, 
CH2O), 3.48 (s, 3H, CH3), 2.26-2.19 (m, 2H), 2.14-2.03 (m, 2H), 2.01-1.32 (m, 14H, Cypent.). 
 
Synthesis of o-diphenylphosphinophenol (57) 
 
PPh2
OH
 
 
5 mL of dry methanol were saturated with HCl(g). Methoxymethyl o-diphenylphosphinophenyl 
ether 56 (1 g, 3.1 mmol, 1 eq) was added at room temperature and under argon. The resulting 
solution was stirred for 1 h then the solvent was evaporated giving a yellow oil. The residue was 
dissolved in dry MeOH (3 mL), then water was added until the cloud point was reached. The 
solution was stirred under argon while cooling, and the resulting white solid was filtered; yield = 
77 %.  
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.43-7.26 (m, 11H, Ph), 7.05-6.86 (m, 3H), 6.42 (bs, 1H, 
OH). 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 26.6 ppm [ oxide 31P = + 40.6 ppm]. 
 
Synthesis of 2-(diphenylphosphino)-4-methoxyphenol (59) 
 
PPh2
OH
MeO
 
 
5 mL of dry methanol were saturated with HCl(g). Methoxymethyl o-diphenylphosphinophenyl 
ether 67 (2.48 g, 7 mmol, 1 eq) was added at room temperature and under nitrogen. The resulting 
solution was stirred for 1 h then the solvent was evaporated giving a orange oil. The residue was 
diluted with AcOEt (100 mL) and washed with NaHCO3 saturated. The organic layer was dried 
over Na2SO4 and concentrated to give a yellow solid. The crude product was purified by flash 
chromatography using 80:20 hexane/AcOEt as the eluent to afford 59 in yield = 57 %.  
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.72-7.40 (m, 10H, Ph), 7.03-6.86 (m, 1H, H-6), 6.88 
(bd, 1H, H-5), 6.50 (bd, 1H, H-3), 5.9 (bs, 1H, OH), 3.61 (s, 3H, OCH3). 13C-NMR (100 MHz, 
C6D6, 25°C): δ = 153.7, 153.5, 133.5, 132.0, 130.0, 128.9, 128.3, 118.8, 118.2, 116.9, 55.7. 31P-
NMR (161 MHz, CDCl3, 25°C): δ = - 21 ppm  
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General procedure for the synthesis of the 2-(diphenylphosphanyl)-fuorinated-phenol  
 
Dry methanol were saturated with HCl(g). Methoxymethyl o-diphenylphosphino-fluorinated-
phenyl ether (1 eq) was added at room temperature and under nitrogen. The resulting solution 
was stirred for 1 h then the solvent was evaporated giving a brown oil. The reaction mixture was 
diluted with AcOEt and extracted with sat. NaHCO3 and water: the organic layer was dried over 
Na2SO4 and concentrated. The crude product was purified by flash chromatography, as indicated 
in each individual case. 
 
2-(Diphenylphosphanyl)-4-fuorophenol (60) 
 
OH
F
PPh2
 
 
The compound was purified by flash chromatography (hexane/AcOEt 80:20) yield = 90 %. 
1H-NMR (400 MHz, C6D6, 25°C): δ = 7.30-7.21 (m, 4H,Ph), 7.03-6.93 (m, 6H, Ph), 6.84 (m, 
1H, H-3), 6.66 (m, 1H, H-3), 6.51 (m, 1H, H-6) 6.10 (bs, 1H, OH). 13C-NMR (100 MHz, C6D6, 
25°C): δ = 157.6, 155.7, 135.4, 133.9, 129.3, 129.0, 124.3, 120.1, 118.1, 116.9. 31P-NMR (161 
MHz, C6D6, 25°C): δ = - 24.8 ppm.  
 
2-(Diphenylphosphanyl)-4-trifuoromethylphenol (61) 
 
OH
F3C
PPh2
 
 
The compound was purified by flash chromatography (hexane/AcOEt 80:20) yield = 85 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42 (d, J = 8.8 Hz, 1H), 7.27-7.7.15 (m, 10H, Ph 7.12 
(s, 1H), 6.86 (dd, J = 4.8 Hz, J = 8.4 Hz, 1H), 6.42 (bs, 1H, OH). 31P-NMR (161 MHz, CDCl3, 
25°C): δ = - 26.8 ppm [ oxide 31P = + 41.3 ppm]. 
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2-(Diphenylphosphanyl)-3,5-ditrifuoromethylphenol (62) 
 
OH
PPh2
F3C
CF3
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 70 %. 
1H-NMR (400 MHz, C6D6, 25°C): δ = 7.71 (s, 1H), 7.52-7.24 (m, 11H, Ph). ESI-MS: m/z 437.28 
(M+Na ). 
 
Synthesis of the 2-(dicyclohexylphosphanyl)-4-fluorophenol (79) 
 
OH
F
P(cyclohexyl)2
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 67 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.01-6.97 (m, 2H, Ar-H), 6.91-6.84 (m ,1H, Ar-H), 
2.01-1.87 (m, 4H, Cyhex), 1.84-1.56 (m, 8H, Cyhex), 1.41-1.02 (m, 10H, Cyhex). 
 
Synthesis of the 2-(dicyclopentylphosphanyl)-4-fluorophenol (80) 
 
OH
F
P(cyclopentyl)2
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 41 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.02-6.99 (m, 1H), 6.96-6.92 (m, 1H), 6.87-6.82 (m, 
1H), 6.76-6.68 (bs, 1H, OH), 2.19-2.04 (m, 2H), 2.02-1.94 (m, 2H), 1.75-1.32 (m, 14H, Cypent). 
 
General procedure for the synthesis of the o-diphenylphosphanyl-phenyl acetate 
 
Acetic anhydride (1.2 eq) and N,N-dimethylaminopyridine (0.1 eq) were added, at room 
temperature and under nitrogen, to a solution of o-diphenylphosphinophenol (1 eq) in dry 
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pyridine (0.15 M). The solution was stirred for 2 h and then concentrated in vacuo. The residue 
was dissolved in CH2Cl2 and washed with 10 % aqueous HCl, 5 % aqueous NaHCO3 and water. 
The organic layer was dried over Na2SO4 and concentrated to give the product. 
 
o-Diphenylphosphanyl-phenyl acetate (81a) 
 
PPh2
O CH3
O
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.40-7.32 (m, 11H, Ph), 7.16 (m, 2H), 6.87 (m, 1H), 2.0 
(s, 3H, CH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 169.1, 153.1 (d, J = 17 Hz), 149.6, 136.6, 
135.8, 135.6, 134.4, 134.0, 133.9, 131.8, 130.1, 129.3, 128.9, 128.7, 128.7, 126.3, 124.1, 122.8, 
20.7. 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 14.7 ppm. Quantitative yield.   
 
2-(Diphenylphosphanyl)-4-methoxyphenyl acetate (82a) 
 
PPh2
O CH3
O
MeO
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.29 (m, 10H, Ph), 7.11 (dd, J = 4.4 Hz, J = 8.2 
Hz, 1H, H-6), 6.91 (dd, J = 3.2 Hz, J = 8.8 Hz, 1H, H-5), 6.42-6.38 (m, 1H, H-3), 3.16 (s, 3H, 
OCH3), 1.99 (s, 3H, CH3). Quantitative yield. 
 
2-(Diphenylphosphanyl)-4-fluorophenyl acetate (83a) 
 
PPh2
O CH3
O
F
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.45-7.36 (m, 10H, Ph), 7.16-7.09 (m, 1H), 7.07-7.04 
(m, 1H), 6.57-6.52 (m, 1H), 1.97 (s, 3H, CH3). Quantitative yield.  
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General procedure for the synthesis of the o-diphenylphosphanyl-phenyl esters  
 
Dry triethylamine (1.1 eq) and the acyl chloride (1.2 eq) were added, at room temperature and 
under argon, to a solution of the o-diphenylphosphinophenol (1 eq) in dry CH2Cl2 (0.1 M). The 
reaction mixture was stirred at room temperature and monitored by TLC (90:10 hexane/AcOEt) 
until disappearance of the o-diphenylphosphinophenol (ca. 1 h). The solvent was then 
evaporated under reduced pressure and the residue was diluted with AcOEt and washed with 5 % 
aqueous NaHCO3 and water. The organic layer was dried over Na2SO4 and concentrated. The 
crude product obtained was purified by flash chromatography, as indicated in each individual 
case. 
 
o-Diphenylphosphanyl-phenyl pentanoate (81b).  
 
PPh2
O
O
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 96 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.40-7.31 (m, 11H, Ph), 7.19-7.12 (m, 2H), 6.86-6.82 
(m, 1H), 2.28 (t, J = 7.5 Hz, 2H, CH2), 1.51 (m, 2H, CH2), 1.29 (m, 2H, CH2), 0.89 (t, J = 7.5 
Hz, 3H, CH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 171.8, 153.2 (d, J = 17 Hz), 134.7, 
134.5, 134.0, 133.9, 133.8, 132.2, 131.8, 130.1, 129.2, 128.9, 128.8, 128.7, 126.2, 125.9, 125.7, 
122.8, 33.9, 26.7, 22.3, 13.9. 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 14.8 ppm [ oxide 31P = + 
27.2 ppm]. 
 
o-Diphenylphosphanyl-phenyl 3-methyl-butanoate (81c)  
 
PPh2
O
O
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 97 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.32 (m, 11H, Ph), 7.20-7.12 (m, 2H), 6.88-6.83 
(m, 1H), 2.17 (d, J = 7.0 Hz, 2H, CH2), 2.05 (m, 1H, CH), 0.94 (d, J = 7.0 Hz, 6H, 2xCH3).13C-
Chapter 3 
 83 
NMR (100 MHz, CDCl3, 25°C): δ = 170.9, 152.9 (d, J = 17 Hz), 135.8 (d, J = 16 Hz), 134.5, 
134.4, 134.1, 133.9, 133.8, 133.5, 131.7 (d, J = 9 Hz), 130.2 (d, J = 14 Hz), 130.2, 129.9, 129.4, 
129, 128.6, 128.6, 126.0, 125.6, 125.5, 123.9, 123.9, 122.6, 42.9, 25.3, 22.4. 31P-NMR (161 
MHz, CDCl3, 25°C): δ = - 15.0 ppm [ oxide 31P = + 27.1 ppm].  
 
o-Diphenylphosphanyl-phenyl i-butanoate (81d) 
 
PPh2
O
O
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 87 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.26 (m, 11H, Ph), 7.18-7.12 (m, 2H), 6.83-6.78 
(m, 1H), 2.55 (m, J = 7.0 Hz, 1H, CH), 1.10 (d, J = 7.0 Hz, 6H, 2xCH3). 13C-NMR (100 MHz, 
CDCl3, 25°C): δ = 174.7, 153 (d, J = 17 Hz), 135.7 (d, J = 10 Hz), 134.1, 133.9, 133.7, 131.8 
(dd, J = 10 Hz), 130.17 (d, J = 15 Hz), 129.9, 128.9, 128.6, 128.6, 126, 122.5, 34.1, 18.6. 31P-
NMR (161 MHz, CDCl3, 25°C): δ = - 15.1 [ oxide 31P = + 28.9 ppm].  
 
o-Diphenylphosphanyl-phenyl 3-methyl-but-2-enoate (81e)  
 
PPh2
O
O
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 84 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.43-7.32 (m, 11H, Ph), 7.22-7.12 (m, 2H), 6.93-6.86 
(m, 1H), 5.69 (m, 1H, CH), 2.09 (d, J = 1.2 Hz, 3H, CH3), 1.90 (d, J = 1.2 Hz, 3H, CH3). 13C-
NMR (100 MHz, CDCl3, 25°C): δ = 164.1, 159.6, 152.9 (d, J = 17 Hz), 135.9 (d, J = 10 Hz), 
134.1, 133.9, 133.7, 131.7 (d, J = 10 Hz), 130.5 (d, J = 14 Hz), 129.8, 129.0, 128.8, 128.4, 125.8, 
122.8, 114.9, 27.5, 20.4. 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 14.8 ppm [ oxide 31P = + 26.8 
ppm]. 
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o-Diphenylphosphanyl-phenyl palmitate (81f) 
 
PPh2
O
O
13
 
 
The compound was purified by flash chromatography (hexane/AcOEt 95:5) yield = 85 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.28 (m, 11H, Ph), 7.18-7.08 (m, 2H), 6.82-6.76 
(m, 1H), 2.23 (t, J = 7.2 Hz, J = 8 Hz, 2H, CH2), 1.48 (t, J = 7.2 Hz, J = 6.8 Hz, 2H, CH2), 1.41-
1.17 (m, 24H, 12xCH2), 0.88 (t, J = 6.8 Hz, 3H, CH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 
171.8, 134.3, 134.1, 133.9, 129.2, 126.2, 122.8, 35.2, 34.3, 32.2, 29.9, 29.8, 29.6, 29.4, 29.3, 
29.1, 24.7, 22.9, 14.3. 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 14.3 ppm [ oxide 31P = + 27.3 
ppm]. 
 
2-(Diphenylphosphanyl)-4-methoxyphenyl pentanoate (82b)  
 
PPh2
O
O
MeO
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 87 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.40-7.31 (m, 10H, Ph), 7.10 (dd, J = 4.4 Hz, J = 8.8 Hz, 
1H, H-6), 6.91 (dd, J = 3.2 Hz, J = 8.8 Hz, 1H, H-5), 6.36 (dd, J = 3.2 Hz, J = 4.4 Hz, 1H, H-3), 
3.53 (s, 3H, OCH3), 2.26 (t, J = 8 Hz, 2H, CH2), 1.51 (m, CH2), 1.31 (m, CH2), 0.89 (t, J = 7.2 
Hz, 3H, CH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 171.9, 157.1, 146.4, 146.3, 135.6, 135.5, 
134.1, 131.5, 131.4, 128.5, 128.3, 123.3, 123.2, 122.3, 118.9, 118.8, 114.5, 55.4, 33.7, 26.6, 
22.2, 13.7. 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 14.5 ppm [ oxide 31P = + 26.9 ppm]. 
 
2-(Diphenylphosphanyl)-4-methoxyphenyl tert-butanoate (82c) 
 
PPh2
O
O
MeO
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The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 83 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.37-7.23 (m, 10H, Ph), 7.04 (dd, J = 4.2 Hz, J = 8.8 Hz, 
1H, H-6), 6.91 (dd, J = 3.2 Hz, J = 8.8 Hz, 1H, H-5), 6.38 (dd, J = 3.2 Hz, J = 4.2 Hz, 1H, H-3), 
3.61 (s, 3H, OCH3), 1.12 (s, 9H, 3xCH3). 
 
2-(Diphenylphosphanyl)-4-methoxyphenyl i-butanoate (82d) 
 
PPh2
O
O
MeO
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 82 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.37-7.28 (m, 10H, Ph), 7.06 (dd, J = 4.2 Hz, J = 8.8 Hz, 
1H, H-6), 6.87 (dd, J = 3.2 Hz, J = 8.8 Hz, 1H, H-5), 6.28 (dd, J = 3.2 Hz, J = 4.4 Hz, 1H, H-3), 
3.61 (s, 3H, OCH3), 2.53-2.47 (m, 1H, CH), 1.07 (s, 3H, CH3), 1.05 (s, 3H, CH3). 
 
2-(Diphenylphosphanyl)-4-methoxyphenyl 3-methyl-but-2-enoate (82e) 
 
PPh2
O
O
MeO
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 84 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.29 (m, 10H, Ph), 7.10 (dd, J = 4.4 Hz, J = 8.8 Hz, 
1H, H-6), 6.91 (dd, J = 3.2 Hz, J = 8.8 Hz, 1H, H-5), 6.38 (dd, J = 3.2 Hz, J = 4.4 Hz, 1H, H-3), 
5.62 (s, 1H, CH), 3.62 (s, 3H, OCH3), 2.03 (s, 3H, CH3), 1.85 (s, 3H, CH3). 13C-NMR (100 MHz, 
CDCl3, 25°C): δ = 159.4, 157, 135.7, 135.6, 134.1, 133.9, 129.1, 128.6, 128.5, 128.4, 123.5, 
123.3, 123.2, 119, 118.9, 114.9, 114.4, 55.4, 27.5, 20.4. 31P-NMR (161 MHz, CDCl3, 25°C): δ = 
- 14.1 ppm [ oxide 31P = + 26.4 ppm]. 
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2-(Diphenylphosphanyl)-4-fluorophenyl pentanoate (83b).  
 
PPh2
O
O
F
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 95 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.44-7.33 (m, 10H, Ph), 7.18-7.12 (m, 1H), 7.11-7.04 
(m, 1H), 6.56-6.51 (m, 1H), 2.30-2.24 (t, J = 7.6 Hz, 2H, CH2), 1.52 (m, CH2), 1.32 (m, CH2), 
0.91 (t, J = 7.6 Hz, 3H, CH3). 
 
2-(Diphenylphosphanyl)-4-fluorophenyl 3-methyl-but-2-enoate (83e).  
 
PPh2
O
O
F
 
 
The compound was purified by flash chromatography (hexane/AcOEt 90:10) yield = 91 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.32 (m, 10H, Ph), 7.18-7.12 (m, 2H), 7.11-7.02 
(m, 2H), 5.65 (s, 1H, CH), 2.13 (s, 3H, CH3), 1.91 (s, 3H, CH3). 
 
Synthesis of o-diphenylphosphanyl-phenyl caprylate (81g) 
 
PPh2
O
O
 
 
A solution of the o-diphenylphosphinophenol 57 (126.2 mg, 0.45 mmol, 1 eq), the caprylic acid 
(77.9 mg, 0.54 mmol, 1.2 eq) and N,N-dimethylaminopyridine (5.5 mg, 0.045 mmol, 0.1 eq) in 
dry CH2Cl2 was added, at room temperature and under nitrogen, to a solution of N,N’-
dicyclohexylcarbodiimide (130.1 mg, 0.63 mmol, 1.4 eq) in dry CH2Cl2 (total volume: 4.5 mL, 
0.1 M). The mixture was stirred at room temperature for 1 h, monitoring by TLC (90:10 
hexane/AcOEt). The reaction mixture was filtered and washed with CH2Cl2. The crude product 
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was purified by flash chromatography using 90:10 hexane/AcOEt as the eluent to afford the 
product in 90 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.45-7.26 (m, 11H, Ph), 7.20-7.07 (m, 2H), 6.83-6.78 
(m, 1H), 2.25 (t, J = 7.6 Hz, 2H, CH2), 1.49 (t, J = 7.2 Hz, 2H, CH2), 1.36-1.19 (m, 8H, 4xCH2), 
0.89 (t, J = 6.8 Hz, CH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 171.8, 135.9, 134.7, 134.3, 
134.1, 130.1, 129.2, 128.8, 128.7, 126.2, 122.8, 34.2, 33.8, 31.8, 29.2, 24.7, 22.8, 14.3 (CH3).  
 
Synthesis of o-diphenylphosphanyl-phenyl citronellate (81h) 
 
PPh2
O
O
 
 
A solution of the o-diphenylphosphinophenol 57 (127.8 mg, 0.46 mmol, 1 eq), the citronellic 
acid  (93.6 mg, 0.55 mmol, 1.2 eq) and N,N-dimethylaminopyridine (5.5 mg, 0.046 mmol, 0.1 
eq) in dry CH2Cl2 was added, at room temperature and under nitrogen, to a solution of N,N’-
dicyclohexylcarbodiimide (132.1 mg, 0.64 mmol, 1.4 eq) in dry CH2Cl2 (total volume: 4.6 mL, 
0.1 M). The mixture was stirred at room temperature for 1 h, monitoring by TLC (90:10 
hexane/AcOEt). The reaction mixture was filtered and washed with CH2Cl2. The crude product 
was purified by flash chromatography using 95:5 hexane/AcOEt as the eluent to afford the 
product in 75 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.45-7.27 (m, 11H, Ph), 7.21-7.08 (m, 2H), 6.84-6.78 
(m, 1H), 5.07 (t, J = 7.2 Hz, J = 6.8 Hz, 1H, CH), 2.25 (dd, J = 5.6 Hz, JHa-Hb = 15.3 Hz, 1H, Ha, 
CH2), 2.06 (dd, J = 8.4 Hz, JHa-Hb = 15.3 Hz, 1H, Hb, CH2), 1.99-1.79 (m, 3H, CHCH2), 1.68 (s, 
3H, CH3), 1.60 (s, 3H, CH3), 1.27-1.12 (m, 2H, CH2), 0.89 (s, 3H, CH3). 13C-NMR (100 MHz, 
CDCl3, 25°C): δ = 171.2, 153.2, 153.1, 136, 135.9, 134.3, 134.1, 133.9, 131.9, 131.8, 131.7, 
130.1, 129.2, 128.8, 128.7, 126.2, 124.5, 122.7, 41.5, 36.9, 29.9, 25.6, 19.8, 17.9. 31P-NMR (161 
MHz, CDCl3, 25°C): δ = - 14.9 ppm [ oxide 31P = + 27.3 ppm]. 
 
Synthesis of o-diphenylphosphanyl-phenyl benzoate (57i) 
 
PPh2
O Ph
O
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Dry pyridine (27 µL, 0.34 mmol, 1.2 eq), benzoic anhydride (76.6 mg, 0.34 mmol, 1.2 eq) and 
N,N-dimethylaminopyridine (3.4 mg, 0.028 mmol, 0.1 eq) were added, at room temperature and 
under nitrogen, to a solution of o-diphenylphosphinophenol (78.6 mg, 0.28 mmol, 1 eq) in dry 
CH2Cl2 (1.87 mL, 0.15 M). The solution was stirred for 3 h and then concentrated in vacuo. The 
residue was dissolved in AcOEt and washed with 5 % aqueous NaHCO3 and water. The organic 
layer was dried over Na2SO4 and concentrated. The product was purified by flash 
chromatography using 95:5 hexane/AcOEt as the eluent. Quantitative yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.81-7.78 (m, 2H), 7.46 (m, 1H), 7.37 (td, J = 7.6, 1.5 
Hz, 1H), 7.32-7.23 (m, 13H, Ph), 7.12 (dd, J = 7.6 Hz, 1H), 6.82 (ddd, J = 9.8 Hz, J = 4.2 Hz, J 
= 2.6 Hz, 1H). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 164.3, 152.9 (d, J = 17 Hz), 135.5 (d, J = 
10 Hz), 134.6, 134.2, 133.58, 133.4, 131.7 (d, J = 11 Hz), 130.7 (d, J = 15 Hz), 130.2, 129.9, 
129.2, 129.0, 128.6, 128.54, 128.3, 128.1, 126.2, 122.6. 31P-NMR (161 MHz, CDCl3, 25°C): δ = 
-14.3 ppm [ oxide 31P = + 27.3 ppm]. 
 
Synthesis of 1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-(Benzyloxycarbonyl)-L-
aspartate (81j) 
 
PPh2
O
O
COOMe
NHCbz
 
 
A solution of the o-diphenylphosphinophenol 57 (103.7 mg, 0.373 mmol, 1 eq), the 
commercially available N-carbobenzyloxy-L- asparagine acid 1-methyl ester (125.8 mg, 0.447 
mmol, 1.2 eq) and N,N-dimethylaminopyridine (4.6 mg, 0.037 mmol, 0.1 eq) in dry CH2Cl2 (3.7 
mL, 0.1 M) were added, at room temperature and under nitrogen, to a suspension of N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (100 mg, 0.522 mmol, 1.4 eq) and 
dry N,N-diisopropylethylamine (89.3 µL, 0.522 mmol, 1.4 eq) in dry CH2Cl2. The mixture was 
stirred at RT for 2 h, monitoring by TLC (60:40 hexane/AcOEt). The reaction mixture was 
diluted with CH2Cl2 and extracted with 5 % aqueous HCl and water: the organic layer was dried 
over Na2SO4 and concentrated. The crude product was purified by flash chromatography using 
60:40 hexane/AcOEt as the eluant to afford 81l in 85 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.39-7.24 (m, 11H, Ph), 7.17-7.08 (m, 2H), 6.86 (m, 
1H), 5.77 (d, J = 8.9 Hz, 1H, NH), 5.17 (d, J = 12.3 Hz, 1H, CH2Ph), 5.12 (d, J = 12.3 Hz, 1H, 
CH2Ph), 4.61 (m, 1H, CH), 3.70 (s, 3H, OCH3), 3.04 (dd, J = 5.1 Hz, 17.4 Hz, 1H, CH2CO), 
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2.75 (dd, J = 4.4 Hz, 17.4 Hz, 1H, CH2CO). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 171.1, 
169.3, 156.2, 152.6 (d, J = 17 Hz), 136.4, 135.6, 135.5, 135.4, 135.3, 134.3, 134.2, 133.9, 133.8, 
130.5, 130.3, 130.2, 129.4, 129.3, 128.9, 128.8, 128.7, 128.4, 128.3, 126.7, 122.6, 122.5, 67.3, 
53.0, 50.4, 36.6. 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 15.6 ppm [ oxide 31P = + 28.2 ppm]. 
 
1-Methyl 5-[2-(Diphenylphosphanyl)-4-methoxyphenyl] N-(Benzyloxy-carbonyl)-L-
aspartate (82j) 
 
PPh2
O
O
COOMe
NHCbz
MeO
 
 
See procedure for the synthesis of Synthesis of 1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-
(Benzyloxycarbonyl)-L-aspartate (81j) 
The compound was purified by flash chromatography (hexane/AcOEt 65:35) yield = 75 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.24 (m, 15H, Ph), 7.06 (dd, J = 4 Hz, J = 8.4 Hz, 
1H, H-6), 6.86 (dd, J = 3.2 Hz, J = 8.4 Hz, 1H, H-5), 6.37 (t, J = 3.6 Hz, 1H, H-3), 5.75 (d, JNH-
CH = 8.2 Hz, 1H, NH), 5.19 (d, J = 6 Hz, 2H, CH2-O), 4.60 (q, JCH-CH2 = 4.4 Hz, 1H, CH), 3.72 (s, 
3H, OCH3), 3.62 (s, 3H, OCH3), 3.01 (dd, J = 4.4 Hz, J = 17.2 Hz, 1H, Ha, CH2), 2.72 (dd, 1H, J 
= 4.4 Hz, J = 17.2 Hz, Hb, CH2).  
 
1-Methyl 5-[2-(Diphenylphosphanyl)-4-fluorophenyl] N-(Benzyloxy-carbonyl)-L-aspartate 
(83j) 
 
PPh2
O
O
COOMe
NHCbz
F
 
 
See procedure for the synthesis of Synthesis of 1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-
(Benzyloxycarbonyl)-L-aspartate (81j) 
The compound was purified by flash chromatography (hexane/AcOEt 60:40) yield = 85 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.48-7.27 (m, 15H, Ph), 7.12-7.02 (m, 2H, H-2, H-3), 
6.55 (m, 1H, H-1), 5.70 (d, JNH-CH = 8.6 Hz, 1H, NH), 5.18 (d, J = 6 Hz, 2H, CH2O), 4.61 (q, JCH-
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CH2 = 4.4 Hz, 1H, CH), 3.72 (s, 3H, OCH3), 3.01 (dd, J = 4.6 Hz, J = 17.2 Hz, 1H, Ha, CH2), 2.75 
(dd, J = 4.6 Hz, J = 17.2 Hz, 1H, Hb, CH2). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.9, 
169.2, 161.8, 159.4 (CO(Cbz)), 134.2, 134.1, 133.9, 133.8, 129.7, 129.6, 129.0, 128.9, 128.7, 
128.6, 128.4, 128.3, 128.1 (5xCAr), 123.9, 123.8, 120.2, 120, 116.9, 116.6, 67.2 (CH2O), 52.9 
(OCH3), 50.3 (CH), 36.5 (CH2). 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 15.3 ppm [ oxide 31P = 
+ 26.7 ppm]. ESI-MS: m/z 582.2 (M+Na ). 
 
1-Methyl 5-[2-(Diphenylphosphanyl)-4-trifluoromethylphenyl] N-(Benzyloxy-carbonyl)-L-
aspartate (84j) 
 
PPh2
O
O
COOMe
NHCbz
F3C
 
 
See procedure for the synthesis of Synthesis of 1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-
(Benzyloxycarbonyl)-L-aspartate (81j) 
The compound was purified by flash chromatography (hexane/AcOEt 70:30) yield = 90 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.48 (d, J = 8.8 Hz, 1H), 7.37-7.21 (m, 16H, Ph), 7.07 
(m, 1H), 5.64 (d, JNH-CH = 8.4 Hz, 1H, NH), 5.14 (d, J = 5.6 Hz, 2H, CH2O), 4.59 (q, JCH-CH2 = 
4.4 Hz, 1H, CH), 3.68 (s, 3H, OCH3),  2.94 (dd, J = 4.4 Hz, J = 17.2 Hz, 1H, Ha, CH2), 2.72 (dd, 
J = 4.4 Hz, J = 17.2 Hz, 1H, Hb, CH2). 
 
1-Methyl 5-[2-(Dicyclohexylphosphanyl)-4-fluorophenyl] N-(Benzyloxy-carbonyl)-L-
aspartate (86j) 
 
P(cyclohexil)2
O
O
COOMe
NHCbz
F
 
 
See procedure for the synthesis of Synthesis of 1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-
(Benzyloxycarbonyl)-L-aspartate (81j) 
The compound was purified by flash chromatography (hexane/AcOEt 80:20) yield = 80 %. 
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1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.31 (m, 5H, Ph), 7.18-7.12 (m, 1H, H-3), 7.11-
7.01 (m, 2H, H-1, H-2), 6.57 (dd, JNH-CH = 8.4 Hz, J = 3.2 Hz, 1H, NH), 5.18 (s, 2H, CH2O), 4.79 
(m, 1H, CH), 3.79 (s, 3H, OCH3), 3.39 (dd, J = 4.8 Hz, J = 16.8 Hz, 1H, Ha, CH2), 3.14 (dd, J = 
4.4 Hz, J = 16.8 Hz, 1H, Hb, CH2), 1.93-1.48 (m, 14H, Cyhex), 1.47-0.97 (m, 8H, Cyhex).  
 
1-Methyl 5-[2-(Dicyclopentylphosphanyl)-4-fluorophenyl] N-(Benzyloxy-carbonyl)-L-
aspartate (87j) 
 
P(cyclopentyl)2
O
O
COOMe
NHCbz
F
 
 
See procedure for the synthesis of Synthesis of 1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-
(Benzyloxycarbonyl)-L-aspartate (81j) 
The compound was purified by flash chromatography (hexane/AcOEt 70:30) yield = 80 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.32-7.27 (m, 5H, Ph), 7.18-7.15 (m, 1H), 7.04-6.94 (m, 
2H), 6.55-6.50 (m, 1H, NH), 5.13 (s, 2H, CH2O), 4.78-4.73 (m, 1H, CH), 3.75 (s, 3H, OCH3), 
3.36 (dd, J = 4.4 Hz, J = 16.8 Hz, 1H, Ha, CH2), 3.01 (dd, J = 4.4 Hz, J = 16.8 Hz, 1H, Hb, CH2), 
2.07-1.98 (m, 2H), 1.86-1.76 (m, 2H), 1.70-1.34 (m, 14H). 
 
Synthesis of 1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-(Benzyloxycarbonyl)-L-
glutamate (81k) 
 
PPh2
O
O
NHCbz
COOMe
 
 
A solution of the o-diphenylphosphinophenol 57 (200 mg, 0.715 mmol, 1 eq), the commercially 
available N-carbobenzyloxy-L-glutamic acid 1-methyl ester (255 mg, 0.86 mmol, 1.2 eq) and 
N,N-dimethylaminopyridine (8.8 mg, 0.072 mmol, 0.1 eq) in dry CH2Cl2 (0.1 M) were added, at 
room temperature and under nitrogen, to a suspension of N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (193.3 mg, 1 mmol, 1.4 eq) and dry N,N-diisopropylethylamine 
(172.6 µL, 1 mmol, 1.4 eq) in dry CH2Cl2. The mixture was stirred at RT for 2 h, monitoring by 
TLC (50:50 hexane/AcOEt). The reaction mixture was diluted with CH2Cl2 and extracted with 
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10 % aqueous HCl and water: the organic layer was dried over Na2SO4 and concentrated. The 
crude product was purified by flash chromatography using 70:30 hexane/AcOEt as the eluant to 
afford 81k in 75 % yield.  
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.29 (m, 11H, Ph), 7.17-7.08 (m, 2H), 6.86 (m, 
1H), 5.40 (d, J = 7.2 Hz, 1H, NH), 5.12 (s, J = 12.3 Hz, 1H, CH2Ph), 4.35 (q, J = 4.8 Hz, 1H, 
CH), 2.35 (m, 2H, CH2CO), 2.07 (m, 1H, Ha, CH2CH), 1.86 (m, 1H, Hb, CH2CH).  
 
1-Methyl 5-[2-(Diphenylphosphanyl)-4-fluorophenyl] N-(Benzyloxy-carbonyl)-L-glutamate 
(83k) 
 
PPh2
O
O
NHCbz
COOMe
F
 
 
See procedure for the synthesis of  1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-
(Benzyloxycarbonyl)-L-glutamate (81k) 
The compound was purified by flash chromatography (hexane/AcOEt 60:40) yield = 85 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.40-7.27 (m, 15 H, Ph), 7.09 (m, 1H, H-2), 7.00 (m, 
1H, H-3), 6.47 (m, 1H, H-1), 5.34 (d, JNH-CH = 7.9 Hz, 1H, NH), 5.11 (d, J = 3.8 Hz, 2H, CH2-
O), 4.35 (m, 1H, CH), 3.74 (s, 3H, O-CH3), 2.28 (m, 2H, CH2-CO), 2.01 (m, 1H, Ha, CH2-CH), 
1.80 (m, 1H, Hb, CH2-CH). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.8, 161.9, 159.4 
(CO(Cbz)), 134.4, 134.4, 134.2, 134.2, 129.8, 129.2, 129.1, 128.9, 128.6, 128.5 (5xCAr), 124.3, 
124.2, 120.2, 119.9, 116.9, 116.7, 67.5 (CH2-O), 53.5 (CH), 52.8 (O-CH3), 30.3 (CH2-CO), 27.6 
(CH2). 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 14.2 ppm [ oxide 31P = + 26.8 ppm]. ESI-MS: 
m/z 596.3 (M+Na ). 
 
1-Methyl 5-[2-(Diphenylphosphanyl)-3,5-ditrifluoromethylphenyl] N-(Benzyloxy-
carbonyl)-L-glutamate (85k) 
 
PPh2
O
O
CF3
F3C COOMe
NHCbz
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See procedure for the synthesis of  1-Methyl 5-[2-(Diphenylphosphanyl)-phenyl] N-
(Benzyloxycarbonyl)-L-glutamate (81k) 
The compound was purified by flash chromatography (hexane/AcOEt 70:30) yield = 95 %. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.94 (s, 1H), 7.61 (s, 1H), 7.38-7.31 (m, 15H, Ph), 5.20 
(d, J = 7.6 Hz, 1H, NH), 4.28-4.23 (m, 1H, CH), 3.73 (s, 3H, OCH3), 1.82-1.58 (m, 4H, 2xCH2). 
 
Synthesis of N-(Benzyloxycarbonyl)-β-alanine 2-(Diphenylphosphanyl)-phenyl Ester (81l) 
 
PPh2
O
O
NHCbz
 
 
A solution of the o-diphenylphosphinophenol 57 (90 mg, 0.32 mmoli, 1 eq.), the protected amino 
acid N-carbobenzyloxy-L-β-alanine (87 mg, 0.39 mmoli, 1.2 eq) and N,N-
dimethylaminopyridine (3.9 mg, 0.032 mmol, 0.1 eq) in dry CH2Cl2 (0.1 M) was added, at room 
temperature and under nitrogen, to a solution of N,N’-dicyclohexylcarbodiimide (94 mg, 0.45 
mmol, 1.4 eq) in dry CH2Cl2. The mixture was stirred at room temperature for 1.5 h, monitoring 
by TLC (80:20 hexane/AcOEt). The reaction mixture was filtered and washed with CH2Cl2. The 
crude product was purified by flash chromatography using 70:30 hexane/AcOEt as the eluent to 
afford 81l in 82 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.39-7.24 (m, 11H, Ph), 7.17-7.08 (m, 2H), 6.86 (m, 
1H), 5.38 (s, J = 8.9 Hz, 1H, NH), 5.13 (s, J = 12.3 Hz, 1H, CH2Ph), 3.4 (q, J = 6 Hz, 2H, 
NHCH2), 2.55 (t, J = 6 Hz, 2H, CH2). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.1, 169.3, 
156.2, 152.6 (d, J = 17 Hz), 136.4, 135.6, 135.5, 135.4, 135.3, 134.3, 134.2, 133.9, 133.9, 130.5, 
130.2, 130.1, 130.0, 129.2, 128.7, 128.6, 128.5, 128.4, 128.0, 126.7, 122.5, 122.4, 66.7, 36.6, 
34.6. 
 
N-(Benzyloxy-carbonyl)-β-alanine 2-(Diphenylphosphanyl)-4-fluorophenyl Ester (83l)  
 
PPh2
O
O
NHCbz
F
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A solution of the 2-diphenylphosphino-p-fluorophenol 60 (283.3 mg, 0.96 mmol, 1 eq), the 
protected amino acid N-carbobenzyloxy-L-β-alanine (257.1 mg, 1.15 mmol, 1.2 eq) and N,N-
dimethylaminopyridine (11.7 mg, 0.096 mmol, 0.1 eq) in dry CH2Cl2 (9.6 ml, 0.1 M) was added, 
at room temperature and under argon, to a solution of N,N’-dicyclohexylcarbodiimide (277.3 mg, 
1.34 mmol, 1.4 eq) in dry CH2Cl2. The mixture was stirred at room temperature for 2 h, 
monitoring by TLC (70:30 hexane/AcOEt). The reaction mixture was filtered and washed with 
CH2Cl2. The crude product was purified by flash chromatography using 70:30 hexane/AcOEt as 
the eluent to afford 83l in 92 % yield. 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.27 (m, 15H, Ph), 7.15-7.05 (m, 2H, H-2, H-3), 
6.52 (m, 1H, H-1), 5.27 (m, 1H, NH), 5.12 (s, 2H, CH2O), 3.48 (q, JCH2-NH = 12 Hz, 2H, 
CH2NH), 2.50 (t, JCH2-CH2 = 6 Hz, 2H, CH2CO). 13C-NMR (100 MHz, CDCl3, 25°C): δ  = 170.8, 
161.9, 159.5 (CO(Cbz)), 156.5, 134.8, 134.7, 134.4, 134.2, 132.1, 132, 129.8, 129.3, 129.2, 128.8, 
128.5, 128.4 (5xCAr), 124.3, 124.2, 120.4, 120.2, 117.1, 116.8, 67 (CH2O), 36.6 (CH2), 34.8 
(CH2CO). 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 15.2 ppm [ oxide 31P = + 27.9 ppm]. ESI-
MS: m/z 524.2 (M+Na ).  
 
N-(Benzyloxy-carbonyl)glycine 2-(Diphenylphosphanyl)-4-fluorophenyl Ester (83m) 
 
PPh2
O
O
NHCbz
F
 
 
A solution of the 2-diphenylphosphino-p-fluorophenol 60 (158,3 mg, 0.53 mmol, 1 eq), the 
protected amino acid N-carbobenzyloxy-L-β-glycine (134 mg, 0.64 mmol, 1.2 eq) and N,N-
dimethylaminopyridine (6.5 mg, 0.053 mmol, 0.1 eq) in dry CH2Cl2 (5.3 ml, 0.1 M) was added, 
at room temperature and under argon, to a solution of N,N’-dicyclohexylcarbodiimide (152.7 mg, 
0.74 mmol, 1.4 eq) in dry CH2Cl2. The mixture was stirred at room temperature for 2 h, 
monitoring by TLC (70:30 hexane/AcOEt). The reaction mixture was filtered and washed with 
CH2Cl2. The crude product was purified by flash chromatography using 70:30 hexane/AcOEt as 
the eluent to afford 83m in 90 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.48-7.30 (m, 15H, Ph), 7.15 (m, 1H, H-2), 7.11 (m, 1H, 
H-3), 6.53 (m, 1H, H-1), 5.12 (s, 2H, CH2O), 4.99 (m, 1H, NH), 3.85 (d, JNH-CH2 = 5.2 Hz, 2H, 
CH2). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 168.4, 159.6 (CO(Cbz)), 156.4, 162.1, 136.4 
(Cipso), 134.8, 134.7, 134.4, 134.2, 129.9, 129.2, 129.1, 128.9, 128.6, 128.4 (5xCAr), 124.2, 
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124.1, 120.4, 120.3, 120.1, 120.1, 117, 116.8, 67.5 (CH2O), 42.8 (CH2). 31P-NMR (161 MHz, 
CDCl3, 25°C): δ = - 14.0 ppm [ oxide 31P = + 27.5 ppm]. ESI-MS: m/z 510.4 (M+Na ).  
 
N-(tert-Butoxycarbonyl)-L-proline 2-(Diphenylphosphanyl)-4-fluorophenyl Ester (83n) 
 
PPh2
O
O
F
Boc
N
 
 
A solution of the 2-diphenylphosphino-p-fluorophenol 60 (119.6 mg, 0.40 mmol, 1 eq), the 
protected amino acid N-Boc-L-β-proline (103.3mg, 0.48 mmol, 1.2 eq) and N,N-
dimethylaminopyridine (4.9 mg, 0.04 mmol, 0.1 eq) in dry CH2Cl2 (4 ml, 0.1 M) was added, at 
room temperature and under argon, to a solution of N,N’-dicyclohexylcarbodiimide (115,5 mg, 
0.56 mmol, 1.4 eq) in dry CH2Cl2. The mixture was stirred at room temperature for 2 h, 
monitoring by TLC (80:20 hexane/AcOEt). The reaction mixture was filtered and washed with 
CH2Cl2. The crude product was purified by flash chromatography using 80:20 hexane/AcOEt as 
the eluent to afford 83n in 94 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.30-7.25 (m, 5H, Ph), 7.24-7.09 (m, 5H, Ph), 7.06-6.92 
(m, 2H, H-2, H-3), 6.36 (m, 1H, H-1), 4.24 (m, 1H, CH), 3.26 (t, J Hc-Hd = 6.8 Hz, Hc, 1H,  CH2), 
3.18 (t, 1H, Hd, CH2), 2.03-1.95 (m, 1H, Ha), 1.78-1.62 (m, 3H, Hb, CH2), 1.45-1.30 (d, 9H, 
Boc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 171.2, 161.9, 159.4, 154.8, 153.9, 148.9, 135.1, 
134.4, 134.2, 133.9, 132.1, 129.7, 129, 124.3, 123.5, 119.9, 117.2, 116.9, 80.4, 80.1, 59.4, 46.8, 
46.6, 30.6, 29.6, 28.8 (Boc), 24.9, 23.8. 31P-NMR (161 MHz, CDCl3, 25°C): δ = - 15.5, - 15.8 
ppm [ oxide 31P = + 27.7, + 28.0 ppm]. 
 
Synthesis of the compound (89) 
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Chloromethylphosphonic dichloride (5g, 30 mmol, 1eq) was dissolved in anyhdrous THF (30 
mL). A solution of 4-methoxyphenylmagnesium bromide (0.5M) in THF (120 mL, 240 mmol, 2 
eq.) was added dropwise over 1 h. The resulting mixture was stirred at reflux for 24 h. The 
reaction was then quenched by the addition of water (5 mL), and the solventwas removed under 
reduced pressure. The residue was dissolved in CH2Cl2, and the resulting solution was washed 
once with water (12 mL). The organic layer was dried over Na2SO4 and filtered, and the solvent 
was removed under reduced pressure. The residue was purified by flash chromatography 
(CH2Cl2/MeOH 97:3). Phosphine oxide was isolated as a white solid in 63 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.77-7.72 (m, 4H, Ph), 7.04-7.00 (m, 4H, Ph), 4.00 (d, J 
= 7 Hz, 2H), 3.88 (s, 6H, 2xCH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 162.9, 133.5, 133.4, 
121.5, 120.4, 114.4, 114.2, 55.4, 38.1. 31P-NMR (161 MHz, CDCl3, 25°C): δ = + 27.4 ppm. ESI-
MS: m/z 310.05 (M+Na ). 
 
Synthesis of the compound (90) 
 
 
 
Phosphine oxide 89 (2.9 g, 9.1 mmol, 1 eq) was dissolved in DMF (25 mL). Potassium 
thioacetate (1.25 g, 10.9 mmol) was then added, and the reaction mixture was stirred under 
nitrogen for 18 h. the solvent was then removed under reduced pressure. The resulting oil was 
purified by flash chromatography (CH2Cl2/MeOH 97:3). Phosphine oxide 90 was isolated as a 
clear, colorless oil in 87 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.70-7.65 (m,4H, Ph), 6.99-6.97 (m,4H, Ph), 3.85 (s, 
6H, 2xOCH3), 3.70 (d, J =8.2 Hz, 2H), 2.28 (s, 3H, CH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ 
= 162.9, 133.2, 123.4, 123.3, 114.4, 55.6, 30.4, 28.0. 31P-NMR (161 MHz, CDCl3, 25°C): δ = + 
29.2 ppm. ESI-MS: m/z 373.06 (M+Na ). 
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Synthesis of the compound (91) 
 
 
 
Phosphine oxide 90 (1.06 g, 2.95 mmol, 1 eq) was dissolved in ahnydrous chloroform (10 mL). 
Trichlorosilane (8 mL, 3.87 mmol, 26.5 eq) was added, and the resulting solution was stirred 
under nitrogen for 72 h. The solvent was then removed under reduced pressure. The residue was 
purified by flash chromatography (CH2Cl2/MeOH 97:3). Phosphine 91 was isolated as a white 
solid in 92 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.38-7.36 (m, 4H, Ph), 6.93-6.89 (m, 4H, Ph), 3.85 (s, 
6H, 2xOCH3), 3.47 (bs, 2H), 2.32 (s, 3H, CH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 194.4, 
160.5, 134.2, 134.0, 127.9, 127.8, 114.2, 55.2, 30.3, 26.4. 31P-NMR (161 MHz, CDCl3, 25°C): δ 
= -19.7 ppm. ESI-MS: m/z 357.06 (M+Na ). 
 
Synthesis of the compound (92) 
 
 
 
Phosphine 91 (200 mg, 0.56 mmol, 1 eq) was dissolved in ahnydrous DMF (1mL). A solution of 
MeONa (34 mg, 0.62 mmol, 1.1 eq) was added dropwise at 0°C, under nitrogen. The resulting 
mixture was stirred at 0°C for 2 h and then valeroyl chloride ( 67.4 mg, 0.56 mmol, 1eq) was 
added. The solution was stirred for 1 h at 0°C, dissolved in CH2Cl2 and washed with 5 % 
aqueous HCl, 5 % satured NaHCO3 and water. The organic layer was dried over Na2SO4 and 
concentrated to give the crude product. The resulting oil was purified by flash chromatography 
(cyclohexane/AcOEt 80:20 to cyclohexane/AcOEt/MeOH 80:20:2). Phosphine 92 was isolated 
as a clear, colorless oil in 57 % yield. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.44 (t, J = 8 Hz, 4H, Ph), 6.94 (d, J = 8 Hz, 4H, Ph), 
3.68 (s, 6H, 2xOCH3), 3.56 (d, J = 2 Hz, 2H, CH2S), 2.53 (t, J = 7.6 Hz, 2H, CH2), 1.59 (m, 2H, 
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CH2), 1.29 (m, 2H, CH2), 0.89 (t, J = 7.2 Hz, 3H, CH3). 31P-NMR (161 MHz, CDCl3, 25°C): δ = -
17.6 ppm [ oxide 31P = + 29.7 ppm]. 
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a reagent screening 
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4.1 Background 
 
Our previous studies on the use of Staudinger ligation for the synthesis of glycosyl amides have 
been summarized in the introduction (Chapter 1). Among them, ligation of unprotected α- and β-
glucosyl azides1 7 and 10 was particularly remarkable because in both cases it occurred 
stereoconservatively (Scheme 1) and allowed simple isolation of the resulting glucosyl amides 
from the phosphane oxide by-product by water extraction. The anomeric ratios of the products 
were consistently good and the yields moderate-to-good for most of the alkyl chains R, 
particularly under MW irradiation.1 
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Scheme 1. Stereoconservative Staudinger ligation of 7 and 10 with phosphine 81a-l 
 
For its novelty and stereoselectivity this method deserved further consideration, but it was far 
from perfect and left many problems open. As noted above, yields were generally modest and 
dropped to poor for some α-glycosylamides. Most notably the aspartic and glutamic acid 
derivativesm 81j and 81k (Scheme 2) gave poor yields of the corresponding glucosyl amino 
acids for both the α and β series. This is particularly disappointing because these amides are 
important glycoconjugates, mimicking the conserved core of natural N-asparagine-linked 
glycopeptides and glycoproteins.2, 3  
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Scheme 2. Phosphines 81j,k give poor yields of N-glycosyl amino acids 
 
Furthermore, the reaction often yielded mixtures of the desired pyranosylamide and the isomeric 
furanosylamide. For instance, reaction of 7 with the pentanoyl phosphine 81b (Scheme 3) in 
DMA at 70°C yielded a complex mixture of compounds in the water fraction that were separated 
by reverse phase HPLC and characterized as the expected pentanamide 93b (50 % yield), the α-
N-pentanoyl-glucofuranosylamine isomer 95b (15 % yield) and α and β-glucose (equilibrium 
mixture of anomers, 30% yield). The configuration of 93b was assigned on the basis of the 
anomeric proton signal (5.45 ppm, J1-2 = 5.4 Hz). The structure of 95b was assigned on the basis 
of ESI-MS and of the 1H-NMR (D2O), which is consistent with the spectrum of the known α-D-
glucofuranoside (Scheme3).4  
 
 
Scheme 3. Staudinger ligation of 7 with phosphine 81b in DMA 
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The anomeric configuration of 95b was further confirmed to be α by the NOESY spectrum 
(D2O), which shows a strong crosspeak for the H1 and H2 protons and no crosspeak for the H1 
and H3
 
protons (Scheme 3). The presence of glucose in the reaction crude was identified by 1H-
NMR spectroscopy. 
The furanoside 95b must clearly derive from a ring-opening process occurring after the azide 
reduction step, presumably from the iminophosphorane 96 (Scheme 4) to afford the 
phosphinimine 97, which can undergo ring-closure to yield 95b. Hydrolysis of the same 
intermediate 97 accounts for the formation of α and β-D-glucose in the reaction mixture. The 
alternative hypothesis that glucose could be formed by direct hydrolysis of the starting azide was 
discarded because 7 was recovered unaltered after treatment with water in DMA at 70°C for 24 
h.  
 
PPh2
O
O
O
HO
H
HO
HO
OH
NN2
O
HO
HO
N
H
HO
OH
PPh2
O
O
NH
H
H OH
OH H
O
H
HO
HO
O
H
PPh2
O
O
O
HO
HO
HO
OH
N
H
O
HO
H
HO
HO
OH
HN
O
H
O
O
HO
HO
N
HO
OH
PPh2
O
H2O
95
96 97
-glucose
acyl transfer
93b
O
HO
HO
HO
OH
N3
PPh2
O
O
+
81b
7
 
 
 
Scheme 4. Mechanism for the formation of the furanosylamide 95b and glucose in the ligation 
of 7 with 81b 
 
This drawback was partly resolved in our previous work1, 5 by reducing the temperature of the 
reaction (high temperatures favor formation of the furanosylamides) while using microwaves to 
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avoid increasing the reaction time. Adding 2 % DMPU to the solvent (DMA) was also found to 
be beneficial, since a high polarity of the solvent appears to accelerate the acyl transfer step.6  
Under these conditions, formation of the undesired furanosyl amide could be contained in most 
cases below 5-10 % and both α and β unprotected glycosyl azides could be transformed 
stereoselectively in the corresponding amides and easily isolated from reaction mixtures. 
However, clearly the process called for further optimization. 
 
4.2 Staudinger ligation with a new group of phosphines 
 
To address the set of problems described above we turned to examining the performance of 
different phosphines in the reaction using as model substrates the α and β-glucopyranosyl azides 
7 and 10.  
The Staudinger ligation of phosphines 81 can be envisaged as taking place in two steps, as 
described in Scheme 5 for the reaction of 81j with α-glucosyl azide 7. In the first step, 
nucleophilic addition of the phosphine to the γ nitrogen of the azide followed by nitrogen 
extrusion leads to the iminophosphorane 98. In the second step, 98 undergoes an intramolecular 
reaction in which the acyl chain transferred from the phenolic ester to the imminophosphorane 
nitrogen and an amide bond is generated.1 Our previous observations indicated that the poor 
amide yields observed upon reaction of glucosylazides with some phosphines were caused by 
inefficient acyl chain transfer in the iminophosphorane  intermediate 98 (Scheme 5).1, 7 
 
 
 
Scheme 5. Two-step mechanism for the Staudinger ligation. 
 
Using the syntheses shown in Chapter 3, we prepared the group of new phosphines collected in 
Figure 1 ( 59-62, 79, 80 and 91)  for further studies on the Staudinger ligation process. 
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Figure 1. Set of new phosphines 
 
The two phosphines 59 and 60 were studied in more detail and were meant to address two 
different and opposite features of the process:  
1. The azide reduction step (formation of the imminophosphorane, Scheme 6) is facilitated 
by a strong basicity of the P atom.  
2. The acyl transfer step (from phenol oxygen to iminophosphorane N, in Scheme 6) would 
be accelerated by EWG groups on the aromatic ring, which, however, will reduce the 
basicity of P. 
Thus, we expected that increasing the leaving group ability of the phenol, such as with 
phosphines 60-62 could improve the overall-yield of the reaction by accelerating the transfer 
step. A possible decrease in reactivity due to the reduced basicity of the P atom induced by the 
electronpoor phenol could be offset by increasing the electonrichness of the phosphines, for 
instance with aliphatic  substituents, such as cyclohexyl or cyclopentyl rings, as in 79 and 80. 
This should result in an increase of the reduction rate, leading to a diminished amount of by-
products related to incomplete azide reduction.  
More generally, we expected that a change in the structure of the phoshine reagent may be 
reflected in a different composition of the reaction mixtures and in particular may affect the 
formation of the furanose isomers in ways that would be difficult to anticipate at this point. 
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Scheme 6. Mechanism of the traceless Staudinger ligation 
 
As a first step we identified a rapid and diagnostic analytical method to evaluate the course of the 
reactions by analysis of the crude reaction mixtures. Since the reaction is performed on 
unprotected sugars, Thin Layer Chromatography cannot be used to monitor its course. Rather, 
after completion of the reactions under a predefined set of conditions (time, temperature etc), the 
crude mixtures were diluted with water and extracted with CH2Cl2 to eliminate the phosphine by-
products. The aqueous layers were analyzed by 1H-NMR (typically in D2O) and the product 
ratios established, based on the integration of the anomeric protons (Figure 2). Typical reaction 
crudes contained both the expected α- or β-pyranosyl amides (93 or 94) and variable amounts of 
the corresponding α-furanosyl amides 95. As we have previously shown (Scheme 4),1 the latter 
are formed by ring-opening/ring-closure of the iminophosphoranes intermediate. Other by-
products consist in free glucose (equilibrium anomeric mixtures) formed by hydrolysis of the 
same intermediates. They were all identified and characterized by isolation and/or comparison 
with known samples. 
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Figure 2. 1H-NMR (D2O) spectra of the crude water extract 
 
As mentioned above, a first set of experiments was perfomed with phoshines 82 and 83 obtained 
by acylation of the corresponding phenols 59 and 60. Phosphine 82 was chosen because 
fluorophenyl esters are well-known as good activating groups in acylic nucleophilic substitution 
and increase the acylating ability of the reagent. The methoxy group on the aromatic ring of 83 
increases the basicitity of the phosphorous atom, allowing fast reduction of the azide, but reduces 
the acylating ability. 
A set of experiments was designed on the unprotected α-glucosyl azide 7 chosen as the standard 
substrate, changing reaction temperature, nature of the R group (R = Me, CH3CH2CH2CH2-, 
(CH3)2C=CH-, Z-L-aspartic acid 1-methyl ester) and type of process (thermal or microwave 
assisted) (Scheme 7 and Tables A, B and C in the appendix). 
Yields and diasteromeric ratios obtained from the ligation were estimated on the basis of the 
weight and on the 1H-NMR spectra of the crude water extract, and all reactions were run in the 
same solvent: 98:2 DMA:DMPU (the results are collected in Tables A and B in the appendix). 
For comparison, the data previously obtained1 in similar conditions for 81 are collected in Table 
C. 
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Scheme 7. Screening for the ligation of α-glucosyl azide 7 
 
Evaluation of results obtained from this screening show that: 
The methoxy-substituted phosphines 82 displayed lower levels of α selectivity, proved by the 
presence of both α- and β-glucosyl amides in the crude water extract, and also in general showed 
a higher tendency to give the formation of α-glucofuranosyl amides and of other hydrolysis by-
products. 
Microwave assisted process with compounds 82 afforded low yield, low stereoselectivity and the 
azide 7 was not completely reduced (see Table A in appendix, entries 5, 6 and 11). In the end, 
the phosphine 82 presented a reduced reactivity and minor α-stereocontrol in comparison with 
compound 81 for the Staudinger ligation. Compound 82 afforded high conversion to α-
glucofuranosyl amides 95, if the reaction was performed above 70°C (Table A, entries 3, 4 and 
6). However, after water extraction we obtained low yield, probably for an inefficient acyl chain 
transfer during the ligation, that stop the reaction to iminophosphorane intermediate 98 step 
(Scheme 5). 
Similarly, the fluorinated compounds 83 showed lower reduction strength and lower acylating 
ability in the ligation of alkyl chains, but were found to perform dependably in the transfer of 
Aspartic acid side-chain to 7. (see Table B in appendix, entries 14 and 15). 
Some general observations were extrapolated from this set of experiments for the Staudinger 
ligation between α-glucosyl azide 7 and functionalized phosphines 82 and 83:  
1.  The results showed a strong and somewhat unpredictable dependence of the process on the                                                    
nature of the R group and the type of phosphine.  
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2.  If the ligation for the thermal process was performed above 40 °C, the quantity of α-  
glucofuranosyl amide increased in each case observed (Table A and B in appendix, 
experiment   perform at 70°C and 100°C). 
3.  The methoxy phosphines 82 gave large amount of pyranose-furanose conversion. 
4.  The fluorinated phosphines 83 gave the best results with amino acids. 
 
The best conditions identified for the synthesis of 93j, consisted in treating the unprotected α-
glucosyl azide with 2 equivalents of phosphines 83j in DMA/DMPU (98:2) at 40°C during 18 h 
(Scheme 8). 
 
 
 
Scheme 8. Staudinger ligation of the unprotected α-glucosyl azide 7 with phosphine 83j 
 
Under these conditions the α-glucopyranosylamide was isolated in good yield and excellent 
anomeric ratio (55 % isolated yield and 98:2 α/β ratio). The presence of the F atom in the 
aromatic-ring appears to play a key role for the reactivity of the phosphine 83j in the acyl 
transfer of aspartic acid.  
As a matter of fact, the reaction occurred with over 55% yield, compared to 25% afforded by the 
non-fluorinated reagent 81j. However, the ligation required more equivalents of phosphines (1.2 
eq. to 2 eq.) and the reaction time became much longer (4 h to 18 h). This proves the low 
reactivity of fluorinated phosphine 83j respect to compound 81j. Microwave assisted process 
also in this case afforded low yield and high presence of by-products (Table B in appendix, 
entries 6, 7, 9 and 13). 
To further explore the ability of electron poor phosphines in the Staudinger ligation of aspartic 
acid residue, azide 7 was treated with 84j and 85k (Figure 3) in the same conditions optimized 
for the precedent ligation (40°C, 18 h and DMA/DMPU 98:2 as mixture solvent). 
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Figure 3. Phosphines 84j and 85k 
 
Unfortunately phoshines 84j and 85k were found to reduce the azide, but not to transfer the acyl 
chain and afforded only hydrolysis by-products, such as α and β-glucose and other not identified 
compounds, whit complet absence of α-glucosyl amide as a product. 
This suggested that the azide reduction step could not be induced in the reaction for the low 
basicity of the phosphorus atom, also increased temperature and time of the reaction.  
For this purpose compound 86j (Figure 4) was synthesized, replacing two phenyl rings with 
cyclohexyl rings to increase the reduction strength of the phosphines. These became able to 
reduce the azide 7 (major reaction product was β-glucosylamine as show by anomeric signal at 
4.18 ppm J1-2 = 8.8 Hz to prove that the reduction step happened), but didn’t have acylating 
ability at all, probably for the major steric hindrance of the alkyl substituent. 
 
 
 
Figure 4. Phosphines 86j and 87j 
 
Compound 87j was synthesized to decrease the steric hindrance of the cyclohexyl ring and tested 
with different reaction conditions, but also in this case the ligation afforded only hydrolysis by-
prodouct with total absence of α-glucosyl amide 93j.  
A final set of experiments were performed treating the unprotected α-glucosyl azides 7 with the 
functionalized (diphenylphosphino)methanethiol 92 (Scheme 9). 8 This phosphine was largely 
used in the orthogonal assembly of a protein,9 site-specific immobilization of peptides and 
proteins to a surface,10, 11 and synthesis of glycopeptides. 12 
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The same procedure employed for the Staudinger ligation between phosphine and protected or 
unprotected glucosyl azides (70 °C/18 h and 40°C/4h, in DMA:DMPU 98:2 as a solvet 
mixture)1, 7 were used, but we observed that 92, is not able to react with the compound 7. 
 
 
 
Scheme 9. Staudinger ligation of 7 with the functionalized (diphenylphosphino)methanethiol 92 
 
The mechanism proposed by Raines and co-workers (Scheme 10)8 for the ligation mediated by 
(diphenylphosphino)methanethiol 99, show that the imminophosphorane 100 can form a 
tetrahedral intermediate 101, which collapses to give an amidophosphonium salt 102 that is 
hydrolyzed in aqueous solution, furnish the final amide. Probably in our case the steric hindrance 
of the tetrahedral intermediate 101, that occour during the ligation, avoid the complete reduction 
of α-glucosyl azide 7 and the acyl transfer of the acyl chain. 
 
 
Scheme 10. Mechanism for the Traceless Staudinger ligation mediated by 
(diphenylphosphino)methanthiol 7 
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4.3 Appendix 
 
 
 
 
 
Table A. Screening for the synthesis of α-glucosylamides 93  
Entry Reagent Process Glucose Azide 
β-
pyranosyl 
amide 94 
α-
pyranosyl 
amide 93 
α-
furanosyl 
amide 95 
1 82a 70 °C, 18 h 6 / 10 48 36 
2 82a 100 °C, 18 h / / 13 37 50 
3 82b 70 °C, 18 h / / 16 24 60 
4 82b 100 °C, 18 h / / 17 18 65 
5 82b M.W.120°C,20’ / 24 15.5 6.5 54 
6 82b M.W.120°C,40’ 5 8 17 8 59 
7 82e 100 °C, 18 h 18 / 51 / 31 
8 82j 40 °C, 18 h ? 43 ? 23 27 
9 82j 70 °C, 18 h 45 / ? 17 38 
10 82j 70 °C, 4 h 12 26 ? 17 26 
11 82j M.W.120°C, 1h 12.5 38 ? 20 29 
 
Ratio estimated on the basis of the 1H-NMR (D2O)spectra of the crude water extract 
(?) 1H-NMR integration not possible 
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Table B. Screening for the synthesis of α-glucosylamides 93  
Entry Phosphin. Process Glucose Azide 
β-
pyranosyl 
amide 94 
α-
pyranosyl 
amide 93 
α-
furanosyl 
amide 95 
1 83a 70 °C, 4 h 16 5 9.5 54 15 
2 83a 70 °C, 18 h 12 7 8 60 13 
3 83b 40 °C, 4 h 15 31 7.5 29.5 16 
4 83b 70 °C, 4 h 15.5 / 10.5 55 19 
5 83b 70 °C, 18 h 20.5 / 24 8 47 
6 83b M.W.50°C,50’ 17 8 17 24.5 33 
7 83b M.W.120°C,20’ 12 7 17 14 50 
8 83e 70 °C, 4 h 22 / 31 6.5 40 
9 83e M.W.120°C,20’ 21 / 33.5 32 13.5 
10 83j 40 °C, 18 h 5 25 ? 44 15 
11 83j 70 °C, 18 h 27 / ? 45 24 
12 83j 70 °C, 4 h 9 19.5 ? 30 19 
13 83j M.W.120°C,40’ 6 28 7 39 19 
14 83j 45 °C, 18 h 20 / / 61 22 
15 83j 40 °C, 18 h 15 / / 65(55a) 20 
 
Ratio estimated on the basis of the 1H-NMR (D2O)spectra of the crude water extract 
(?) 1H-NMR integration not possible. a) Isolated yield 
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Table C. Screening for the synthesis of α-glucosylamides 93  
Entry Phosphin. Process Glucose Azide 
β-
pyranosyl 
amide 94 
α-
pyranosyl 
amide 93 
α-
furanosyl 
amide 95 
1 81a 70 °C, 18 h 20 / / 77 3 
2 81b 40 °C, 4 h 20 / / 75(65a) 5 
3 81b 70 °C, 18 h 20 / / 65(50a) 15 
4 81b M.W.50°C,50’ 20 / / 75(65a) 2 
5 81b M.W.120°C,10’ 20 / / 75(65a) 2 
6 81e 40 °C, 4 h 20 / / 40 40 
7 81e M.W.50°C,50’ / / / 10a 52a 
8 81j 40 °C, 4 h 35 / / 25a 15 
9 81j M.W.50°C,50’ 35 / / 25a 10 
10 81j M.W.120°C,10’ / / / 25a 10 
 
Ratio estimated on the basis of the 1H-NMR (D2O)spectra of the crude water extract 
(?) 1H-NMR integration not possible. a) Isolated yield 
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Stereoselective synthesis of N-glycosyl amino acids by 
traceless Staudinger ligation of unprotected glycosyl 
azides  
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In chapter 4 we showed that monofluorophosphine 83j improve the yields of aspartic acid 
transfer, which occurred with over 55 % yield, compared to 25 % afforded by the non-
fluorinated analogue 81j (Scheme 1). Hence, improving the leaving group ability of the activated 
ester appears to result in higher yields for this difficult transfer step and the novel functionalized 
phosphanis 83j affords the corresponding N-glucosyl aspartic acid 93j in a stereoconservative 
and synthetically pratical manner. This preliminary result prompted us to further explore the 
scope of phosphines derived from monofluorophosphino phenol 60 in the ligation of amino acids 
and glycosyl azides.  
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Scheme1. Ligation of α-glucosyl azide 7 with functionalized phosphines 81j and 83j 
 
5.1 Synthesis of α- and β-glucosyl amino acids 
 
The monofluoro phosphines 83j-n, could be obtained in high yields from the known phosphine 
601 by reaction with the appropriate amino acids and condensing agents as show in Scheme 2, 
(See chapter 3 experimental ct for the procedures). The functionalized phosphines 83j-n were 
synthesized to examine the Staudinger ligation of the aspartic and glutamic acid side-chains (83j 
and 83k, respectively) as well as the reactions of simple α- and β-amino acids such as β-alanine 
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(83l), glycine (83m) and proline (83n). Optimal yields were obtained by using either N-[3-
(dimethylamino) propyl]-N-ethylcarbodiimide (EDC) (83j and 83k) or DCC (83l-n) as the 
condensing agent. The ligation reagents could be isolated by simple filtration through a silica gel 
plug. Analytical samples were purified by flash chromatography. In general, and like the parent 
non-fluorinated compounds, phosphines 83j-n were found to be air-stable compounds that could 
be handled under standard conditions with minimal precautions. 
 
 
 
Scheme 2. Synthesis of the fluorinared phosphines 83j-n 
 
The ligation experiments were performed by treating the unprotected α- and β-glucosyl azides 7 
and 10 with 2 equivalents of phosphine 83j-n in DMA/DMPU (98:2) at 40 °C for 18 h. After 
completion of the reaction, the crude mixtures were stirred with water for an additional 2 h, then 
diluted with water and extracted with CH2Cl2 to eliminate the phosphine by-products. The 
aqueous layers were analyzed by 1H NMR (typically in D2O) and the product ratios established 
on the basis of the integration of the anomeric protons. Typical reaction crudes contained both 
the expected α- or β-pyranosyl amides 93 or 94 and variable amounts of the corresponding 
furanosyl amides 95 (Scheme 3). The anomeric configuration of 95j-n was consistent with the 
previously data reported for the α-glucofuranosyl amides.2 As we have previously shown 
(Scheme 4, chapter 4),2 the latter are formed by ring-opening/ring-closure of the intermediate 
iminophosphoranes.3 Free glucose (equilibrium anomeric mixtures) is also formed by hydrolysis 
of the same intermediates.  
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Scheme 3. Synthesis of α- and β- glucosyl aminoacids 93j-m and 94 j-n. 
 
The glucosyl amides were purified by flash chromatography on silica gel (CHCl3/MeOH/H2O 
80:20:2) and fully characterized as their acetylated counterparts 103j-m and 104j-n (Scheme 4). 
 
 
Scheme 4. Acetylated compounds 103j-m and 104j-n 
 
Ligation of the α-azide was generally accompanied by ring contraction and sizeable quantities of 
the glucofuranosyl amides 95 were formed (Table 1, entries 1-4). Strict control of anhydrous 
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conditions and temperature were found to minimize the formation of ring-contraction by-
products. In our previous studies with phosphines 81j,2 the use of MW irradiation proved 
beneficial for reducing the amount of furanose formation, but this was not the case with 
phosphines 83j as MW irradiation (50 °C, 50 min) gave lower yields of the desired pyranosyl 
amides and more by-products. 
The reactions with β-glucosyl azide 10 (Table 1, entries 5-9) gave good-to-excellent yields of the 
corresponding pyranosyl amides 94j-n, which were essentially pure after water extraction. The 
1H NMR spectra of the reaction crudes showed no trace of the anomeric α-pyranosyl epimer and 
very minor quantities (3 %) of a by-product to which the furanosyl amide structure 95 was 
tentatively assigned; α-, β- and γ-amino acids were transferred with equal efficiency. The 
aspartic acid amide 94j (Table 1, entry 5) was the most difficult to obtain, but could still be 
isolated in 77 % yield, as opposed to the yield of 32 % obtained under the same conditions with 
phosphane 81j.2 
 
Table 1. Synthesis of α- and β-glucosylaminoacids 93 and 94 by ligation of  α- and β-
glucosylazides 7 and 10 with 83j-n 
Entry Phosphine Azide Product Isolated yieldsa  (%) 
α/β 
ratiob Pyranose/Furanose ratio
c
 
1 83j 7 93j 56 98:2 85:15 
2 83k 7 93k 59 98:2 87:13 
3 83l 7 93l 60
 98:2 90:10 
4 83m 7 93m 36 (12)d 98:2 67:33 
5 83j 10 94j 77 < 1:99  98:2 
6 83k 10 94k 87 < 1:99 98:2 
7 83l 10 94l 85 < 1:99 98:2 
8 83m 10 94m 75 < 1:99 97:3 
9 83n 10 94n 70 < 1:99 98:2 
a) Yields based on glucopyranosylamide b) Ratio of the anomeric proton signals of the α- and β-pyranosylamides 
93 and 94 in  the crude 1H-NMR spectrum c) Ratio of the anomeric proton signals in the crude 1H-NMR spectrum. 
d) Isolated yield of furanosyl amide 95m. 
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A significant difference in the reactivity of α- and β-glucopyranosyl azides towards the traceless 
Staudinger ligation was noted, in particular reaction of α-glucosyl azide 7 (Table 1, entries 1-4) 
with 83j-m afforded the corresponding α-amide 93j-m in lower yields compared to the β-
anomers 94j-n formed from 10 (Table 1, entries 5-9). 
In 2010 Field and co-worker4 reported a comparison of X-ray crystallographic data for both the 
α- and β-peracetylated glucopyranosyl azides 1 and 2 highlighted the impact of anomeric effect 
on the dipolar character of the anomeric azides, which likely accounts for the observed reactivity 
difference. This comparison revealed that the acetylated glucopyranose rings of 1 and 2 are very 
similar, except for the anomeric azido groups having different configurations (axial vs 
equatorial). In addition, the interatomic distances within the C(1)-N(A)-N(B)-N(C) fragment 
(Table 2 and Figure1) are in keeping with the expected influence of the anomeric effect. The 
C(1)-N(A) distance in 1 is shorter than the corresponding distance in 2; the terminal N(B)-N(C) 
bond is shorter than the inner N(A)-N(B) bond in β-isomer 1, whereas in α-isomer 2 these bonds 
are more similar value. 
 
 
 
Figure 1. Resonance structures for α- and β-glucopyranosyl azides 
 
Table 2. Interatomic distance (Å) for CN3 fragment in tetra-O-acetyl-glucosyl azides 1 and 2 
 β-azide 1 α-azide 2 
C(1)-N(A) 1.460 1.510 
N(A)-N(B) 1.243 1.165 
N(B)-N(C) 1.119 1.195 
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This particular difference between the azido group in 1 and 2 indicates a significant difference in  
electron distribution within this group for two isomeric compounds, which manifest itself as a 
difference in dipolar charge character and hence the different reaction rates. 
The higher reactivity of β-azides 1 can be interpreted as a result of a partial negative charge on 
atom N(A). 
 
 
5.2 Synthesis of other β-glycosyl amino acids 
 
To probe the scope of the fluorinated phosphines 83, other β-unprotected glycosyl azides were 
tested in the Staudinger ligation (Scheme 5, Table 3). The reactions of phosphines 83j-n with β-
galactosyl azide 43, β-fucosyl azide 50 and β-glucosyl-N-acetyl azide 42 were performed and 
afforded the corresponding glycosyl amides 105, 106 and 107 in good yields. 
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Scheme 5. Synthesis of β- amides 105-107 with 83j-n 
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1H NMR analysis of the crude reaction mixtures showed no trace of the anomeric α-pyranosyl 
epimer. Variable quantities (5-13 %) of the isomeric furanosyl amides were formed, depending 
both on the nature of the azide and the amino acid transferred (see Table 3). In all cases, this by-
product could be separated from the pyranose isomer by flash chromatography. With the β-
galactosyl azide 43, β- and γ-amino acids were transferred with an average yield of 70 % (Table 
3, entries 1-4). Similar results were obtained with β-fucosyl azide 50 (Table 3, entries 5-9). β-
Glucosyl-N-acetyl azide 105 was found to be less reactive and the corresponding amides were 
formed in an average yield of 55 % (Table 3, entries 10-12).5 Comparison with the yields 
obtained with the corresponding β-glucosyl azide 10 (Table 1, entries 5-7), which on average are 
higher by 30 %, suggests a deactivating role of the acetamido group in 42. 
Table 3. Synthesis of β-amides 105-107 with 83j-n.  
Entry Phosphine Azide Product Isolated yieldsa  (%) Pyranose/Furanose ratiob 
1 83j 43 105j 74 - 
2 8k 43 105k 70 5 % 
3 83l 43 105l 71
 10 %  
4 83m 43 105m 73 5 % 
5 83j 50 106j 60c 9 % 
6 83k 50 106k 68
 c 9 % 
7 83l 50 106l 70
 c 13 % 
8 83m 50 106m 75
 c 6 % 
9 83n 50 106n 87 c - 
10 83j 42 107j 56 - 
11 83k 42 107k 54 - 
12 83l 42 107l 50 - 
 
a) Yields based on β-pyranosylamide . b) Ratio of the anomeric proton signals estimated from 1H-NMR spectra of 
the crude reaction mixtures. c. ca. 10 % of hydrolysis product (fucose) also observed  
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The propensity of galactopyranose and fucopyranose (Table 3, entries 2-8) to gives the formation 
of furanose configuration, in non aqueous media was already known in literature.6  
The β-galactosyl, β-fucosyl and β-Glucosyl-N-acetyl amides were purified by flash 
chromatography on silica gel (CHCl3/MeOH/H2O 80:20:2 or CHCl3/MeOH 80:20) and fully 
characterized as their acetylated counterparts 108j-l, 109j-n and 110j-k (Scheme 6). 
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Scheme 6. Acetylated compounds 108j-l, 109j-n and 110j-k 
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5.3 Conclusions 
 
The results reported shown that unprotected α- and β-glycosyl azides can be stereoselectively 
ligated to α-, β- and γ-amino acids by traceless Staudinger ligation using fluorinated phosphines 
83. All the N-glycosyl amino acid products could be isolated from the crude reaction mixtures by 
simple water extraction and were further purified by flash chromatography on silica gel. 
The starting phosphine 60 is not commercially available, but it can be easily prepared on the 
gram scale by following the reported procedure (Chapter 3).1 It is stable to air at room 
temperature for weeks and can be handled with no special precautions. 
Acylation followed by silica gel filtration affords the ligation agents 83j-n, which can be used 
without further purification. The stereoselective synthesis of the required azide precursors has 
been reported in the Chapter 2. The ligation method described herein works reliably well for 
unprotected β-azides of the gluco, galacto and fuco series. Lower yields (ca. 55 %) were 
obtained with β-glucosyl-2-N-acetyl and α-glycosyl azides. Only one method for the synthesis of 
β-D-2-deoxy-2-N-acetylglucopyranosyl-asparagine from unprotected N-acetylglucosamine has 
been described.7 
There are only a handful of methods that can be used to synthesize α-N-glycosyl amides,2, 8, 9, 10 
among them, the traceless Staudinger ligation of α-glycosyl azides with functionalized 
phosphines was found to perform poorly with amino acids. The fluorophenylphosphines 83j-n 
described allow the synthesis of α-N-glucosyl amino acids in reasonable yields and in a 
synthetically practical manner. 
The elaboration of unprotected carbohydrates has received considerable attention in recent 
years.11, 12, 13 Unprotected glycosyl amino acids can be used directly for the linear synthesis of 
glycopeptides (direct insertion of the glycosyl amino acid into a growing peptide chain).10, 14 
Methods of glycopeptide synthesis that do not involve protected sugars do not require further 
manipulation of the sugar, which can lead to racemization of the amino acid.15 
Beyond affording N-glycosylated Asn and Gln building blocks, the functionalized phosphines 
described in this chapter could also be used to achieve traceless ligation of glycosyl azides to 
glycine, proline and to the non-proteinogenic amino acid β-Ala. 
The resulting compound are not meant to be incorporated into N-glycopeptides sequences, but 
can be used for the bioconjugation of carbohydrates to aglycons using chemically stable bonds 
and for the design of carbohydrate mimics which may resist in vivo to hydrolytic enzymes.16, 17 
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5.4 Experimental Section 
 
Solvents were dried by standard procedures: dichloromethane, methanol, N,N-
diisopropylethylamine and triethylamine were dried over calcium hydride; N,N-
dimethylacetamide (DMA), 1,3-dimethyltetrahydro-2(1H)pyrimidinone (DMPU), chloroform 
and pyridine were dried over activated molecular sieves. Reactions requiring anhydrous 
conditions were performed under nitrogen. 1H, 13C and 31P-NMR spectra were recorded at 400 
MHz on a Bruker AVANCE-400 instrument. Chemical shifts (δ) for 1H and 13C spectra are 
expressed in ppm relative to internal Me4Si as standard. Signals were abbreviated as s, singlet; 
bs, broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet. Mass spectra were obtained with a 
Bruker ion-trap Esquire 3000 apparatus (ESI ionization) or an Autospec Fission Instrument 
(FAB ionization) and FT-ICR Mass Spectrometer APEX II & Xmass software (Bruker 
Daltonics) - 4.7 Magnet. Thin layer chromatography (TLC) was carried out with pre-coated 
Merck F254 silica gel plates. Flash chromatography (FC) was carried out with Macherey-Nagel 
silica gel 60 (230-400 mesh).  
 
 
 
General procedure for stereoselective ligation of 3 in DMA:DMPU mixtures. 
 
The phosphine (2 eq) was added, at room temperature, to a 0.1 M solution of azide (1 eq) in 98:2 
N,N-dimethylacetamide and DMPU. The solution was stirred for 16 h at 40 °C, then water was 
added and the mixture was stirred for an additional 2H at the same temperature. The solvent was 
evaporated under reduced pressure, and the residue was diluted with water and extracted with 
CH2Cl2. The water layer was evaporated under reduced pressure and the crude was purified as 
indicated below for each compound. 
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Nα-(Benzyloxycarbonyl)-Nγ-(α-D-glucopyranosyl)-L-asparagine O-Methyl Ester (93j) 
 
OHO
OH
HO
HO
O
HN COOMe
NHCbz
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.35) or 
automated reverse phase chromatography (H2O:CH3CN gradient);  
1H-NMR (400 MHz, D2O, 25°C): δ = 7.42-7.28 (m, 5H, Ph), 5.48 (d, J1,2 = 5.6 Hz, 1H, H-1), 
5.06 (bs, 2H, CH2O), 4.55 (t, J = 6.4 Hz, 1H, CH), 3.72 (dd, J2,3 = 5.6 Hz, 1H, H-2), 3.54-3.76 
(m, 4H, H-3, H-4, H-5, H-6), 3.68 (s, 3H, OCH3), 3.34 (m, 1H, H-6’), 2.88 (d, J = 6.4 Hz, 2H, 
CH2). 13C-NMR (100 MHz, D2O):δ 179.4, 128.8, 128.4, 127.6, 76.6 (C-1), 72.9 (C-3), 72.6 (C-
5), 69.2 (C-2), 69.1 (C-4), 67.3 (CH2O), 60.5 (C-6), 53.14 (OCH3), 50.8 (CH). MS (ESI): m/z = 
465.2 [M + Na]+. [α]D25 = + 57.2 (c 0.2, MeOH). Yield = 55 %. 
 
 
Nα-(Benzyloxycarbonyl)-Nδ-(α-D-glucopyranosyl)-L-glutamine O-Methyl Ester (93k) 
 
OHO
OH
HO
HO
O
NHCbz
COOMe
HN
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.33); 
1H-NMR (400 MHz, D2O, 25°C): δ = 7.42-7.28 (m, 5H, Ph), 5.52 (d, J1,2 = 5.5 Hz, 1H, H-1), 
5.10 (s, 2H, CH2O), 4.20 (q, J = 5 Hz, JCH,CH2 = 9 Hz, 1H, CH), 3.72 (m, 4H, H-2, OCH3), 3.54-
3.76 (m, 6H, H-3, H-4, H-5, H-6, H-6’), 2.47 (t, J = 7 Hz, 2H, COCH2), 2.18 (m, 1H, Ha, CH2), 
1.95 (m, 1H, Hb, CH2). MS (ESI): m/z = 457.3 [M + H]+. [α]D25 = + 50.4 (c 0.3, MeOH). Yield = 
59 %. 
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N-(N-Benzyloxycarbonyl-β-alanyl)-α-D-glucopyranosylamine (93l) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.38);  
1H-NMR (400 MHz, D2O, 25°C): δ = 7.41-7.33 (m, 5H, Ph), 5.52 (d, 1H, J1,2 = 5.4 Hz, H-1) 5.05 
(s, 2H, CH2O), 3.78-3.58 (m, 4H, H-2, H-6, H-6’), 3.50-3.27 (m, 4H, CH2), 2.53-2.48 (m, 2H, 
CH2). 13C-NMR (100 MHz, D2O, 25°C): δ = 175.9, 158.2 (CO(Cbz)), 136.4 (Cipso), 128.8, 128.5, 
127.7 (5xCAr), 76.6 (C-1), 73.0, 72.6, 69.3, 69.2, 66.9 (CH2O), 60.4 (C-6), 38.1 (CH2), 36.1 
(CH2). [α]D25 = + 46.4 (c 1, MeOH). Yield = 60 %. 
 
 
N-(N-Benzyloxycarbonylglycyl)-α-D-glucopyranosylamine (93m) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.23);  
1H-NMR (400 MHz, D2O, 25°C): δ = 7.43-7.29 (m, 5H, Ph), 5.53 (d, J1,2 = 5.6 Hz, 1H, H-1), 
5.09 (s, 2H, CH2O), 3.89 (bs, 2H, CH2), 3.87-3.34 (m, 6 H, H-2, H-3, H-4, H-5, H-6, H-6’). 13C-
NMR (100 MHz, D2O, 25°C): δ = 170.3, 128.8, 128.4, 127.8 (5xCAr), 79.4 (C-1), 76.7, 72.7, 
72.4, 69.4, 67.3 (CH2O), 60.6 (C-6), 43.4 (CH2). [α]D25 = + 16.3 (c 0.5, MeOH). Yield = 36 %. 
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Nα-(Benzyloxycarbonyl)-Nγ-(β-D-glucopyranosyl)-L-asparagine O-Methyl Ester (94j) 
 
OHO
OH
HO
HO
O
H
N COOMe
NHCbz
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.43); 
1H-NMR (400 MHz, D2O, 25°C): δ = 7.45-7.35 (m, 5H, Ph), 5.10 (s, 2H, CH2O), 4.96 (d, J1,2 = 
9.2 Hz, 1H, H-1), 4.65 (t, J = 6.4 Hz, 1H, CH-N), 3.88 (dd, J6,6’ = 12.4 Hz, J5,6 = 2.4 Hz, 1H, H-
6), 3.80-3.69 (m, 4H, H-6’, OCH3), 3.60-3.51 (m, 2H, H-4, H-5), 3.46-3.37 (m, 2H, H-3, H-2), 
2.95-2.89 (m, 2H, CH2). 13C-NMR (100 MHz, D2O, 25°C): δ  = 173.4, 173.1, 157.7 (CO(Cbz)), 
136.2 (Cipso), 128.8, 128.4, 127.6 (5xCAr), 79.2 (C-1), 77.5 (C-5), 76.4 (C-4), 71.7 (C-2), 69.2 
(C-3), 67.2 (CH2O), 53.1 (OCH3), 50.6 (CH), 37.1 (CH2). MS (FAB): m/z = 465 [M + Na]+. 
[α]D25 = - 0.6 (c 1, MeOH). Yield = 77 %. 
 
 
Nα-(Benzyloxycarbonyl)-Nδ-(β-D-glucopyranosyl)-L-glutamine O-Methyl Ester (94k) 
 
OHO
OH
HO
HO
O
NHCbz
COOMe
H
N
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.47);  
1H-NMR (400 MHz, D2O, 25°C): δ = 7.49-7.38 (m, 5H, Ph), 5.14 (s, 2H, CH2O), 4.95 (d, J1,2 = 
9.2 Hz, 1H, H-1), 4.25 (m, 1H, CH-N), 3.86 (dd, J5,6 = 2 Hz, J6,6’ = 12.4 Hz, 1H, H-6), 3.72 (s, 
3H, OCH3), 3.67 (dd, J5,6’ = 5.2 Hz, 1H, H-6’), 3.54-3.47 (m, 2H, H-4, H-5), 3.44-3.35 (m, 2H, 
H-3, H-2), 2.44 (t, J = 7.6 Hz, 2H, CH2CO), 2.27-2.18 (m, 1H, Ha, CH2CH), 2.04-1.95 (m, 1H, 
Hb, CH2CH). 13C-NMR (100 MHz, D2O, 25°C): δ = 176.2, 174.2, 158 (CO(Cbz)), 136.3 (Cipso), 
128.8, 128.4, 127.6 (5xCAr), 79.2 (C-1), 77.5 (C-5), 76.4 (C-4), 71.8 (C-2), 69.2 (C-3), 67.2 
(CH2O), 60.5 (C-6), 53.5 (CH), 52.9 (OCH3), 31.7 (CH2CO), 26.2 (CH2). MS (FAB): m/z = 479 
[M + Na]+. [α]D25 = - 10 (c 1, MeOH). Yield = 87 %. 
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N-(N-Benzyloxycarbonyl-β-alanyl)-β-D-glucopyranosylamine (94l) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.34);  
1H-NMR (400 MHz, D2O, 25°C): δ = 7.50-7.38 (m, 5H, Ph), 5.11 (s, 2H, CH2O), 4.97 (d J1,2 = 
8.8 Hz, 1H, H-1),  3.88 (d, J6,6’ = 12.4 Hz, 1H, H-6), 3.72 (dd, J6,6’ = 12.4 Hz, 1H, H-6’), 3.60-
3.30 (m, 6H, H-5, H-4, H-2, H-3, CH2NHCbz), 2.54 (t, 2H, CH2). 13C-NMR (100 MHz, D2O, 
25°C): δ = 175.3, 158.2 (CO(Cbz)), 136.4 (Cipso), 128.8, 128.3, 127.6 (5xCAr), 79.2 (C-1), 77.5 (C-
5), 76.4 (C-4), 71.7 (C-2), 69.2 (C-3), 66.9 (CH2O), 60.5 (C-6), 36.7 (CH2), 35.8 (CH2). MS 
(FAB): m/z = 407 [M + Na]+. [α]D25 = + 3.5 (c 0.7, MeOH). Yield = 85 %. 
 
 
 
 
N-(N-Benzyloxycarbonylglycyl)-β-D-glucopyranosylamine (94m) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.32);  
1H-NMR (400 MHz, D2O, 25°C): δ = 7.45-7.30 (m, 5H, Ph), 5.09 (s, 2H, CH2O), 4.94 (d, J1,2 = 
9.2 Hz, 1H, H-1), 3.88-3.77 (m, 3H, CH2, H-6), 3.64 (dd, J5,6’ = 5.2 Hz, J6,6’ = 12.4 Hz, 1H, H-
6’), 3.53-3.44 (m, 2H, H-5, H-3), 3.39-3.28 (m, 2H, H-2, H-4). 13C-NMR (100 MHz, D2O, 
25°C): δ  = 173.4, 158.6 (CO(Cbz)), 136.2 (Cipso), 128.8, 128.2, 127.7 (5xCAr), 79.3 (C-1), 77.6, 
76.4 , 71.7, 68.9, 66.4 (CH2O), 60.5 (C-6), 43.7 (CH2). [α]D25 = + 4.1 (c 1, MeOH). Yield = 75 
%. 
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N-(N-tert-Butoxycarbonyl-L-prolyl)-β-D-glucopyranosylamine (94n) 
 
O
NHHO
OH
HO
HO
O
Boc
N
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.36);  
1H-NMR (400 MHz, MeOD, 25°C): δ = 4.95 (d, J1,2 = 8.8 Hz, 1H, H-1), 4.26 (dd, J = 3.6 Hz, J = 
8.4 Hz, 1H, CH), 3.87 (bdd, J6,6’ = 11.6 Hz, 1H, H-6), 3.75-3.68 (m, 1H, H-6’), 3.63-3.52 (m, 
1H, CH2CH, Ha), 3.51-3.42 (m, 2H, H-3, CH2CH, Hb), 3.41-3.30 (m, 3H, H-2, H-4, H-5), 2.37-
2.18 (m,1H, Hc), 2.08-1.88 (m, 3H, Hd, CH2), 1.50 (m, 9 H, Boc). 13C-NMR (100 MHz, MeOD, 
25°C): δ = 81.4 (C-1), 79.8, 79.1, 74.2, 71.6, 62.8 (C-6), 61.8 (CH), 48 (CH2), 32 (CH2), 28.8 
(Boc), 25.1 (CH2). FT-ICR MS (ESI): calcd. for C16H28N2O8 Na [M +Na]+ 399.17379; found 
399.17314. [α]D25 = - 39.2 (c 0.6, MeOH). Yield = 70 %. 
 
 
 
Nα-(Benzyloxycarbonyl)-Nγ-(β-D-galactopyranosyl)-L-asparagine O-Methyl Ester (105j) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.18);  
1H-NMR (400 MHz, MeOD, 25°C): δ = 7.42-7.28 (m, 5H, Ph), 5.11 (s, 2H, CH2O), 4.58 (m, 1H, 
CH), 3.89 (d, J = 2.4 Hz, 1H, H-4), 3.77-3.64 (m, 5H, H-6, H-6’, OCH3), 3.63-3.47 (m, 3H, H-2, 
H-3, H-5), 2.89-2.78 (m, 2H, CH2). 13C-NMR (100 MHz, MeOD, 25°C): δ = 129.6, 129.1, 129 
(5xCAr), 81.6 (C-1), 78.4, 75.9, 71.4, 70.6 (C-4), 67.9 (C-6), 62.7 (CH2O), 53.1 (OCH3), 52.1 
(CH), 38.2 (CH2). Yield = 74 %. 
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Nα-(Benzyloxycarbonyl)-Nδ-(β-D-galactopyranosyl)-L-glutamine O-Methyl Ester (105k) 
 
 
 
1H-NMR (400 MHz, DMSO, 25°C): δ = 7.47-7.7.26 (m, 5H, Ph), 5.04 (s, 2H, CH2O), 4.63 (d, 
J1,2 = 5.2 Hz, 1H, H-1), 4.10-4.01 (m, 1H, CH), 3.70-3.67 (m, 1H, H-5), 3.64 (s, 3H, OCH3), 
3.52-3.31 (m, 5H, H-2, H-3, H-4, H-6, H-6’), 2.25-2.20 (t, J = 7.6 Hz, 2H, CH2), 2.03-1.95 (m, 
1H, Ha, CH2CH), 1.78-1.73 (m, 1H, Hb, CH2CH). 13C-NMR (100 MHz, DMSO, 25°C): δ = 
172.6, 171.6, 156.1 (CO(Cbz)), 136.8 (Cipso), 128.3, 127.7, 127.1 (5xCAr), 79.9 (C-1), 76.7, 74.1, 
69.7, 68.2, 65.5 (CH2O), 60.4 (C-6), 53.5 (CH), 51.8 (OCH3), 31.6 (CH2CO), 26.3 (CH2). Yield 
= 70 %. 
 
N-(N-Benzyloxycarbonyl-β-alanyl)-β-D-galactopyranosylamine (105l) 
 
 
 
1H-NMR (400 MHz, DMSO, 25°C): δ = 7.46-7.29 (m, 5H, Ph), 5.04 (s, 2H, CH2O), 4.70 (d, J1,2 
= 8.8 Hz, 1H, H-1), 3.71 (d, J = 2.4 Hz, 1H, H-4), 3.54-3.29 (m, 5H, H-2, H-3, H-5, H-6, H-6’), 
3.27-3.23 (m, 2H, CH2), 2.41-2.28 (m, 2H, CH2). 13C-NMR (100 MHz, DMSO, 25°C): δ = 
170.6, 155.9 (CO(Cbz)), 137.2 (Cipso), 128.4, 127.8, 127.7 (5xCAr), 79.8 (C-1), 76.6, 73.9, 69.5, 
68.1 (C-4), 62.2 (CH2O), 60.4 (C-6), 36.6 (CH2), 35.5 (CH2). Yield = 71 %. 
 
N-(N-Benzyloxycarbonylglycyl)-β-D-galactopyranosylamine (105m) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.35);  
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1H-NMR (400 MHz, MeOD, 25°C): δ = 7.42-7.28 (m, 5H, Ph), 5.14 (s, 2H, CH2O), 4.92 (d, J1,2 
= 8.8 Hz, 1H, H-1), 3.95-3.83 (m, 3H, H-5, CH2), 3.78-3.70 (m, 2H), 3.60-3.58 (m, 2H, H-2), 
3.55-3.52 (dd, J5,6’ = 3.2 Hz, J6,6’ = 9.6 Hz, 1H, H-6’). 13C-NMR (100 MHz, MeOD, 25°C): δ = 
172.9, 159.1 (CO(Cbz)), 138.1 (Cipso), 129.5, 129.0, 128.9 (5xCAr), 81.6 (C-1), 78.3, 75.7, 71.4, 
70.4, 67.9 (CH2O), 62.6 (C-6), 46.1 (CH2). Yield = 73 %. 
 
Nα-(Benzyloxycarbonyl)-Nγ-(β-D-fucopyranosyl)-L-asparagine O-Methyl Ester (106j) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20, Rf = 0.45);  
1H-NMR (400 MHz, MeOD, 25°C): δ = 7.41-7.31 (m, 5H, Ph), 5.12 (s, 2H, CH2O), 4.60 (m, 1H, 
Ha, CH-N), 3.68 (s, 3H, OCH3), 3.67-3.56 (m, 3H, H-2, H-3, H-5), 3.52 (d, J = 6.4 Hz, 1H, H-4), 
2.84 (m, 2H, CH2CH), 1.25 (d, J5,6 = 8 Hz, 3H, H-6). 13C-NMR (100 MHz, MeOD, 25°C) : δ = 
173.5, 172.8, 158.4 (CO(Cbz)), 138.1 (Cipso), 129.5, 128.8 (5xCAr), 81.3 (C-1), 75.9, 73.7, 73.1, 
71.1, 67.1 (CH2O), 53.0 (OCH3), 52.0 (CH), 38.5 (CH2), 16.9 (C-6). FT-ICR MS (ESI): calcd. 
for C19H26N2O9Na [M +Na]+ 449.15305; found 449.15235. [α]D25 = -0.04 (c 0.6, MeOH). Yield 
= 60 % 
 
Nα-(Benzyloxycarbonyl)-Nδ-(β-D-fucopyranosyl)-L-glutamine O-Methyl Ester (106k) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20, Rf = 0.68);  
1H-NMR (400 MHz, D2O, 25°C) : δ = 7.52-7.43 (m, 5H, Ph), 5.18 (s, 2H, CH2O), 4.92 (d, 1H, 
J1,2 = 9.2 Hz, H-1), 4.30 (m, 1H, CH), 3.89-3.67 (m, 6 H, H-3, H-4, H-5, OCH3), 3.59 (t, 1H, J2,3 
= 9.2 Hz, H-2), 2.47 (m, 2H, CH2CO), 2.24 (m, 1H, Ha, CH2), 2.06 (m, 1H, Hb, CH2), 1.25 (d, 
3H, J5,6 = 6.4 Hz, H-6). 13C-NMR (100 MHz, D2O, 25°C) : δ = 175.8, 174.0, 157.8 (CO(Cbz)), 
136.0 (Cipso), 128.6, 128.2, 127.4 (5xCAr), 79.3 (C-1), 73.3 (C-2), 72.4, 71.2, 68.9, 67.0 (CH2O), 
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53.4 (CH), 52.7 (OCH3), 31.5 (CH2CO), 26.0 (CH2CH), 15.3 (C-6). FT-ICR MS (ESI): calcd. for 
C20H28N2O9 Na [M +Na]+ 463.16870; found 463.16891. [α]D25 = -23.4 (c 0.2, MeOH). Yield = 
68 %. 
 
N-(N-Benzyloxycarbonyl-β-alanyl)-β-D-fucopyranosylamine (106l) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.35);  
1H-NMR (400 MHz, D2O, 25°C): δ = 7.49-7.39 (m, 5H, Ph), 5.11 (s, 2H, CH2O), 4.91 (d, 1H, 
J1,2 = 9.2 Hz, H-1), 3.85 (q, 1H, J5,6 = 6.4 Hz, H-5), 3.79 (d, 1H, J3,4 = 3.2 Hz, H-4), 3.71 (dd, 1H, 
J2,3 = 9.4 Hz, H-3), 3.59 (t, 1H, H-2), 3.43 (t, 2H, CH2) 2.53 (m, 2H, CH2CO), 1.24 (d, 3H, H-6). 
13C-NMR (100 MHz, D2O, 25°C): δ = 175.1, 158.2 (CO(Cbz)), 136.4 (Cipso), 128.7, 128.3, 127.7 
(5xCAr), 79.4 (C-1), 73.5 (C-3), 72.5 (C-5), 71.4 (C-4), 69.1 (C-2), 66.9 (CH2O), 36.7 (CH2), 
35.7 (CH2CO), 15.6 (C-6). FT-ICR MS (ESI): calcd. for C17H24N2O7Na [M +Na]+ 391.14757; 
found 391.14714. [α]D25 = - 14.1 (c 1, MeOH). Yield = 70 %. 
 
 
 
N-(N-Benzyloxycarbonylglycyl)-β-D-fucopyranosylamine (106m) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf  = 0.34);  
1H-NMR (400 MHz, D2O, 25°C): δ = 7.52-7.37 (m, 5H, Ph), 5.19 (s, 2H, CH2O), 4.96 (d, 1H, 
J1,2 = 9 Hz, H-1), 3.95 (d, 2H, J = 3.4 Hz, CH2), 3.89 (q, 1H, J5,6 = 6.4 Hz, H-5), 3.82 (dd, 1H, 
J3,4 = 3.4 Hz, H-4), 3.74 (dd, 1H, J2-3 = 9.4Hz, H-3), 3.64 (t, 1H, H-2), 1.26 (d, 3H, H-6). 13C-
NMR (100 MHz, D2O, 25°C): δ = 173.2, 158.6 (CO(Cbz)), 136.2 (Cipso), 128.8, 128.5, 127.8 
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(5xCAr), 79.6 (C-1), 73.5 (C-3), 72.7 (C-5), 71.4 (C-4), 69.1 (C-2), 67.4 (CH2O), 43.5 (CH2), 
15.5 (C-6). FT-ICR MS (ESI): calcd. for C16H22N2O7Na [M +Na]+ 377.13192; found 377.13165. 
[α]D25 = - 12.1 (c 1, MeOH). Yield = 75 %. 
 
N-(N-tert-Butoxycarbonyl-L-prolyl)-β-D-fucopyranosylamine (106n) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.48);  
1H-NMR (400 MHz, MeOD, 25°C): δ = 4.21-4.13 (m, 1H, CH), 3.70 (q, J5,6 = 6.4 Hz, 1H, H-5), 
3.64 (s, 1H, H-4), 3.56-3.47 (m, 3H, H-2, H-3, Ha), 3.43-3.37 (m, 1H, Hb), 2.31-2.17 (m, 1H, Hc, 
CH2), 2.15-1.78 (m, 3H, CH2, Hd), 1.52-1.39 (bs, 9 H, Boc), 1.21 (d, 3H, H-6). 13C-NMR (100 
MHz, MeOD, 25°C): δ = 176.8, 156.3 (COBoc), 81.5 (C-1), 76.3, 73.7 (C-5), 73,4 (C-4), 71.3, 
61.9 (CH), 48.0 (CH2), 32.6 (CH2), 28.8 (Boc), 24.8 (CH2), 17.1 (H-6). FT-ICR MS (ESI): calcd. 
for C16H28N2O7Na [M +Na]+ 383.17887; found 383.17848. [α]D25 = - 49.7 (c 1, MeOH). Yield = 
87 %. 
 
 
 
Nα-(Benzyloxycarbonyl)-Nγ-(2-acetamido-2-deoxy- β-D-glucopyranosyl)-L-asparagine O-
Methyl Ester (107j) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20, Rf = 0.20); 
1H-NMR (400 MHz, MeOD, 25°C) : δ = 7.39-7.31 (m, 5H, Ph), 5.11 (s, 2H, CH2O), 4.96 (d, J1,2 
= 9.7 Hz, 1H, H-1), 4.60 (t, JCH-CH2 = 6.8 Hz, 1H, CH-N), 3.85 (bd, J6,6’ = 11.8 Hz, 1H, H-6), 
3.77-3.70 (m, 4H, H-2, OCH3), 3.66 (dd, J5,6’ = 3.8 Hz, 1H, H-6’), 3.47 (m, 1H, H-3), 3.40-3.32 
(m, 2H, H-4, H-5), 2.73 (t, 2H, CH2), 1.94 (s, 3H, NHAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ 
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= 174.6, 173.5, 172.6, 129.6, 129.2, 129.0 (5xCAr), 80.4 (C-1), 79.9, 76.5 (C-3), 72.0, 67.9 
(CH2O), 62.8 (C-6), 56.2 (C-2), 53.1 (OCH3), 52.2 (CH), 38.7 (CH2), 23.0 (CH3). MS (FAB): 
m/z = 484 [M +1]+. [α]D25 = + 19.2 (c 1, MeOH). Yield = 56 %. 
 
Nα-(Benzyloxycarbonyl)-Nγ-(2-acetamido-2-deoxy- β-D-glucopyranosyl)-L-glutamine-O-
Methyl Ester (107k) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20, Rf = 0.42); 
1H-NMR (400 MHz, MeOD, 25°C): δ = 7.45 (m, 5H, Ph), 5.15 (s, 2H, CH2O), 5.05 (d, J1,2 = 9.7 
Hz, 1H, H-1), 4.20 (m, 1H, CH), 3.47-3.81 (m, 6 H, H-2, H-3, H-4, H-5, H-6, H-6’), 3.75 (s, 3H, 
OCH3), 2.38 (t, J = 7.4 Hz, 2H, CH2CO), 2.15-2.05 (m, 1H, Ha, CH2), 2.03-1.92 (m, 4H, Hb, 
NHAc). 13C-NMR (100 MHz, MeOD, 25°C) : δ = 175.7, 174.8, 152.6 (CO(Cbz)), 136.4 (Cipso), 
128.9, 128.5, 127.7 (5xCAr), 78.4 (C-1), 77.6, 74.2, 69.6, 67.3 (CH2O), 60.6 (C-6), 54.4 (CH), 
53.6 (C-2), 53.0 (OCH3), 31.8 (CH2CO), 26.3 (CH2), 22.0 (OCH3). FT-ICR MS (ESI): calcd. for 
C22H31N3O10Na [M +Na]+ 520.19017; found 520.19006. [α]D25 = + 3.5 (c 0.6, MeOH). Yield = 
54 %. 
 
N-(N-Benzyloxycarbonyl-β-alanyl)-2-acetamido-2-deoxy-β-D-glucopyranosylamine (107l) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH:H2O 80:20:2, Rf = 0.24);  
1H-NMR (400 MHz, MeOD, 25°C): δ = 7.31-7.24 (m, 5H, Ph), 5.01 (s, 2H, CH2O), 4.91 (d, J1,2 
= 9.6 Hz, 1H, H-1) 3.78 (d, J6,6’ = 11.6 Hz, 1H, H-6), 3.69 (t, J2,3 = 10 Hz, 1H, H-2), 3.60 (dd, 
J5,6’ = 2.4 Hz, 1H, H-6’), 3.39 (m, 1H, H-3), 3.31-3.24 (m, 4H, H-4, H-5, CH2), 2.34 (t, J = 6.7 
Hz, 2H, CH2), 1.88 (s, 3H, NHAc). 13C-NMR (100 MHz, D2O, 25°C): δ = 173.0, 172.8, 157.2 
(CO(Cbz)), 136.9 (Cipso), 128.1, 127.6, 127.4 (5xCAr), 78.9 (C-1), 78.1, 74.9 (C-3), 71.1, 66.1 
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(CH2O), 61.3 (C-6), 54.8 (C-2), 37.9 (CH2), 35.8 (CH2), 21.4 (CH3). MS (FAB): m/z = 448 [M + 
Na]+. [α]D25 = + 18.6 (c 1, MeOH). Yield = 60 %. 
 
General procedure for acetylation of unprotected glycosyl amides. 
 
Acetic anhydride (10 eq) and a catalytic amount of N,N-dimethylaminopyridine were added, at 
room temperature, to a solution of substrate (1 eq) in pyridine dried on molecular sieves (0.1 M). 
The solution was stirred for 24H and then was concentrated in vacuo. The residue was dissolved 
in AcOEt and washed with aqueous 5 % HCl, aqueous 5 % NaHCO3 and water. The organic 
layer was dried over Na2SO4 and concentrated to give the product in quantitative yield.  
 
Nα-(benzyloxycarbonyl)-Nγ-(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)-L-asparagine-O-
Methyl Ester (103j) 
 
OAcO
OAc
AcO
AcO
NH
NHCbzO
COOMe
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.41-7.32 (m, 5H, Cbz), 6.78 (s,1H, NH), 5.95 (m, 1H, 
NH-Cbz), 5.85 (t, J1,2 = 6.4Hz, JN-H = 6.4 Hz, 1H, H-1), 5.48 (t, J3,4 = 9.6 Hz, J2,3 = 9.6 Hz, 1H, 
H-3), 5.17 (m, 1H, H-2), 5.17 (m, 2H, CH2O), 5.08 (m, 1H, H-4) 4.65 (m, 1H, CH), 4.30 (dd, J5,6 
= 2.4 Hz, J6,6’ = 12.4Hz, 1H, H-6), 4.08 (m, 1H, H-6’), 3.92 (m, 1H, H-5), 3.75 (s, 3H, OCH3), 
3.03 (m, 1H, Ha, CH2), 2.85 (m, 1H, Hb, CH2). 
 
Nα-(benzyloxycarbonyl)-Nδ-(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)-L-glutamine-O-
Methyl Ester (103k) 
 
OAcO
OAc
AcO
AcO
O
NHCbz
COOMe
HN
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1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.50-7.48 (m, 1H, NH), 7.42-7.32 (m, 5H, Cbz), 5.90 (t, 
J1,2 = 6 Hz, JN-H = 6 Hz, 1H, H-1), 5.62 (d, J1,NH-Cbz = 8.6 Hz, 1H, NHCbz,), 5.51 (m,1H, H3), 
5.20 (m, 2H, CH2O), 5.18 (m, 1H, H-2), 5.09 (m, 1H, H-4), 4.34 (m, 1H, CH), 4.27 (m, 1H, H-
6), 4.06 (m, 1H, H-6’), 4.04 (m, 1H, H-5), 3.75 (s, 3H, OCH3), 2.35 (m, 2H, CH2CO), 2.30 (m, 
1H, Ha, CH2), 2.05 (m, 12H, 4xOAc), 1.91 (m, 1H, Hb, CH2). 
HETCOR-NMR (400 MHz, CDCl3, 25°C): δ = 128.8, 128.5, 127.7, 73 (C-1), 72 (C-3), 71 (C-4), 
70 (C-5), 69 (C-2), 68 (CH), 64 (C-6), 54 (OCH3), 37-35 (2xCH2), 29 (4xOAc). 
 
N-(N-Benzyloxycarbonyl-β-alanyl)-2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl amine (103l) 
 
O
NH
AcO
OAc
AcO
AcO
O
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.45-7.26 (m, 5H, Ph), 6.95 (m, 1H, NH), 5.87 (m, 1H, 
H-1), 5.48-5.30 (m, 2H, NHCbz, H-3), 5.23-5-03 (m, 4H, CH2O, H-2, H-4), 4.26 (dd, J5,6 = 3.6 
Hz, J6,6’ = 12 Hz, 1H, H-6), 4.10-4.01 (bd, 1H, H-6’), 3.97-3.82 (m, 1H, H-5), 3.51 (m, 2H, 
CH2), 2.55 (m, 2H, CH2CO), 2.14-1.96 (m, 12H, 4xOAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ 
= 176.4, 172.4, 170.8, 169.5, 169.2, 156.9 (CO(Cbz)), 136.4 (Cipso), 128.7, 128.3, 128.2 (5xCAr), 
74.4 (C-1), 70.3 (C-3), 68.6 (C-2), 68.5 (C-4), 68.3 (C-5), 67.1 (CH2O), 61.9 (C-6), 37 (CH2), 
36.9 (COCH2), 20.7, 20.6, 19.7 (4xOAc). MS (FAB): m/z = 575 [M + Na]+. [α]D25 = + 44.0 (c 
0.5, CHCl3). Rf = 0.25 (hexane:AcOEt 40:60). 
 
N-(N-Benzyloxycarbonylglycyl)-2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl amine (103m) 
 
O
NH
AcO
OAc
AcO
AcO
O
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.32-7.20 (m, 5H, Ph), 6.78 (m, 1H, NH), 5.77 (bd, 1H, 
H-1),5.48-5.27 (m, 2H, H-3, NHCbz), 5.17-4.98 (m, 4H, H-2, H-4, CH2O), 4.75 (bdd, 1H, H-6), 
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4.27 (bdd, 1H, H-6’), 4.05-3.88 (m, 3H, H-5, CH2), 2.05-1.87 (m, 12H, 4xOAc). 13C-NMR (100 
MHz, CDCl3, 25°C): δ = 170.8, 170.3, 169.7, 169.3, 169.1, 158.2 (CO(Cbz)), 136.0 (Cipso), 128.8, 
128.5, 128.3 (5xCAr), 80.1 (C-1), 76.5 (C-3), 75.1, 73.9, 72.7, 68.4, 67.7(CH2O), 61.9 (C-6), 45.2 
(CH2), 20.8, 20.7, 20.6 (4xOAc). MS (FAB): m/z = 561 [M + Na]+. [α]D25 = + 14.7 (c 0.6, 
CHCl3). Rf = 0.24 (hexane:AcOEt 40:60). 
 
Nα-(benzyloxycarbonyl)-Nγ-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-L-asparagine-O-
Methyl Ester(104j) 
 
O
NHAcO
OAc
AcO
AcO
NHCbzO
COOMe
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.45-7.30 (m, 5H, Ph), 6.37 (d, JNH,1 = 9.2 Hz, 1H, NH), 
5.96 (d, J = 8.8 Hz, 1H, NHCbz), 5.29 (t, J2,3  = 9.6 Hz, J3,4 = 9.6 Hz, 1H, H-3), 5.20 (t, J1,2 = 9.6 
Hz, 1H, H-1), 5.12 (s, 2H, CH2O), 5.05 (t, 1H, H-4), 4.90 (t, 1H, H-2), 4.60 (m, 1H, CH), 4.29 
(dd, J5,6 = 4.4 Hz, J6,6’ = 12.6 Hz, 1H, H-6), 4.06 (m, J5,6’ = 2 Hz, J6,6’ = 12.6 Hz, 1H, H-6’), 3.77 
(m, 1H, H-5), 3.73 (s, 3H, OCH3), 2.89 (dd, JCH,Ha = 4.4 Hz, JHa,Hb = 16.4 Hz, Ha, 1H, CH2CO), 
2.70 (dd, JCH,Hb = 4 Hz, Hb, 1H, CH2CO), 2.10-1.98 (m, 12H, 4xOAc). 13C-NMR (100 MHz, 
CDCl3, 25°C): δ = 171.7, 171.6, 170.9, 170.2, 169.9, 156.4 (CO(Cbz)), 136.5 (Cipso), 128.9, 128.5, 
128.4 (5xCAr), 78.5 (C-1), 74.1 (C-5), 72.8 (C-3), 70.8 (C-2), 68.4 (C-4), 67.5 (CH2O), 61.9 (C-
6), 53.1 (OCH3), 50.7 (CH), 38.1 (CH2), 21.1, 20.9, 20.9 (4xOAc). MS (FAB): m/z = 611 [M + 
H]+. [α]D25 = + 11.4 (c 0.7, CHCl3). Rf = 0.31 (hexane:AcOEt 40:60). 
 
Nα-(benzyloxycarbonyl)-Nδ-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-L-glutamine-O-
Methyl Ester (104k) 
 
O
NHAcO
OAc
AcO
AcO
O
NHCbz
COOMe
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.40-7.32 (m, 5H, Ph), 6.58 (d, 1H, JNH,1 = 9.2 Hz, NH), 
5.55 (d, J = 8 Hz, 1H, NHCbz), 5.29 (t, J2,3  = 9.6 Hz, J3,4 = 9.6 Hz, 1H, H-3), 5.25 (m, 1H, H-1), 
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5.10 (s, 2H, CH2O), 5.07 (t, J3,4 = 9.6 Hz, J4,5 = 10 Hz, 1H, H-4), 4.92 (t, J1,2 = 9.2 Hz, J2,3  = 9.6 
Hz, 1H, H-2), 4.34 (m, 1H, CH-N), 4.28 (dd, J5,6 = 4.4 Hz, J6,6’ = 12.4 Hz, 1H, H-6), 4.07 (dd, 
J5,6’ = 2 Hz, J6,6’ = 12.4 Hz, 1H, H-6’), 3.80 (m, 1H, H-5), 3.74 (s, 3H, OCH3), 2.30-2.20 (m, 2H, 
CH2CO), 2.08-1.98 (m, 12H, 4xOAc), 1.90-1.80 (m, 2H, CH2). 13C-NMR (100 MHz, CDCl3, 
25°C): δ = 172.5, 172.5, 171.3, 170.9, 170.2, 169.9, 156.5 (CO(Cbz)), 136.4 (Cipso), 128.9, 128.6, 
128.5 (5xCAr), 78.5 (C-1), 73.9 (C-5), 73.2 (C-3), 70.9 (C-2), 68.4 (CH2O), 61.9 (C-6), 53.5 
(CH), 52.9 (OCH3), 32.4 (CH2CO), 28.4 (CH2), 20.9 (4xOAc). MS (FAB): m/z = 625 [M + H]+. 
[α]D25 = + 44.1 (c 1, CHCl3). Rf = 0.27 (hexane:AcOEt 40:60). 
 
N-(N-Benzyloxycarbonyl-β-alanyl)-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl amine (104l) 
 
O
NHAcO
OAc
AcO
AcO
O
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.45-7.28 (m, 5H, Ph), 6.40 (d, JNH-1 = 9.2 Hz, 1H, NH), 
5.30 (bd, 1H, NHCbz), 5.27 (t, J2,3 = 9.6 Hz, J3,4 = 9.6 Hz, 1H, H-3), 5.24 (t, J1,2 = 9.4 Hz, JNH-1 = 
9.2 Hz, 1H, H-1), 5.05 (s, 2H, CH2O), 5.04 (m, 1H, H-4), 4.90 (t, J1,2 = 9.4 Hz, J2,3 = 9.6 Hz, 1H, 
H-2), 4.30 (dd, J5,6 = 4.4 Hz, J6,6’ = 12.6 Hz, 1H, H-6), 4.10 (dd, J5,6’ = 2Hz, J6,6’ = 12.6 Hz, 1H, 
H-6’), 3.81 (m, 1H, H-5), 3.46 (q, 2H, CH2), 2.41 (m, 2H, CH2CO), 2.10-1.98 (m, 12H, 4xOAc). 
13C-NMR (100 MHz, CDCl3, 25°C): δ = 172.1, 171.4, 170.9, 170.2, 169.9, 156.4 (CO(Cbz)), 
136.7 (Cipso), 128.9, 128.5, 128.4 (5xCAr), 78.4 (C-1), 73.9 (C-5), 72.9 (C-3), 70.9 (C-2), 68.4 
(C-4), 67.1 (CH2O), 61.9 (C-6), 36.9 (CH2), 36.4 (CH2-CO), 21.1, 20.9 (4xOAc). MS (FAB): m/z 
= 553 [M + H]+. [α]D25 = + 45.4 (c 1, CHCl3). Rf = 0.24 (hexane:AcOEt 40:60). 
 
N-(N-Benzyloxycarbonylglycyl)-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl amine (104m) 
 
O
NHAcO
OAc
AcO
AcO
O
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.47-7.30 (m, 5H, Ph), 6.93 (d, 1H, JNH,1 = 8.4 Hz, NH), 
5.33-5.23 (m, 3H, H-3, H-1, NHCbz), 5.14 (s, 2H, CH2O), 5.06 (t, J3,4 = 9.6 Hz, 1H, H-4), 4.94 
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(t, J1,2 = 9.6 Hz, J2,3 = 9.6 Hz, 1H, H-2), 4.28 (dd, J5,6 = 4.4 Hz, J6,6’ = 12.6 Hz, 1H, H-6), 4.15-
4.05 (m, 1H, H-6’), 3.97-3.75 (m, 3H, H-5, CH2), 2.15-1.97 (m, 12H, 4xOAc). 13C-NMR (100 
MHz, CDCl3, 25°C): δ = 171.6, 170.9, 170.2, 169.9, 169.8, 156.8 (CO(Cbz)), 136.2 (Cipso), 128.9, 
128.7, 128.6 (5xCAr), 78.6 (C-1), 74 (C-5), 72.9 (C-3), 70.7 (C-2), 68.5 (C-4), 67.9 (CH2O), 61.9 
(C-6), 45 (CH2), 21, 20.9 (4xOAc). MS (FAB): m/z = 539 [M + H]+. [α]D25 = + 6.3 (c 1, CHCl3). 
Rf = 0.24 (hexane:AcOEt 40:60). 
 
N-(N-tert-Butoxycarbonyl-L-prolyl)-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl amine (104n) 
 
O
NHAcO
OAc
AcO
AcO
O
Boc
N
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.31-5.21 (m, 2H, H-3, H-1), 5.03 (t, 1H, H-4), 4.89 (m, 
1H, H-2), 4.25-4.05 (m, 3H, CH, H-6, H-6’), 3.82 (m, 1H, H-5), 3.51-3.25 (m, 2H, CH2), 2.30-
1.75 (m, 16 H, 2CH2, 4xOAc), 1.43 (bs, 9 H, Boc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 
170.7, 170.6, 170, 169.6, 78.1 (C-1), 73.7 (C-5), 72.8 (C-3), 70.8 (C-2), 68.4 (C-4), 61.9 (C-6), 
47.1 (CH2), 29.8 (CH2), 28.2 (Boc), 20.8, 20.7, 20.6 (4xOAc). MS (FAB): m/z = 545 [M + H]+. 
[α]D25 = - 20.1 (c 1, CHCl3). Rf = 0.25 (hexane:AcOEt 40:60). 
 
Nα-(benzyloxycarbonyl)-Nγ-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-L-asparagine-O-
Methyl Ester (108j) 
 
O
NH
AcO OAc
AcO
AcO
NHCbzO
COOMe
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.41-7.28 (m, 5H, Ph), 6.39 (d, JNH,1 = 8.8 Hz, 1H, NH), 
5.97 (d, J = 8.8 Hz, 1H, NHCbz), 5.42 (bs, 1H, H-4), 5.18 (t, 1H, H-1), 5.13-5.06 (m, 4H, H-2, 
H-3, CH2O), 4.60 (m, 1H, CH), 4.17-3.96 (m, 3H, H-5, H-6, H-6’), 3.73 (s, 3H, OCH3), 2.88 (dd, 
1H, JCH,Ha = 4.4 Hz, JHa,Hb = 16.4 Hz, Ha, CH2), 2.70 (dd, 1H, JCH,Hb = 4 Hz, JHa,Hb = 16.4 Hz, Hb, 
CH2) 2.08-1.98 (m, 12H, 4xOAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 171.6, 171.4, 170.6, 
170.4, 169.9, 169.8, 156.1 (CO(Cbz)), 136.2 (Cipso), 128.6, 128. 2, 128.1 (5xCAr), 78.4 (C-1), 72.5 
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(C-5), 70.7, 68.3, 67.2 (CH2O), 67.1, 61.1 (C-6), 52.8 (OCH3), 50.4 (CH), 37.8 (CH2), 20.7-20.6 
(4xOAc). MS (FAB): m/z = 611 [M + H]+. [α]D25 = + 17.4 (c 1, CHCl3). Rf = 0.36 
(hexane:AcOEt 40:60). 
 
Nα-(benzyloxycarbonyl)-Nδ-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-L-glutamine-O-
Methyl Ester (108k) 
 
O
NH
AcO OAc
AcO
AcO
O
NHCbz
COOMe
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.28 (m, 5H, Ph), 6.47 (d, J NH,1 = 8.8 Hz, JHa,Hb = 
16.4 Hz, NH), 5.56 (d, J = 7.6 Hz, JHa,Hb = 16.4 Hz, NHCbz), 5.43 (bs, 1H, H-4), 5.22 (t, 1H, H-
1), 5.20-5.03 (m, 4H, H-2, H-3, CH2O), 4.36 (m, 1H, CH), 4.20-3.97 (m, 3H, H-5, H-6, H-6’), 
3.74 (s, 3H, OCH3), 2.33-1.90 (m, 16 H, 2xCH2, 4xOAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ 
= 172.4, 171.7, 170.7, 170.3, 170.1, 156 (CO(Cbz)), 136.5 (Cipso), 128.9, 128.6, 128.5 (5xCAr), 
78.8 (C-1), 72,6 (C-5), 71.2 , 68.6, 67.5, 67,4 (CH2O), 61.4 (C-6), 53.6 (CH), 52.9 (OCH3), 32.4 
(CH2CO), 28.2 (CH2), 21.1, 20.9, 20.9 (4xOAc). MS (FAB): m/z = 625 [M + H]+. [α]D25 = + 15.7 
(c 1, CHCl3). Rf = 0.36 (hexane:AcOEt 40:60). 
 
N-(N-Benzyloxycarbonyl-β-alanyl)-2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl amine 
(108l) 
 
O
NH
AcO OAc
AcO
AcO
O
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.47-7.28 (m, 5H, Ph), 6.36 (d, JNH,1 = 9.2Hz, 1H, NH), 
5.43 (d, J3,4 = 3.2 Hz, 1H, H-4), 5.35 (m, 1H, NHCbz), 5.21 (t, JNH,1 = 9.2Hz, 1H, H-1), 5.18- 
5.05 (m, 4H, H-2, H-3, CH2O), 4.15-3.98 (m, 3H, H-5, H-6, H-6’), 3.46 (m, 2H, CH2), 2.42 (m, 
2H, CH2CO), 2.13 (s, 3H, OAc), 2.04-1.98 (m, 9 H, 3xOAc). 13C-NMR (100 MHz, CDCl3, 
25°C): δ = 172, 171.7, 170.7, 170.3, 170.1, 156.6 (CO(Cbz)), 136.7 (Cipso), 128.9, 128.5, 128.4 
(5xCAr), 78.7 (C-1), 72.7 (C-5), 71.1, 68.7, 67.4, 67.1 (CH2O), 61.4 (C-6), 36.9 (CH2), 36.4 
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(CH2CO), 21.0, 20.9, 20.9 (4xOAc). MS (FAB): m/z = 553 [M + H]+. [α]D25 = + 13.9 (c 1, 
CHCl3). Rf = 0.21 (hexane:AcOEt 40:60). 
 
Nα-(benzyloxycarbonyl)-Nδ-(2,3,4,6-tetra-O-acetyl-β-D-fucopyranosyl)-L-asparagine-O-
Methyl Ester (109j) 
 
NHOH3C
OAc
OAc
OAc
O
COOMe
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.45-7.27 (m, 5H, Ph), 6.30 (dd, JNH,1 = 8.8 Hz, 1H, 
NH), 5-78 (d, J = 7.2 Hz, 1H, NHCbz), 5.29 (s, 1H, H-4), 5,26 (bs, 1H, H-2), 5.20-5.02 (m, 4H, 
H-1, H-3, CH2O), 4.58 (m, 1H, CH), 3.88 (q, J5,6 = 6.4 Hz, 1H, H-5), 3.75 (s, 3H, OCH3), 2.94 
(dd, JHa,Hb = 16.2 Hz, JHa,CH = 3.6 Hz, 1H, Ha, CH2), 2.71 (dd, JHa,Hb = 16.2 Hz, JHb,CH = 4 Hz, 
1H, Hb, CH2), 2.16 (s, 3H, OAc), 2.02-1.97 (m, 6 H, 2xOAc), 1.17 (d, J5,6 = 6.4 Hz, 3H, H-6). 
13C-NMR (100 MHz, CDCl3, 25°C): δ = 171.4, 170.7, 170.1, 128.9, 128.6, 128.4 (5xCAr), 78.6 
C-1, 71.5, 71.3 (C-5), 70.6 (C-4), 68.8, 67.5 (CH2O), 53.1 (OCH3), 50.8 (CH), 38.5 (CH2), 20.9, 
20.9, 16.4 (C-6). MS (FAB): m/z = 553 [M + H]+. [α]D25 = -3.1(c 0.4, CHCl3). Rf = 0.33 
(hexane:AcOEt 40:60). 
 
Nα-(benzyloxycarbonyl)-Nδ-(2,3,4,6-tetra-O-acetyl-β-D-fucopyranosyl)-L-glutamine-O-
Methyl Ester (109k) 
 
NHOH3C
OAc
OAc
OAc
O
COOMe
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.44-7.28 (m, 5H, Ph), 6.35 (d, JNH,1 = 8.8 Hz, 1H, NH), 
5.52 (d, J = 7.2 Hz, 1H, NHCbz), 5.26 (bs, 1H, H-4), 5.20-5.02 (m, 5H, H-1, H-2, H-3, CH2O), 
4.35 (m, 1H, CH), 3.89 (bq, 1H, H-5), 3.74 (s, 3H, OCH3), 2.38-1.94 (m, 11H, CH2, 3xOAc), 
1.17 (d, J5,6 = 6.4 Hz, 3H, H-6). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 172.5, 172.3, 171.9, 
170.7, 170.2, 156.3 (CO(Cbz)), 136.5 (Cipso), 128.9, 128.6, 128.5 (5xCAr), 78.7 (C-1), 71.6, 71.2 
(C-5), 70.7 (C-4), 68.7, 67.4 (CH2O), 53.7 (CH), 52.9 (OCH3), 32.5 (CH2CO), 27.9 (CH2), 21.1, 
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20.9, 20.8 (3xOAc), 16.4 (C-6). MS (FAB): m/z = 567 [M + H]+. [α]D25 = - 7.1 (c 0.7, CHCl3). Rf 
= 0.30 (hexane:AcOEt 40:60). 
 
N-(N-Benzyloxycarbonyl-β-alanyl)-2,3,4-tri-O-acetyl-β-L-fucopyranosyl amine (109l) 
 
NHOH3C
OAc
OAc
OAc
O
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.40-7.27 (m,5H, Ph), 6.34 (d, JNH,1 = 8.8 Hz, 1H, NH), 
5.36 (m, 1H, NHCbz), 5.27 (bd, J3,4 = 2.4 Hz, 1H, H-4), 5.18 (t, JNH,1 = 8.8 Hz, 1H, H-1), 5.15-
5.02 (m, 4H, H-2, H-3, CH2O), 3.92 (q, J5,6 = 6.4 Hz, 1H, H-5), 3.46 (bq, 2H, CH2), 2.49-2.32 
(m, 2H, CH2CO), 2.17 (s, 3H, OAc), 2.04-1.98 (m, 6 H, 2xOAc), 1.18 (d, J5,6 = 6.4 Hz, 3H, H-
6). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 172.0, 171.8, 170.7, 170.2, 156.7(CO(Cbz)), 136.8 
(Cipso), 128.8, 128.4, 128.4 (5xCAr), 78.6 (C-1), 71.5 (C-5), 71.2, 70.6 (C-4), 68.8, 67.1 (CH2O), 
36.9 (CH2), 36.3 (CH2CO), 21.0, 20.9, 20.9 (3xOAc), 16.4 (C-6). MS (FAB): m/z = 495 [M + 
H]+. [α]D25 = - 19.6 (c 1, CHCl3). Rf = 0.23 (hexane:AcOEt 40:60).  
 
 
 
N-(N-Benzyloxycarbonylglycyl)-2,3,4-tri-O-acetyl-β-L-fucopyranosyl amine (109m) 
 
NHOH3C
OAc
OAc
OAc
O
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.45-7.28 (m, 5H, Ph), 6.90 (d, J = 8.8 Hz, 1H, NH), 
6.43 (d, J = 8.8 Hz, 1H, NH), 5.27-5.11 (m, 6 H, H-1, H-2, H-3, H-4, CH2O), 3.96-3.88 (m, 2H, 
H-5, Ha, CH2), 3.80 (dd, J = 6 Hz, JHa,Hb = 17.2 Hz, 1H, Hb, CH2), 2.22 (s, 3H, OAc), 2.17 (s, 
3H, OAc), 1.99 (s, 3H, OAc), 1.18 (d, 3H, J5,6 = 6.4 Hz, H-6). 13C-NMR (100 MHz, CDCl3, 
25°C): δ = 172.9, 170.1, 169.9, 169.6, 156.4 (CO(Cbz)), 136.1 (Cipso), 128.8, 128.7, 128.4 (5xCAr), 
78.6 (C-1), 71.2 (C-5), 72.0, 70.5, 68.5, 67.6 (CH2O), 44.8 (CH2), 20.9, 20.8, 20.7 (3xOAc), 16.2 
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(C-6). MS (ESI): m/z = 503.5 [M + Na]+. [α]D25 = - 16.1 (c 0.7, CHCl3). Rf = 0.28 
(hexane:AcOEt 40:60). 
 
N-(N-tert-Butoxycarbonyl-L-prolyl)-2,3,4-tri-O-acetyl-β-L-fucopyranosyl amine (109n) 
 
NHOH3C
OAc
OAc
OAc
O
Boc
N
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.27 (s, 1H, H-4), 5.25-5.05 (m, 3H, H-1, H-2, H-3), 
4.30-4.23 (m, 1H, CH), 3.91 (q, J5,6 = 6.4 Hz, 1H, H-5), 3.53-3.30 (m, 2H, CH2), 2.24-1.81 (m, 
13H, 2xCH2, 3xOAc), 1.16 (d, 3H, H-6). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 173.3, 171, 
170.6, 170.1, 78.5 (C-1), 71.6, 71.1 (C-5), 70.6 (C-4), 60.9 (CH), 48.0 (CH2), 29.8 (CH2), 28.5 
(CH2), 20.8, 20.7 (3xOAc), 16.2 (C-6). MS (ESI): m/z = 487.2 [M + H]+. [α]D25 = - 61.5 (c 1, 
CHCl3). Rf = 0.38 (hexane:AcOEt 40:60). 
 
 
 
 
Nα-(Benzyloxycarbonyl)-Nγ-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy)-β-D-glucopyranosyl-
L-asparagine-O-Methyl Ester (110j) 
 
O
NHAcO
OAc
AcHN
AcO
NHCbzO
COOMe
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.42-7.28 (m, 5H, Ph), 7.08 (d, JNH,1 = 3.6 Hz, 1H, NH), 
5.87 (bd, 2H, NH), 5.05 (m, 1H, H-4), 5.05 (s, 2H, CH2O), 4.96-4.91 (bt, 2H, H-1, H-3), 4.52 
(m, 1H, CH), 4.22 (dd, J5,6 = 4.0 Hz, J6,6’ = 12.4 Hz, 1H, H-6), 4.06-3.99 (m, 2H, H-2, H-6’), 
3.66 (s, 3H, OCH3), 3.67-3.62 (m, 1H, H-5), 2.65 (bd, 1H, Ha, CH2), 2.05 (dd, JHa,Hb = 16.5 Hz, 
JHb,CH = 4.3 Hz, 1H, Hb, CH2), 2.01 (s, 3H, OAc), 2.00 (s, 3H, OAc), 1.97 (s, 3H, OAc), 1.90 (s, 
3H, NHAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 172.4, 170.1, 169.5, 128.9, 128.4 (5xCAr), 
80.8 (C-1), 74.5 (C-3), 73.1 (C-5), 67.8 (C-4), 67.4 (CH2O), 61.9 (C-6), 53.9 (C-2), 53.0 (OCH3), 
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50.7 (CH), 38.0, 30.0 (CH2), 23.4 (NHAc), 21.0, 20.9 (3xOAc). MS (FAB): m/z = 610 [M + H]+. 
[α]D25 = + 6.4 (c 0.6, CHCl3). Rf = 0.55 (hexane:AcOEt 40:60). 
 
N-(N-Benzyloxycarbonyl-β-alanyl)-2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-
glucopyranosyl amine (110l) 
 
O
NHAcO
OAc
AcHN
AcO
O
NHCbz
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 7.41-7.28 (m, 5H, Ph), 7.07 (d, JNH,1 = 8.4 Hz, 1H, NH), 
6.06 (d, J = 7.6 Hz, 1H, NHAc), 5.42 (bs, 1H, NHCbz), 5.09-4.98 (m, 5H, H-1, H-3, H-4, 
CH2O), 4.28 (dd, J5,6 = 4.2 Hz, J6,6’ = 12.6 Hz, 1H, H-6), 4.1-4.03 (m, 2H, H-2, H-6’), 3.74 (m, 
1H, H-5), 3.44 (q, 2H, CH2), 2.51-2.31 (m, 2H, CH2), 2.09-1.98 (m, 9 H, 3xOAc), 1.91 (s, 3H, 
NHAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 172.3, 172.1, 170.8, 169.4, 156.4 (CO(Cbz)), 
136.7 (Cipso), 128.6, 128.3, 128.2 (5xCAr), 80.4 (C-1), 73.7 (C-5), 73.1, 67.8, 66.8 (CH2O), 61.8 
(C-6), 53.7 (C-2), 36.8 (CH2), 36.2 (CH2CO), 23.2 (NHAc), 20.9, 20.8, 20.7 (3xOAc). MS (ESI): 
m/z = 551.2 [M + H]+. [α]D25 = + 2.75 (c 0.8, CHCl3). Rf = 0.23 (hexane:AcOEt 40:60). 
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6.1 Glycofuranosyl amides: preliminary studies  
 
The formation of glucofuranosides 95 in Staudinger ligation reactions of glucosyl azide 7 
(Chapter 4) drew our attention towards this atypical class of compounds ( Scheme 1). In 
particular the furanose form of D-glucose is known to be unstable1 and rarely isolated only as 
bis-acetonides 2 or esters of boronic acid.3 
 
 
 
Scheme 1. Formation of α-gluco-furanosyl amide in the Staudinger ligation of 7 
 
Usually, at 40°C the reaction of 7 with functionalized phosphines 81 afforded the α-
glucofuranosyl amides 95 in average yield of 5-15 % depending on the acyl chain. The amount 
of furanose increases at higher temperatures. During the ligation of particular acyl chains (for 
instance 81e), up to 50 % of furanose was obtained (95e, Scheme 2 and entries 6 and 7 of Table 
C, Chapter 4).4 
 
 
 
Scheme 2. Formation of N-3-methyl-2-butenoyl-α-D-glucofuranosylamide 95e 
 
Other interesting observations were obtained during the screening performed on α-
glucopyranosyl azides 7 and 10 with fluorinated phosphines 83 for the transfer of amino acids 
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residues (Chapter 4 and 5). With the α-glucosyl azide 7 variable amounts of furanosylamide 
were formed, depending on the nature of the acyl chain transferred during the ligation (entries 1-
4, Table1, Chapter 5). When the same reaction conditions were extended to unprotected β-
glucosyl azides 10, formations of 95 was not observed and only β-pyranosyl amides 94 were 
obtained (Scheme 3 and entries 5-9 in Table1, Chapter 5).5 
 
O
HO
HO
HO
OH
HN R
O
O
HO
HO
HO
OH
H
N R
O
94j-m
93j-m 95j-m
NH
H
H OH
OH H
O
H5
HO
HO
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+
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N3
HO
HO
HO
OH
O
PPh2
O
R
7
83j-n
O
N3
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HO
HO
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10 83k83j R= CH2CHCO2Me R= CH2CH2CHCO2Me
83l R= CH2CH2NHCbz 83m R= CH2NHCbz
F
NHCbzNHCbz
 
 
Scheme 3. Synthesis of α- and β- glucosyl aminoacids 93j-m and 94 j-m 
 
On the other hand, ligation of unprotected β-galactopyranosyl azide 43 with fluorinated 
phosphines 83j-m under similar conditions afforded α-furanosyl amides 111 in average yield of 
5-15 % (Scheme 4, and entries 1-9 in Table 3, Chapter 5). 
 
 
 
Scheme 4. Formation of α-galactofuranosyl amides 111j-m as by-products in the ligation of 43 
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The propensity of glucose and galactose to give furanosides in non-aqueous media was described 
in the literature.1 Data show (Table 1) that no furanose is observed for glucose. Galactose forms 
ca. 30 % of furanose, and the β-furanose configuration (1,2-trans) is more stable than the α (1,2-
cis) one. So, the Staudinger ligation of 7 and 43 appears to promote only the formation of the 
less stable α furanosyl compounds. 
 
Table 1. Furanose configuration of monosaccharide, in DMSO mediaa 
Entry Monosaccharide β-pyranose (%) 
α-pyranose 
(%) 
β-furanose 
(%) 
α-furanose 
(%) 
1 Glucose 63.1 36.9 - - 
2 Galactose 39 28 24 9 
a) From ref 1 
 
This series of experiments allowed us to draw the following general conclusion: 
• The formation of α-furanosyl amides 95 and 111 is favored by a temperature increase 
and can be increased by running the ligation at temperatures above 40°C. 
• The nature of the acyl chains transferred plays a fundamental and still unpredictable role 
for the furanosyl ring formation. 
• In each of the reactions evaluated the glycofuranosyl amide was formed as a unique α-
furanose isomer. 
• Strikingly, despite the pyranose-furanose isomerization must involve a ring opening step, 
formation of the β-pyranosyl amide, a more obvious candidate product of an equilibration 
process, is not observed.  
 
To clarify the mechanism of this intriguing reaction and to analyze the potential activity of 
furanosyl compounds as sugar mimics, a new set of experiments was performed starting from the 
β-D-galactofuranosyl azide (β-D-Galf azide, Scheme 5) as a model substrate. The synthesis of 
penta-O-acetyl-galactofuranose (D-AcGalf) 35 was described.6 We reasoned that the reactivity of 
the corresponding azide 36 could shed light on the formation of the unusual and alternative α-
furanosyl by-products obtained in the ligation of unprotected α-pyranosyl azides. Furthermore, 
D-Galf derivatives have been reported to posses biological activity against Mycobacterium 
tubercolosis,7, 8 and thus the corresponding amides constitute by themselves an interesting 
synthetic target. 
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6.2 Synthesis of α- and β-galactofuranosyl amides 
 
The starting galactofuranosyl azide 36 was prepared in 90 % yields from known penta-O-acetyl-
galactofuranose 35 5 using TMSN3/SnCl4 (Scheme 5). Zemplen’s deacetylation afforded the 
unprotected Galf azide 37, whose anomeric configuration was established by NOE difference 
experiments, showing a clear correlation between protons H1 and H3. 
 
Scheme 5. Synthesis of Galf azide 
 
Initial studies focused on the functionalization of 36 using standard methodology, such as 
catalytic hydrogenation followed by in situ acetylation or intermolecular Staudinger reaction 
with Ph3P/AcOH (Scheme 6). However, both methods led to a mixture of epimers at the 
anomeric carbon. Similar results were obtained upon treatment of 37 with H2 and Pd/C. 
 
 
 
Scheme 6. Derivatization of 36 with conventional methods leads to mixtures of epimers 
The reaction mixtures could be analyzed by 1H-NMR spectrscopy. As shown in Figure 1, the 
anomeric protons of all four isomeric galactosyl amides are clearly observed in the 1H-NMR of 
the reaction mixture (Figure 1, peaks 1-4). They are well separated from one another, as well as 
from the starting azide (doublet at 5.22 ppm, not shown in Figure 1) and from the hydrolysis 
products (α- and β-galactose, peaks 5 and 6 in Figure 1, respectively) which originate from 
incomplete acyl transfer in the intermediate iminophosphorane.  
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Figure 1. 1H-NMR (D2O) spectra of the anomeric proton of the four isomeric galactosyl amides 
(peaks 1-4). Doublets 5 and 6 correspond to α- and β-glucose, respectively 
 
On the contrary, traceless Staudinger ligation of 36 with 2-diphenylphosphanyl-phenyl valeroate 
81b in a 98:2 DMA:DMPU solvent mixture for 4h at 70°C 4, 5, 9 afforded the corresponding tetra-
O-acetyl-galactofuranosylamide 112b in 60% yield as a single anomer (Scheme 7). The structure 
and anomeric configuration of 112b were confirmed by NMR after deacetylation (cat. MeONa in 
MeOH) to yield the unprotected amide 113b. The chemical shift of C4 in 113b at 83.6 ppm is 
diagnostic for the furanose form and NOESY experiments (D2O) showed the expected crosspeak 
between protons H1 and H3. The deprotection step was found to be critical to preserve the 
configurational integrity of the anomeric carbon. While 0.05 M MeONa solutions and short 
contact times (1h) were used successfully, exposure of 112b to more concentrated (0.1 M) 
MeONa in MeOH caused partial anomeric epimerization to 111b, presumably via MeONa 
induced deprotonation of the amide nitrogen.  
 
 
5 
6 
1 
2 
3 
4 
Chapter 6 
 154 
N3
H OAc
AcO HO
AcO
AcO
H
PPh2
O
O
+
NHCOC4H9
H OAc
AcO HO
AcO
AcO
H
112b
81b
H
H
NHCOC4H9
H3 OH
HO HO
HO
HO
H
113b
H1
a) 70°C, 4h, DMA/DMPU; b) H2O, 2 h, 70°C; c) 0.05M MeONa, MeOH
a, b c
y = 60 %, 100 %
NOESY
contact
36
 
 
Scheme 7. Synthesis of β-furanosyl amides 112b by ligation of 36 
 
Surprisingly ligation of unprotected β-Gal-f-azide 37 with 81b under the same conditions used 
for 36 afforded only amide 111b with complete inversion of anomeric configuration (Scheme 8). 
Products from the Staudinger ligation of 37 were isolated by water extraction from the crude 
reaction mixtures and purified by silica gel chromatography. Anomeric ratio were evaluated on 
the crude by 1H-NMR spectroscopy. The structure of 111b was confirmed by the C4 chemical 
shift (84.4 ppm) and by the absence of crosspeaks between protons H1 and H3 in the NOESY 
spectrum (CD3OD; H1 and H3 of 111b are isochronous in D2O at 400 MHz). 
 
 
 
Scheme 8. Synthesis of α-furanosyl amides 111b by ligation of 37 
 
Compound 111b was fully characterized as the 1,2-cis isomer after acetylation to 114b (Scheme 
9), by the presence of crosspeaks between protons H1 and H4 in the NOESY spectrum (CDCl3 at 
400 MHz). 
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Scheme 9. Acetylation of 111b and NOESY characterization of 114b 
 
 
6.3 Synthesis of arabinofuranosyl and ribofuranosyl amides 
 
In Chapter 1 we showed that the reaction of phosphines 9 with tetra-O-acetyl-α-glucopyranosyl 
azides 2 was non-stereoconservative 9 (Scheme 10), and that β-glycosyl amides are obtained in 
good yield and complete stereoselectivity starting from both α- and β-azides. 
 
 
 
 
Scheme 10. Staudinger ligation of tetra-O-acetyl azides is non-stereoconservative  
 
Usually tetra-O-acetyl-pyranosyl azides give β-anomerization, while unprotected pyranosyl 
azides give complete retention of the anomeric configuration (Scheme 11). 
 
 
 
Scheme 11. β-anomerization of the tetra-O-acetyl-α-pyranosyl azides  
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It was surprising, therefore, to establish that tetra-O-acetyl-β-furanosyl azides 36 do not 
anomerize, but unprotected furanosyl azides 37 do, and afford 1,2-cis compounds with total 
inversion on the anomeric carbon. The inversion of configuration during the reaction of 
unprotected galactofuranosyl azides suggests that an unexpected mechanism may be involved in 
the formation of α-galactofuranosyl amides. 
To further explore the scope of this reaction and to investigate the reasons of this unexpected 
result, a new set of experiments were designed using phosphine 81b as the standard substrate. 
The ribofuranosyl azides 41 and 53 (Scheme 12) and the arabinofuranosyl azides 40 and 49 
(Scheme 14) were subjected to traceless ligation with compound 81b in the same reaction 
conditions used above (70°C for 4h in  98:2 DMA:DMPU). Both ribofuranosyl and 
arabinofuranosyl azides present a 1,2-trans configuration but with the opposite absolute 
configuration at C2. 
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Scheme 12. Staudinger ligation of 81b with β-ribofuranosyl azides 41 and 53 
 
Reaction of the β-tetra-O-acetyl ribofuranosyl azide 41 with 81b yielded a β-amide. Its anomeric 
configuration of was characterized after Zemplen’s deacetylation (Scheme 12), which afforded 
the unprotected 1,2-trans ribofuranosyl amide 116b. NOESY correlation between protons H1  
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and H4, and the high value of C4 (83.5 ppm) in 116b are diagnostic for a β-furanosyl ring. 
Reaction of the unprotected β-ribofuranosyl azide 53 gave the α-anomer 115b. After acetylation 
(Scheme 13) of 115b the structure of 117b was assigned on the basis of strong crosspeak for the 
H1 and H3 protons in the NOESY spectrum (CD3OD). 
 
 
 
Scheme 13. Acetylation of the N-pentanoyl-α-D-ribofuranosylamide 115b 
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Scheme 14. Staudinger ligation of 81b with α-arabinofuranosyl azides 40 and 49 
 
Similarly inversion of configuration was observed upon reaction of the unprotected 
arabinofuranosyl azide 49 to give 118b. NOESY experiments on 118b, showed a clear 
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correlation between protons H1 and H4, and also the chemical shift of C4 in 118b at 85.4 ppm is 
diagnostic for the furanose form. On the contrary no inversion was observed upon ligation of the 
tetra-O-acetyl azide 40, which gave 119b.  
Thus, under the conditions developed all reactions occurred with selective inversion on the 
anomeric carbon to afford 1,2-cis compounds for the unprotected azides 53, 49 and 37 while they 
were stereoconservative for the O-acetyl azides 41,  40 and 36, leading to 1,2-trans amides. 
Products from the Staudinger ligation of the unprotected ribofuranosyl azides 53 and 
arabinofuranosyl 49 were isolated by water extraction from the crude reaction mixtures and 
purified by silica gel chromatography (CHCl3/MeOH 85:15). Also in this case to facilitate 
products isolation from phosphine oxide, the tetra-O-acetyl ribofuranosyl and tetra-O-acetyl 
arabinofuranosyl amides were not directly isolated, but first deacetylated to afford the 
corresponding deprotected amides 116b and 119b. Finally the compounds were isolated by water 
extraction and purified by flash chromatography on silica gel. Under this conditions the 1,2-cis 
(115b and 118b) and 1,2-trans (116b and 119b) furanosyl amides were generally obtained in 
moderate yields and excellent anomeric ratio. 
For comparison purpose and to fully characterize the ligation products, the corresponding 
pyranosyl azides β-ribopyranosyl azide 29 (tri-O-acetyl) and 45 (unprotected) (Scheme 15) and 
β-arabinopyranosyl azide 28 (tri-O-acetyl) and 48 (unprotected) (Scheme 16) were subjected to 
Staudinger ligation with 81b. They afforded the corresponding 1,2-trans glycopyranosyl amides 
120b and 121b in good yields and without anomeric inversion. 1H NMR analysis of the crude 
reaction mixtures showed no trace of isomeric azides also starting from  unprotected 1,2-trans 
azides 45 and 48. The anomeric configuration of 120b was confirmed by the typical high value 
of the trans-diaxial coupling constant (J1,2 = 8 Hz) for the β compounds and also the chemical 
shift of C4 (68.8 ppm) is diagnostic for the pyranose form. 
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Scheme 15. Staudinger ligation of 81b with β-ribopyranosyl azides 29 and 45 
 
The structure of 121b was established on the basis of the chemical shift of the C4 carbon at 68.8 
ppm, which is consistent with the pyranose form and of the J1,2 of 8.8 Hz consistent with a trans 
configuration of C1-C2. 
 
 
 
Scheme 16. Staudinger ligation of 81b with β-arabinopyranosyl azides 28 and 48 
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In conclusion, the ligation of 81b with α-arabinopyranosyl and β-ribopyranosyl azides confirm 
the previous observation on the stereoselectivity for the intramolecular Staudinger ligation of 
glucopyranosyl azide:9  
 
 
6.4 Proposed mechanism for the α-furanosylamide formation 
 
The ligation of unprotected 1,2-trans furanosyl azides 37, 53 and 49 with phosphines 81b 
afforded glycofuranosyl amides  with the opposite 1,2-cis anomeric configuration respect to the 
starting azide precursor. This anomeric epimerization must derive from a ring-opening process 
occurring after the azide reduction step. A likely mechanism is shown in Scheme 17 for the 
reaction of 81b with β-galactofuranosyl azide 37. Upon azide reduction, the iminophosphorane 
122 (Scheme 17) is formed and ring opening of 122 affords phosphinimine 123. From this open-
chain intermediate, the ring clousure step could be biased by the unprotected hydroxyl group at 
position 2, which can trap the phosphorous atom of 123 as the cyclic oxazaphospholane 
intermediate 124, thus enforcing, after ring clousure, the formation of the α-iminophosphorane 
125. In other words, the anomeric carbon of the sugar is blocked by chelation of phosphorous in 
an intermediate 124 which can only afford α-amides upon ring closure. Finally, intramolecular 
acyl transfer and subsequent hydrolysis give α-galactofuranosyl amide 111b with total inversion 
on the anomeric carbon. 
This mechanism implies that ligation of the unprotected furanosyl azides will enforce a 1,2-cis 
configuration in the resulting amides by coordination of the free OH in positon 2 with the 
phosphorous atom of the iminophosphorane and can be used to clarify also the epimerizations 
observed during the ligation of 81b with unprotected arabinofuranosyl 49 and ribofuranosyl 
azides 53.  
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Scheme 17. Proposed mechanism for the anomeric epimerization of 37  
 
To support this mechanistic picture, we attempted to examine the ligation of the isomeric 1,2-cis 
α-galactofuranosyl azide 46 (Scheme 20), with the expectation that anomeric inversion should 
be no longer observed on this isomer. This compound has never been described. However, the 
conversion of free galactopyranose 19 into 2,3,5,6-tetra-O-tert-butyldimethylsilyl-β-
galactofuranosyl iodide10 127 (Scheme 19) has been recently reported by Baldoni and Marino. 
The authors treated the free hexose sugar with an excess of tert-butyldimethylsilyl chloride in 
dimethylformamide and in the presence of imidazole at room temperature obtaining 1,2,3,5,6-
penta-O-tert-butyldimethylsilyl-β-galactofuranose 126 which was isolated from the reaction 
mixture in 75 % yield by crystallization from methanol (Scheme 18). 
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Scheme 18. Stereoselective synthesis of 1,2,3,5,6-penta-O-tert-butyldimethylsilyl-β-
galactofuranose 126 
 
Treating 126 with 1.2 equiv. of tri-methylsilyliodide (TMSI) in anhydrous 1,2-dichloromethane 
at 0°C for 30 minutes, the anomeric iodide is formed.10 When TLC examination showed a total 
consumption of the starting material 126, tetra-butylammonium azide 11 (nBu4NN3) was added 
and the mixture was stirred overnight at room temperature. The reaction afforded good yields 
and an optimal stereoselectivity for the 2,3,4,6-tetra-O-tert-butyldimethylsilyl-α-galactofuranose 
azide 128, the structure was confirmed by NOESY correlation between H1-H4 (Scheme 19). 
 
 
 
Scheme 19. Synthesis of α-galactofuranosyl azide 128 via in situ formed galactofuranosyl iodide 
 
Removal of the TBS groups from 128 was accomplished with tetra-butylammonium floride 
(nBu4NF) in THF 12 and afforded unprotected α-galactofuranose azide 46 (Scheme 20). The 
anomeric configuration of 46 was confirmed by NOESY experiments that showed a clear 
correlation between protons H1 and H4 (Scheme 20, Figure 2), and also the chemical shift of C4 
in 46 at 84.5 ppm is diagnostic for the furanose form. 
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Scheme 20. Deprotection of 128  
 
 
 
Figure 2. 1H-NMR (CD3OD) spectra of α-D-galactofuranosyl azide 46 
 
Acetylation of the unprotected α-galactofuranosyl azide 46 (Scheme 21, Figure 3), with classical 
procedure (acetic anhydride in pyridine) afforded the 2,3,5,6-tetra-acetyl-α-galactofuranosyl 
azide 129. Also in this case we observed a NOESY contact between H1-H4 (CDCl3). 
 
 
Scheme 21. Acetylation of unprotected α-galactofuranosyl azide 46  
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Figure 3. 1H-NMR (CDCl3) spectra of tetra-O-acetyl-α-D-galactofuranosyl azide 129 
 
The unprotected and tetra-O-acetyl-α-galactofuranosyl azides 46 and 129 (Scheme 22) were 
subjected to traceless ligation with compound 81b in the same reaction conditions used for the 
ligation of protected and unprotected β-galactofuranosyl azides 36 and 37 (70°C for 4h in 
solvent mixture DMA:DMPU 98:2). 
The ligation of unprotected α-galactofuranosyl azide 46 with phosphines 81b afforded the amide 
130b with the same anomeric configuration of the starting azide precursor, in a 
stereoconservative process. Unprotected α-furanosyl azides 46, thus, did not anomerize but 
afforded the 1,2-cis azide, as it would be expected based on the proposed mechanism. 
Surprisingly, ligation of the of tetra-O-acetyl-α-furanosyl azides 129 afforded a 4:1 β:α ratio, 
thus revealing that an equilibration process is taking place for this acetylated azide, which favors 
the 1,2-trans amide 113b with inversion on the anomeric carbon (Scheme 22). The inversion of 
configuration during the reaction of protected galactofuranosyl azide 129 suggests that this 
configuration may be more stable for the tetra-acetylated compound. 
 
H1
H OAc
RO HO
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AcO
H
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NOESY contact
129
 
Tetra-O-acetyl-α-D-galactofuranosyl azide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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Scheme 22. Staudinger ligation of 81b with α-galactofuranosyl azide 46 and 129  
 
 
After these observations the mechanism proposed in Scheme 17 for α-furanosylamide formation 
appears totally confirmed. The full implications of this proposed mechanism relative to the 
ligation of furanosyl and pyranosyl azides will be discussed in Chapter 7. 
 
 
 
6.5 Synthesis of small library of α and β galactofuranosylamides as inhibitors 
of Mycobacteria 
 
The arabinogalactan constituent of mycobacterial cell walls contains a galactan polymer made of 
galactose residues in their furanose form. In particular galactofuranose (D-Galf ) was found to be 
an important coustituent of the cell wall of mycobacteria the causative agent of tuberculosis 
(TB).7, 8 The development of new drugs for tuberculosis has taken on some urgency in the recent 
years. The World Health Organization reports that the global incidence rate ot TB is rising, and 
more than 4000 people die of TB everyday. 13 More new cases are expected since TB is also the 
main cause of death in AIDS patients. Inhibition of the incorporation of D-galactofuranose (D-
Galf ) has become a potential therapeutic strategy since Galf-containing oligosaccharides are 
critical for survival and infectivity 14, 15 of mycobacteria. Incorporation of Galf into 
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oligosaccharides involves two steps. First, the activated precursor UDP-galactofuranose (UDP-
Galf 1) is synthesized from UDP-galactopyranose (UDP-Galp 2) in a reaction catalyzed by UDP-
galactopyranose mutase (UGM). Subsequently, Galf is transferred from UDP-Galf 1 onto 
acceptors to form various Galf-containing oligosaccharides by UDP-galactofuranosyltransferase 
(GalfT).16, 17 
The furanose form of D-galactose, Galf, is uknown in mammals and UDP-galactopyranose 
(UDP-Galp 2) mutase has become an interesting target for the development of drugs against the 
many pathogens which contain Galf, most prominently Mycobacterium tuberculosis. UDP-Galp 
2 mutase inhibitors have been reported and shown to block mycobacterial growth.18, 19, 20, 21, 22, 23 
Various molecules containing a structural unit mimicking the Galf monosaccharide have been 
synthesised, including iminosugars, thiosugars, galactofuranosyl thioglycosides and C-
glycosides (Figure 4), but no galactofuranosylamides have been described so far. The ability of 
some of these compounds to inhibit bacterial growth makes galactofuranose mimics interesting 
biological targets with potential therapeutic value.7, 24, 25, 26 
 
 
 
 
Figure 4. Some analogues of β-galactofuranose which have shown activity against 
Mycobacterium tubercolosis 
 
 
To explore the scope of galactofuranosyl amides as bacterial growth inhibitors, we used the 
stereodivergent ligation of furanosyl azides just discovered and applied it to a set of phosphines 
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variously functionalized, to obtain a small library of α- and β-galactofuranosyl amides (Scheme 
23).  
 
 
 
Scheme 23. Traceless Staudinger ligation of 36 and 37 with phosphines 81b-i 
 
 
The results of this screening are collecetd in Table 2. Transfer of linear aliphatic (81b, f, g), 
branched aliphatic (81c, e), unsaturated (81e, h) and aromatic (81i) amide chains was performed 
with uniform results. All reactions gave the expected products in moderate yields. As previously 
reported for unprotected glycopyranosyl azides,3 microwaves were found to accelerate the 
ligation of 37 (entries 7 and 11). The stereoselectivity was complete, as determined by 1H-NMR 
of the crudes. In all cases, β-anomers were obtained from the tetra-O-acetyl azide 36 and α-
anomers from the unprotected azide 37. Experimental procedures, purification and 
characterization data were performed as described before in par. 6.2. 
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Table 2. Ligation of 36 and 37 with phosphines 81b-i.a 
Entr
y 
Azid
e 
Phosphine R Product α/β b Yields 
1 36 81b -(CH2)3CH3 113b 2:98 60 
2 36 81c -CH2CH(CH3)2 113c > 1:99  53 
3 36 81e -CH=C(CH3)2 113e 2:98  48 
4 36 81f -(CH2)14CH3 113f > 1:99  60 
5 36 81g -(CH2)6CH3 113g > 1:99  56 
6 36 81h -CH2CH(CH3)(CH2)2CH=C(CH3)2 113h > 1:99 51 
7 37 81b -(CH2)3CH3 111b > 99:1c 60 
8 37 81c -CH2CH(CH3)2 111c > 99:1  57 
9 37 81e -CH=C(CH3)2 111e > 99:1  51 
10 37 81f -(CH2)14CH3 111f > 99:1 55 
11 37 81g -(CH2)6CH3 111g > 99:1 c 63 
12 37 81h -CH2CH(CH3)(CH2)2CH=C(CH3)2 111h > 99:1  56 
13 37 81i -Ph 111i > 99:1  62 
 
a) Unless otherwise stated, all reactions were performed in 98:2 DMA:DMPU mixtures for 4h at 70°C. Then water 
was added and the solution stirred for additional 2h at 70°C before work up. b)1H-NMR ratio of the crude. c) 
Reaction performed under microwave: irradiation at 30 min, 70°C.  
 
All these compounds were tested in minimal inhibition concentration (MIC) tests against a panel 
of bacteria. One compound, the α-galactofuranosyl amides 111f displayed a modest activity 
against Mycobacterium bovis with a MIC value of 64 µg/ml. The β-anomer 113f showed no 
activity. 
This finding may represent the discovery of a new potential class of antibacterial agents, because 
the totality of the molecules reported so far which contain a structural unit mimicking Galf are all 
in the β-configuration. More work is required to verify this finding and to optimize the structure 
and activity of these compounds.  
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6.6 Experimental Section 
 
Solvents were dried by standard procedures: dichloromethane, methanol, N,N-
diisopropylethylamine and triethylamine were dried over calcium hydride; N,N-
dimethylacetamide (DMA), 1,3-dimethyltetrahydro-2(1H)pyrimidinone (DMPU), chloroform 
and pyridine were dried over activated molecular sieves. Reactions requiring anhydrous 
conditions were performed under nitrogen. 1H, 13C and 31P-NMR spectra were recorded at 400 
MHz on a Bruker AVANCE-400 instrument. Chemical shifts (δ) for 1H and 13C spectra are 
expressed in ppm relative to internal Me4Si as standard. Signals were abbreviated as s, singlet; 
bs, broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet. Mass spectra were obtained with a 
Bruker ion-trap Esquire 3000 apparatus (ESI ionization) and FT-ICR Mass Spectrometer APEX 
II & Xmass software (Bruker Daltonics) - 4.7 Magnet. Thin layer chromatography (TLC) was 
carried out with pre-coated Merck F254 silica gel plates. Flash chromatography (FC) was carried 
out with Macherey-Nagel silica gel 60 (230-400 mesh).  
 
General procedure for stereoselective ligation of protected and unprotected glycosyl azides 
in DMA:DMPU mixtures. 
 
The phosphine (1.2 eq) was added, at room temperature, to a 0.1 M solution of glycosyl azide (1 
eq) in 98:2 N,N-dimethylacetamide and DMPU. The solution was stirred for 4 h at 70 °C, then 
water was added and the mixture was stirred for an additional 2 h at the same temperature. The 
solvent was evaporated under reduced pressure, and the residue was purified as indicated below 
for each compound. 
 
General procedure for acetylation of unprotected glycosyl amides. 
 
Acetic anhydride (10 eq) and a catalytic amount of N,N-dimethylaminopyridine were added, at 
room temperature, to a solution of substrate (1 eq) in pyridine dried on molecular sieves (0.1 M). 
The solution was stirred for 24 h and then was concentrated in vacuo. The residue was dissolved 
in AcOEt and washed with aqueous 5 % HCl, aqueous 5 % NaHCO3 and water. The organic 
layer was dried over Na2SO4 and concentrated to give the product in quantitative yield.  
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N-pentanoyl-α-D-galactofuranosyl amide (111b) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20) yield = 60 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.69 (d, J1,2 = 4.4 Hz, 1H, H-1), 4.13 (t, J2,3 = 3.4, J3,4 = 
3.6 Hz, 1H, H-3), 3.88 (dd, J1,2 = 4.4, J2,3 = 3.4 Hz, 1H, H-2), 3.80 (dd, J3,4 = 3.6, J4,5 = 3 Hz, 1H, 
H-4), 3.74 (ddd, J4,5 = 3, J5,6 = 6, J5,6’ = 6.8 Hz, 1H, H-5), 3.62 (dd, J5,6 = 6, J6,6’ = 11.6 Hz, 1H, 
H-6), 3.57 (dd, J5,6’ = 6.8, J6,6’ = 11.6 Hz, 1H, H-6’), 2.29 (t, J = 7.6 Hz, 2H, CH2), 1.64-1.56 (m, 
2H, CH2), 1.43-1.32 (m, 2H, CH2), 0.95 (t, J = 7.4 Hz, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 
25°C): δ = 176.7, 84.4 (C-4), 82.2 (C-1), 78.5 (C-3), 77.4 (C-2), 73 (C-5), 64.3 (C-6), 37 (CH2), 
28.9 (CH2), 23.5 (CH2), 14.3 (CH3). [α]D25 = +18.1 (c 1, MeOH). FT-ICR (ESI) calcd. for 
C11H21N1O6 [M+Na]+ 286.12611; found 286.12597. 
 
 
 
 
 
N-pentanoyl-α-D-galactofuranosyl amide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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2,3,5,6-tetra-O-acetyl-N-pentanoyl-α-D-galactofuranosyl amide (114b) 
 
 
 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 6.14 (d, JNH,1 = 10 Hz, 1H, NH), 6.06 (d, J1,2 = 4.4 Hz, 
JNH,1 = 10, 1H, H-1), 5.34 (ddd, J4,5 = 6.8, J5,6 = 3.6, J5,6’ = 6.8 Hz, 1H, H-5), 5.21 (dd, J1,2 = 4.4, 
J2,3 = 1.8 Hz, 1H, H-2),5.07 (dd, J2,3 = 1.8, J3,4 = 3.2 Hz, 1H, H-3), 4.38 (dd, J5,6 = 3.6, J6,6’ = 12 
Hz, 1H, H-6), 4.09 (dd, J5,6’ = 6.8, J6,6’ = 12 Hz, 1H, H-6’), 3.92 (dd, J3,4 = 3.2, J4,5 = 6.8 Hz, 1H, 
H-4), 2.23 (t, J
 
= 7.6 Hz, 2H, CH2), 2.18 (s, 3H, OAc), 2.12 (s, 3H, OAc), 2.10 (s, 3H, OAc), 
2.05 (s, 3H, OAc), 1.61-1.56 (m, 2H, CH2), 1.41-1.32 (m, 2H, CH2), 0.92 (t, J = 7.6 Hz, 3H, 
CH3). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 176.7, 173, 170.7, 169.8, 169.1, 79.9 (C-1), 79.7 
(C-4), 76.7 (C-3), 75.1 (C-2), 70.3 (C-5), 62.9 (C-6), 36.7 (CH2), 29.9 (CH2), 22.5 (CH2), 21.1-
20.8 (4xOAc), 14.3 (CH3). NOESY (400 MHz, CDCl3, 25°C): contact between H-1/H-4. 
 
 
 
 
 
 
2,3,5,6-tetra-O-acetyl-N-pentanoyl-α-D-galactofuranosyl amide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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N-(3-Methylbutanoyl)-α-D-galactofuranosyl amide (111c) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20) yield = 57 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.72 (d, J1,2 = 4.4 Hz, 1H, H-1), 4.16 (t, J2,3 = 3.2, J3,4 = 
3.6 Hz, 1H, H-3), 3.92 (dd, J1,2 = 4.4, J2,3 = 3.2 Hz, 1H, H-2), 3.84 (dd, J3,4 = 3.6, J4,5 = 3.2 Hz, 
1H, H-4), 3.78 (ddd, J4,5 = 3.2, J5,6 = 5.6, J5,6’ = 6.8 Hz, 1H, H-5), 3.65 (dd, J5,6 = 5.6, J6,6’ = 11.2 
Hz, 1H, H-6), 3.61 (dd, J5,6’ = 6.8, J6,6’ = 11.2 Hz, 1H, H-6’), 2.18 (d, J = 6.4 Hz, 2H, CH2), 2.16-
2.08 (m, 1H, CH), 1.01 (d, J = 2.4 Hz, 3H, CH3), 0.99 (d, J = 2.4 Hz, 3H, CH3). 13C-NMR (100 
MHz, CD3OD, 25°C): δ = 176, 85.6 (C-4), 84.5 (C-1), 82.2 (C-3), 77.4 (C-2), 73 (C-5), 64.3 (C-
6), 46.5 (CH2), 27.3 (CH), 22.9 (CH3). [α]D25 = +33.4 (c 1, MeOH). FT-ICR (ESI) calcd. for 
C11H21N1O6 [M+Na]+ 286.12611; found 286.12591. 
 
N-3-methyl-2-butenoyl-α-D-galactofuranosyl amide (111e) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 85:15) yield = 51 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.86 (s, 1H, CH), 5.77 (d, J1,2 = 4 Hz, 1H, H-1), 4.17 (t, 
J2,3 = 3.2, J3,4 = 3.6 Hz, 1H, H-3), 3.94 (dd, J1,2 = 4, J2,3 = 3.2 Hz, 1H, H-2), 3.85 (bt, J3,4 = 3.6, 
J4,5 = 3.2 Hz, 1H, H-4), 3.79 (ddd, J4,5 = 3.2, J5,6 = 6, J5,6’ = 6.8 Hz, 1H, H-5), 3.68 (dd, J5,6 = 6, 
J6,6’ = 11.2 Hz, 1H, H-6), 3.62 (dd, J5,6’ = 6.8, J6,6’ = 11.2 Hz, 1H, H-6’), 2.20 (s, 3H, CH3), 1.94 
(s, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 169.5, 154.2, 119.4 (CH), 84.4 (C-4), 
82.1 (C-1), 78.7 (C-3), 77.5 (C-2), 73.1 (C-5), 64.4 (C-6), 27.4 (CH3), 20.3 (CH3). [α]D25 = +30.2 
(c 0.8, MeOH). FT-ICR (ESI) calcd. for C11H21N1O6 [M+Na]+ 284.11046; found 284.11044. 
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N-palmitoyl-α-D-galactofuranosyl amide (111f) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 90:10) yield = 55 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.74 (d, J1,2 = 4 Hz, 1H, H-1), 4.18 (t, J2,3 = 3.2, J3,4 = 
3.6 Hz, 1H, H-3), 3.94 (dd, J1,2 = 4, J2,3 = 3.2 Hz, 1H, H-2), 3.85 (bt, J3,4 = 3.6, J4,5 = 2.8 Hz, 1H, 
H-4), 3.79 (ddd, J4,5 = 2.8, J5,6 = 6, J5,6’ = 6.8 Hz, 1H, H-5), 3.67 (dd, J5,6 = 6, J6,6’ = 11.2 Hz, 1H, 
H-6), 3.63 (dd, J5,6’ = 6.8, J6,6’ = 11.2 Hz, 1H, H-6’), 2.33 (t, J = 7.2 Hz, 2H, CH2), 1.68 (bt, J = 
7.2 Hz, 2H, CH2), 1.44-1.28 (m, 24H), 0.96 (t, J = 6.8 Hz, 3H, CH3). 13C-NMR (100 MHz, 
CD3OD, 25°C): δ = 176.7, 84.4 (C-4), 82.2 (C-1), 78.5 (C-3), 77.4 (C-2), 73 (C-5), 64.4 (C-6), 
37.3, 33.2, 30.9, 30.8, 30.6, 30.4, 26.8, 23.9, 14.6 (CH3). [α]D25 = +9 (c 1, MeOH). FT-ICR (ESI) 
calcd. for C22H43N1O6 [M+Na]+ 440.29826; found 440.29797. 
 
N-capryloyl-α-D-galactofuranosyl amide (111g) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 85:15) yield = 63 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.68 (d, J1,2 = 4.4 Hz, 1H, H-1), 4.12 (t, J2,3 = 3.6, J3,4 = 
3.2 Hz, 1H, H-3), 3.87 (dd, J1,2 = 4.4, J2,3 = 3.6 Hz, 1H, H-2), 3.79 (t, J3,4 = 3.2, J4,5 = 2.8 Hz, 1H, 
H-4), 3.73 (ddd, J4,5 = 2.8, J5,6 = 6, J5,6’ = 6.8 Hz, 1H, H-5), 3.61 (dd, J5,6 = 6, J6,6’ = 11.2 Hz, 1H, 
H-6), 3.57 (dd, J5,6’ = 6.8, J6,6’ = 11.2 Hz, 1H, H-6’), 2.27 (t, J = 7.2 Hz, 2H, CH2), 1.62 (bt, J = 
7.2 Hz, 2H, CH2), 1.40-1.24 (m, 8H, 4xCH2), 0.91 (t, J = 6.4, J = 7.2 Hz, 3H, CH3). 13C-NMR 
(100 MHz, CD3OD, 25°C): δ = 176.7, 84.4 (C-4), 82.2 (C-1), 78.5 (C-3), 77.3 (C-2), 72.9 (C-5), 
64.3 (C-6), 37.3 (CH2), 33.0, 30.4, 30.3 (3xCH2), 26.8 (CH2), 23.8 (1xCH2), 14.6 (CH3). [α]D25 = 
+12.2 (c 1, MeOH). FT-ICR (ESI) calcd. for C14H27N1O6 [M+Na]+ 328.17306; found 328.17314. 
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N-citronelloyl-α-D-galactofuranosyl amide (111h) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 90:10) yield = 56 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.74 (d, J1,2 = 4 Hz, 1H, H-1), 5.17 (t, J = 5.8 Hz, 1H, 
CH) 4.18 (t, J2,3 = 3.4, J3,4 = 3.6 Hz, 1H, H-3), 3.93 (dd, J1,2 = 4, J2,3 = 3.4 Hz, 1H, H-2), 3.85 (dd, 
J3,4 = 3.6, J4,5 = 3.2 Hz, 1H, H-4), 3.79 (ddd, J4,5 = 3.2, J5,6 = 5.6, J5,6’ = 6.8 Hz, 1H, H-5), 3.68 
(dd, J5,6 = 5.6, J6,6’ = 11.2 Hz, 1H, H-6), 3.63 (dd, J5,6’ = 6.8, J6,6’ = 11.2 Hz, 1H, H-6’), 2.34 (dd, J 
= 13.6, J = 6 Hz, 1H, Ha, CH2), 2.18-1.98 (m, 4H), 1.73 (s, 3H, CH3), 1.67 (s, 3H, CH3), 1.48-
1.40 (m, 1H), 1.33-1.22 (m, 1H), 0.95 (d, J = 6.8 Hz, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 
25°C): δ = 175.9, 132.4, 125.7 (CH), 84.5 (C-4), 82.3 (C-1), 78.5 (C-3), 77.4 (C-2), 73 (C-5), 
64.4 (C-6), 44.9, 38.1, 31.7, 26.6, 26, 19.9, 17.9. [α]D25 = +13.2 (c 1, MeOH). FT-ICR (ESI) 
calcd. for C16H29N1O6 [M+Na]+ 354.18871; found 354.18864. 
 
N-benzoyl-α-D-galactofuranosyl amide (111i) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 85:15) yield = 62 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 7.91 (m, 2H, Horto), 7.60 (m, 1H, Hpara), 7.53 (m, 2H, 
Hmeta), 5.94 (d, J1,2 = 4.8 Hz, 1H, H-1), 4.27 (t, J2,3 = 4.2, J3,4 = 4.4 Hz, 1H, H-3), 4.13 (t, J1,2 = 
4.8, J2,3 = 4.2 Hz, 1H, H-2), 3.93 (dd, J3,4 = 3.6, J4,5 = 2.8 Hz, 1H, H-4), 3.84 (ddd, J4,5 = 2.8, J5,6 
= 5.4, J5,6’ = 6.8 Hz, 1H, H-5), 3.70 (dd, J5,6 = 5.6, J6,6’ = 11.2 Hz, 1H, H-6), 3.66 (dd,  J5,6’ = 6.8, 
J6,6’ = 11.2 Hz, 1H, H-6’). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 169.8, 135.4, 133.2, 129.8, 
128.6, 84.5 (C-4), 82.7 (C-1), 78.2 (C-3), 77.9 (C-2), 72.7 (C-5), 64.4 (C-6). [α]D25 = +7.9 (c 1, 
MeOH). FT-ICR (ESI) calcd. for C13H17N1O6 [M+Na]+ 306.09481; found 306.09465. 
 
 
 
Chapter 6 
 175 
N-pentanoyl-β-D-galactofuranosyl amide (113b) 
 
 
 
After Zemplen deacetylation the compound was purified by flash chromatography 
(CHCl3:MeOH 80:20) yield = 60 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.38 (d, J1,2 = 5.2 Hz, 1H, H-1), 4.14 (t, J2,3 = 5.8, J3,4 = 
6.4 Hz, 1H, H-3), 3.95 (t, J1,2 = 5.2, J2,3 = 5.8 Hz, 1H, H-2), 3.90 (dd, J3,4 = 6.4, J4,5 = 2.8 Hz, 1H, 
H-4), 3.68-3.63 (m,1H, H-5), 3.62-3.57 (m, 2H, H-6, H-6’), 2.22 (t, J
 
= 7.4 Hz ,2H, CH2), 1.71-
1.54 (m, 2H, CH2), 1.48-1.32 (m, 2H, CH2), 0.95 (t, J = 7.2 Hz, 3H, CH3). 13C-NMR (100 MHz, 
CD3OD, 25°C): δ = 177.4, 85.5 (C-1), 83.6 (C-4), 81.1 (C-2), 77.5 (C-3), 72.7 (C-5), 64.4 (C-6), 
37.1 (CH2), 28.9 (CH2), 23.5 (CH2), 14.3 (CH3). NOESY (400 MHz, CD3OD, 25°C): contact 
between H-1/H-3. 
 [α]D25 = -17.9 (c 0.2, MeOH). FT-ICR (ESI) calcd. for C11H21N1O6 [M+Na]+ 286.12611; found 
286.12586. 
 
 
 
 
N-pentanoyl-β-D-galactofuranosyl amide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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N-(3-Methylbutanoyl)-β-D-galactofuranosyl amide (113c) 
 
 
 
After Zemplen deacetylation the compound was purified by flash chromatography 
(CHCl3:MeOH 85:15) yield = 53 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.40 (d, J1,2 = 5.2 Hz, 1H, H-1), 4.15 (t, J2,3 = 5.8, J3,4 = 
6.4 Hz, 1H, H-3), 3.97 (t, J1,2 = 5.2, J2,3 = 5.8 Hz, 1H, H-2), 3.92 (dd, J3,4 = 6.4, J4,5 = 2.8 Hz, 1H, 
H-4), 3.71-3.65 (m,1H, H-5), 3.63-3.58 (m, 2H, H-6, H-6’), 2.35 (d, J
 
= 7.2 Hz, 2H, CH2), 1.01 
(d, J
 
= 6.4 Hz , 3H, CH3), 0.97 (d, J = 6 Hz, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 
176.6, 85.6 (C-1), 83.7 (C-4), 81.2 (C-2), 77.5 (C-3), 72.7 (C-5), 64.4 (C-6), 46.5 (CH2), 22.9 
(CH3), 22.7 (CH3). [α]D25 = -24.5 (c 1, MeOH). FT-ICR (ESI) calcd. for C11H21N1O6 [M+Na]+ 
286.12611; found 286.12584. 
 
N-3-methyl-2-butenoyl-β-D-galactofuranosyl amide (113e). 
 
 
 
After Zemplen deacetylation the compound was purified by flash chromatography 
(CHCl3:MeOH 85:15) yield = 48 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.74 (s, 1H, CH), 5.41 (d, J1,2 = 5.6 Hz, 1H, H-1), 4.15 
(t, J2,3 = 5.8, J3,4 = 6.4 Hz, 1H, H-3), 3.96 (t, J1,2 = 5.6, J2,3 = 5.8 Hz, 1H, H-2), 3.90 (dd, J3,4 = 6.4, 
J4,5 = 2.8 Hz, 1H, H-4), 3.68-3.63 (m,1H, H-5), 3.61-3.57 (m, 2H, H-6, H-6’), 2.15 (s, 3H, CH3), 
1.89 (s, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 170.2, 154.3, 119.3 (CH), 85.4 (C-
1), 83.4 (C-4), 81.1 (C-2), 77.5 (C-3), 72.8 (C-5), 64.4 (C-6), 27.5 (CH3), 20.3 (CH3). [α]D25 = -
27.8 (c 0.2, MeOH). FT-ICR (ESI) calcd. for C11H21N1O6 [M+Na]+ 284.11046; found 
284.11027. 
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N-palmitoyl-β-D-galactofuranosyl amide (113f). 
 
 
 
After Zemplen deacetylation the compound was purified by flash chromatography 
(CHCl3:MeOH 90:10) yield = 60 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.40 (d, J1,2 = 5.2 Hz, 1H, H-1), 4.15 (t, J2,3 = 6, J3,4 = 6 
Hz, 1H, H-3), 3.96 (t, J1,2 = 5.2, J2,3 = 5.6 Hz, 1H, H-2), 3.93 (dd, J3,4 = 6.4, J4,5 = 2.8 Hz, 1H, H-
4), 3.70-3.65 (m, 1H, H-5), 3.63-3.58 (m, 2H, H-6, H-6’), 2.24 (t, J
 
= 8 Hz, 2H, CH2), 1.63 (m, 
2H, CH2), 1.41-1.25 (m, 24 H, 12x CH2), 0.92 (t, J = 6.8 Hz, 3H, CH3). 13C-NMR (100 MHz, 
CD3OD, 25°C): δ = 177.1, 85.7 (C-1), 83.8 (C-4), 81.2 (C-2), 77.6 (C-3), 72.8 (C-5), 64.4 (C-6), 
37.4, 33.2, 30.9, 30.7, 30.6, 30.4, 26.8, 23.8, 14.6 (CH3). [α]D25 = -37.3 (c 1, MeOH). FT-ICR 
(ESI) calcd. for C22H43N1O6 [M+Na]+ 440.29826; found 440.29844. 
 
N-capryloyl-β-D-galactofuranosyl amide (113g) 
 
 
 
After Zemplen deacetylation the compound was purified by flash chromatography 
(CHCl3:MeOH 85:15) yield = 56 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.42 (d, J1,2 = 5.2 Hz, 1H, H-1), 4.17 (t, J2,3 = 5.8, J3,4 = 
6.4 Hz, 1H, H-3), 3.98 (t, J1,2 = 5.2, J2,3 = 5.8 Hz, 1H, H-2), 3.95 (dd, J3,4 = 6.4, J4,5 = 2.8 Hz, 1H, 
H-4), 3.73-3.68 (m, 1H, H-5), 3.65-3.59 (m, 2H, H-6, H-6’), 2.28 (t, J
 
= 7.2, J
 
= 8 Hz, 2H, CH2), 
1.65 (m, 2H, CH2), 1.47-1.27 (m, 8H, 4xCH2), 0.94 (t, J = 6.8 Hz, 3H, CH3). 13C-NMR (100 
MHz, CD3OD, 25°C): δ = 177.1, 85.4 (C-1), 83.6 (C-4), 81 (C-2), 77.3 (C-3), 72.6 (C-5), 64.2 
(C-6), 37.2, 32.8, 30.2, 30.1, 26.7, 23.6, 14.4 (CH3). [α]D25 = -50.4 (c 0.9, MeOH). FT-ICR (ESI) 
calcd. for C14H27N1O6 [M+Na]+ 328.17306; found 328.17317. 
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N-citronelloyl-β-D-galactofuranosyl amide (113h) 
 
 
 
After Zemplen deacetylation the compound was purified by flash chromatography 
(CHCl3:MeOH 90:10) yield = 51 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.45 (d, J1,2 = 5.2 Hz, 1H, H-1), 5.16 (t, J = 6.8 Hz, 1H, 
CH) 4.20 (t, J2,3 = 5.6, J3,4 = 6.2 Hz, 1H, H-3), 4.01 (t, J1,2 = 5.2, J2,3 = 5.6 Hz, 1H, H-2), 3.97 (dd, 
J3,4 = 6.2, J4,5 = 2.8 Hz, 1H, H-4), 3.71 (ddd, J4,5 = 2.8, J = 6, J = 6.8 Hz, 1H, H-5), 3.68-3.63 (m, 
2H, H-6, H-6’), 2.29 (dd, J = 13.6, J = 6 Hz, 1H, Ha, CH2), 2.18-1.98 (m, 4H), 1.73 (s, 3H, CH3), 
1.67 (s, 3H, CH3), 1.48-1.40 (m, 1H), 1.33-1.22 (m, 1H), 1.01 (d, J = 6.4 Hz, 3H, CH3). 13C-
NMR (100 MHz, CD3OD, 25°C): δ =176.6, 132.4, 125.7, 85.7 (C-1), 83.8 (C-4), 81.2 (C-2), 
77.6 (C-3), 72.8 (C-5), 64.4 (C-6), 44.9, 38.1, 30.9, 26.6, 26, 19.9, 17.9. [α]D25 = -55.8 (c 0.9, 
MeOH). FT-ICR (ESI) calcd. for C16H29N1O6 [M+Na]+ 354.18871; found 354.18866. 
 
N-pentanoyl-α-D-ribofuranosyl amide (115b)  
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20) yield = 59 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.67 (d, J1,2 = 4.8 Hz, 1H, H-1), 4.12-4.06 (m, 2H, H-2, 
H-3), 3.93-3.87 (q, J4,5 = 3.2 Hz, J4,5’= 4.4 Hz, 1H, H-4), 3.69 (dd, J4,5 = 3.2 Hz, J5,5’= 12 Hz, 1H, 
H-5), 3.55 (dd, J4,5’ = 4.4 Hz, J5,5’= 12 Hz, 1H, H-5’) 2.24 (t, J = 7.2 Hz ,2H, CH2), 1.65-1.57 (m, 
2H, CH2), 1.43-1.33 (m, 2H, CH2), 0.95 (t, J = 7.2 Hz, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 
25°C): δ = 176.6, 84.2 (C-4), 81.5 (C-1), 72.6, 71.8, 62.9 (C-5), 36.9 (CH2), 28.8 (CH2), 23.3 
(CH2), 14.1 (CH3).  
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N-pentanoyl-β-D-ribofuranosyl amide (116b) 
 
 
 
After Zemplen deacetylation the compound was purified by flash chromatography 
(CHCl3:MeOH 80:20) yield = 55 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.38 (d, J1,2 = 4.8 Hz, 1H, H-1), 4.06 (t, J2,3 = 5.2, J3,4 = 
5.2 Hz, 1H, H-3), 3.91 (t, J1,2 = 4.8, J2,3 = 5.2 Hz, 1H, H-2), 3.88-3.83 (q, J4,5 = 3.6 Hz, J4,5’= 4.4 
Hz, 1H, H-4), 3.70 (dd, J4,5 = 3.6 Hz, J5,5’= 12 Hz, 1H, H-5), 3.61 (dd, J4,5’ = 4.4 Hz, J5,5’= 12 Hz, 
1H, H-5’) 2.23 (t, J
 
= 7.2 Hz ,2H, CH2), 1.65-1.57 (m, 2H, CH2), 1.43-1.33 (m, 2H, CH2), 0.95 
(t, J
 
= 7.2 Hz, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 176.8, 85.8 (C-1), 85.1 (C-4), 
75.9 (C-2), 71.9 (C-3), 63.3 (C-5), 37.1 (CH2), 28.9 (CH2), 23.5 (CH2), 14.3 (CH3). NOESY (400 
MHz, CD3OD, 25°C): contact between H-1/H-4. 
 
N-pentanoyl-α-D-ribofuranosyl amide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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Tetra-O-acetyl N-pentanoyl-β-D-ribofuranosyl amide (117b) 
 
 
 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 6.06 (d, J1,2 = 4.8 Hz, 1H, H-1), 5.45 (t, J1,2 = 4.8, J2,3 = 
5.6 Hz, 1H, H-2), 5.36 (t, J2,3 = 5.6 Hz, 1H, H-3), 4.36-4.31 (m, 2H, H-4, H-5), 4.21 (dd, J4,5’ = 
4.8, J5,5’= 12 Hz, 1H, H-5’) 2.23 (t, J = 7.2 Hz ,2H, CH2), 2.19 (s, 3H, OAc), 2.15 (s, 3H, OAc), 
2.12 (s, 3H, OAc), 1.67-1.59 (m, 2H, CH2), 1.44-1.35 (m, 2H, CH2), 0.99 (t, J = 7.2 Hz, 3H, 
CH3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 176.1, 172.2, 171.5, 171.3, 80.8 (C-1), 79.2 (C-
4), 72.9 (C-3), 71.9 (C-2), 64.8 (C-5), 36.8 (CH2), 29 (CH2), 23.4 (CH2),20.7-20.5 (3xOAc), 14.2 
(CH3). NOESY (400 MHz, CD3OD, 25°C): contact between H-1/H-3 and H-1/H-5. 
 
 
 
 
 
N-pentanoyl-β-D-ribofuranosyl amide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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N-pentanoyl-β-D-arabinobofuranosyl amide (118b) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20) yield = 57 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.72 (d, J1,2 = 4.4 Hz, 1H, H-1), 4.01 (t, J2,3 = 3.6 Hz, 
J3,4= 3.6 Hz, 1H, H-3), 3.90 (dd, J1,2= 4.4 Hz, J2,3 = 3.6 Hz, 1H, H-2), 3.76 (ddd, J3,4= 3.6 Hz, J4,5 
= 3.6 Hz, J4,5’= 5.2 Hz, 1H, H-4), 3.70 (dd, J4,5 = 3.6 Hz, J5,5’= 11.6 Hz, 1H, H-5), 3.64 (dd, J4,5’ 
= 5.2 Hz, J5,5’= 11.6 Hz, 1H, H-5’) 2.28 (t, J = 7.6 Hz ,2H, CH2), 1.65-1.57 (m, 2H, CH2), 1.43-
1.33 (m, 2H, CH2), 0.94 (t, J = 7.6 Hz, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 
176.8, 84.4 (C-4), 82.2 (C-1), 78.3 (C-3), 77.3 (C-2), 63.5 (C-5), 36.9 (CH2), 28.9 (CH2), 23.5 
(CH2), 14.3 (CH3). NOESY (400 MHz, CD3OD, 25°C): contact between H-1/H-4. 
 
 
 
 
 
 
N-pentanoyl-β-D-arabinobofuranosyl amide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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N-pentanoyl-α-D-arabinobofuranosyl amide (119b)  
 
 
 
After Zemplen deacetylation the compound was purified by flash chromatography 
(CHCl3:MeOH 80:20) yield = 53 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.39 (d, J1,2 = 4.8 Hz, 1H, H-1), 4.03 (t, J2,3 = 5.2 Hz, 
1H, H-3), 3.88 (t, J1,2 = 4.8, J2,3 = 5.2 Hz, 1H, H-2), 3.84 (q, J4,5 = 3.6 Hz, J4,5’= 4.4 Hz, 1H, H-4), 
3.67 (dd, J4,5 = 3.6, J5,5’= 12 Hz, 1H, H-5), 3.55 (dd, J4,5’ = 4.4 Hz, J5,5’= 12 Hz, 1H, H-5’) 2.20 (t, 
J
 
= 7.6 Hz ,2H, CH2), 1.60-1.54 (m, 2H, CH2), 1.40-1.29 (m, 2H, CH2), 0.92 (t, J = 7.2 Hz, 3H, 
CH3).  
 
 
 
 
 
 
 
 
N-pentanoyl-α-D-arabinobofuranosyl amide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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N-pentanoyl-β-D-ribopyranosyl amide (120b) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20) yield = 68 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.15 (d, J1,2 = 9.2 Hz, 1H, H-1), 4.07 (d, J2,3 = 2.8 Hz, 
1H, H-3), 3.73-3.57 (m, 3H, H-4, H-5, H-5’), 3.39 (dd, J1,2 = 9.2, J2,3 = 2.8 Hz, 1H, H-2), 2.22 (t, 
J
 
= 7.6 Hz ,2H, CH2), 1.64-1.56 (m, 2H, CH2), 1.43-1.32 (m, 2H, CH2), 0.94 (t, J = 7.6 Hz, 3H, 
CH3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 177.5, 78 (C-1), 72.4 (C-3), 71.3 (C-2), 68.8 (C-
4), 65.7 (C-5), 37 (CH2), 28.9 (CH2), 23.5 (CH2), 14.3 (CH3). 
 
 
 
 
 
 
 
 
 
N-pentanoyl-β-D-ribopyranosyl amide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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N-pentanoyl-β-D-arabinopyranosyl amide (121b) 
 
 
 
The compound was purified by flash chromatography (CHCl3:MeOH 80:20) yield = 70 %. 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 4.90 (d, J1,2 = 8 Hz, 1H, H-1), 3.95-3.88 (m, 2H, H-3, 
H-5), 3.73-3.66 (m, 3H, H-2, H-4, H-5’), 2.34 (t, J
 
= 7.6 Hz ,2H, CH2), 1.74-1.67 (m, 2H, CH2), 
1.53-1.42 (m, 2H, CH2), 1.03 (t, J = 7.6 Hz, 3H, CH3). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 
177.2, 81.8 (C-1), 75.3 (C-2), 71.4 (C-4), 70.3 (C-3), 68.9 (C-5), 37.1 (CH2), 29 (CH2), 23.5 
(CH2), 14.2 (CH3).  
 
 
 
 
 
 
 
 
 
N-pentanoyl-β-D-arabinopyranosyl amide 
1H-NMR (400 MHz, CDCl3, 25°C) 
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Synthesis of 1,2,3,5,6-penta-O-tert-butyldimethylsislyl-β-D-galactofuranose (126) 
 
 
 
To a solution of D-galactose (0.5 g, 2.77 mmol) in dry DMF (14mL), imidazole (2.74 g, 18.25 
mmol) and TBSCl (3 g, 20.08 mmol) were added, and the reaction mixture was stirred at room 
temperature. After 48h TLC (Hexane/AcOEt 10:1) monitoring showed total consumption of the 
starting material. The solution was poured into ice/water and was diluted with CH2Cl2. The 
organic layer was washed with HCl (5 %), water, NaHCO3 (ss), and water, dried (Na2SO4), and 
concentrated. Addition of MeOH (5 mL) to the syrup afforded crystalline compound 126. 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 4.41 (d, J = 7.1 Hz, 1H, H-1), 4.00 (d, J = 2.3 Hz, 1H, 
H-4), 3.85 (dd, J = 10.0, 5.8, 2.9 Hz, 1H, H-6), 3.71 (dd, J = 10.0, 5.8 Hz, 1H, H-6’), 3.57 (m, 
2H, H-2, H-3), 3.38 (ddd, J = 9.3, 5.4, 2.9 Hz, 1H, H-5), 0.93-0.87 (m, 45H, SiC(CH3)3), 0.14-
0.04 (m, 30H, Si(CH3)2). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 98.7, 76.2, 75.2, 74.1, 69.2, 
61.6, 26.3-18.0, -3.2 to -4.45. 
 
Synthesis of 2,3,5,6-tetra-O-tert-butyldimethylsislyl-α-D-galactofuranosyl azide (128) 
 
 
 
A solution of 126 (200 mg, 0.26 mmol) in anhydrous CH2Cl2 (10 mL) was cooled to 0°C and 
stirred for 10 min. under nitrogen. Then, iodotrimethylsilane (1.2 eq.,0.042 mL, 0.32 mmol) was 
added, and the solution was stirred at 0°C until TLC (Hexane/AcOEt 10:1) monitoring showed 
complete transformation of 129 in two products Rf = 0.70 and Rf = 0.54. In parallel a solution of 
tetrabutylammonium hydroxide was prepared by addition 280 µL of 10M sodium hydroxide 
solution (an excess) to 383.3 mg (0.2 mol) of tetrabutylammonium hydrogene sulphate in 560 µL 
of water. 
A solution of 147 mg (0.4 mol) of sodium azide in 280 µL of water was added and 
tetrabutylammonium azide extracted with 1 mL of dichloromethane. The organic layer, was 
separated off and the aqueous phase again extracted with 1 mL of dichloromethane. The 
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combined organic phases were evaporated in vacuo at 40°C to yield a crude tetrabutylammonium 
azide as a colourless oil. The solutions thus obtained were used directly in the following step. 
Then EtN(iPr)2 (0.054 mL, 0.032 mmol) and a solution of the azide were added, and the stirring 
was continued until consumption of the components of Rf = 0.70 and Rf = 0.54. The solution was 
diluted with CH2Cl2 washed with HCl 5 %, NaHCO3 (ss) and water, dried (Na2SO4), and 
concentrated. The syrup obtained was purified by flash column chromatography (Hexane:AcOEt 
98:2). Yield = 75 % 
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.11 (d, J1,2 = 4 Hz, 1H, H-1), 4.24 (t, J2,3 = 4.4, J3,4 = 4.6 
Hz, 1H, H-3), 3.99 (t, J1,2 = 4, J2,3 = 4.4 Hz, 1H, H-2), 3.87 (t, J3,4 = 4.6, J4,5 = 4.4 Hz, 1H, H-4), 
3.79 (ddd, J4,5 = 4.4, J5,6 = 6, J5,6’ = 5.6 Hz, 1H, H-5), 3.66 (dd, J5,6 = 6, J6,6’ = 10 Hz, 1H, H-6), 
3.60 (dd, J5,6’ = 5.6, J6,6’ = 10 Hz, 1H, H-6’), 0.92-0.84 (m, 36H, SiC(CH3)3), 0.18-0.06 (m, 24 H, 
Si(CH3)2). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 90.9 (C-1), 85.5 (C-4), 79.5 (C-2), 76.3 (C-
3), 73 (C-5), 65 (C-6), 26.2, 26.1, 26, 25.9, - 0.25 to -0.5. NOESY (400 MHz, CDCl3, 25°C): 
contact between H-1/H-4. 
 
Synthesis of α-D-galactofuranosyl azide (46) 
 
 
 
A solution of 128 (60 mg, 0.09 mmol, 1 eq.) in anhydrous THF dry (180 µL,) was cooled to 0°C 
and stirred for 10 min. under nitrogen. Then, tetrabutylammonium fluoride 1M in THF (157 µL, 
0.54 mmol, 5 eq.) was added, and the solution was stirred at room temperature until TLC 
(Hexane/AcOEt 60:40 and CHCl3/MeOH 80.20) monitoring showed complete transformation of 
128 in 46. 
The solution was diluted with water 
 
washed with dichloromethane and AcOEt and then 
concentrated.The syrup obtained was purified by flash column chromatography (CHCl3:MeOH 
90:10). Quantitative yield 
1H-NMR (400 MHz, CD3OD, 25°C): δ = 5.17 (d, J1,2 = 4.8 Hz, 1H, H-1), 4.08 (t, J2,3 = 6.4, J3,4 = 
6 Hz, 1H, H-3), 4.04 (t, J1,2 = 4.8, J2,3 = 6.4 Hz, 1H, H-2), 3.77 (dd, J3,4 = 6, J4,5 = 4.4 Hz, 1H, H-
4), 3.69 (ddd, J4,5 = 4.4, J5,6 = 5.2, J5,6’ = 6.8 Hz, 1H, H-5), 3.66 (dd, J5,6 = 5.2, J6,6’ = 11.2 Hz, 1H, 
H-6), 3.60 (dd, J5,6’ = 6.8, J6,6’ = 11.2 Hz, 1H, H-6’). 13C-NMR (100 MHz, CD3OD, 25°C): δ = 
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92.8 (C-1), 84.5 (C-4), 79 (C-2), 76.2 (C-3), 73.5 (C-5), 64.1 (C-6). NOESY (400 MHz, CD3OD, 
25°C): contact between H-1/H-4. 
 
 
 
 
 
Synthesis of 2,3,4,6-tetra-O-acetyl-α-D-galactofuranosyl azide (129) 
 
 
 
Acetic anhydride (10 eq) and a catalytic amount of N,N-dimethylaminopyridine were added, at 
room temperature, to a solution of substrate 46 (1 eq) in pyridine dried on molecular sieves (0.1 
M). The solution was stirred for 24 h and then was concentrated in vacuo. The residue was 
dissolved in AcOEt and washed with aqueous 5 % HCl, aqueous 5 % NaHCO3 and water. The 
organic layer was dried over Na2SO4 and concentrated to give the product 129 in quantitative 
yield.  
1H-NMR (400 MHz, CDCl3, 25°C): δ = 5.55 (d, J1,2 = 5.6 Hz, 1H, H-1), 5.41 (t, J2,3 = 6.8, J3,4 = 
6.4 Hz, 1H, H-3), 5.28 (ddd, J4,5 = 2, J5,6 = 4.8, J5,6’ = 6.4 Hz, 1H, H-5), 5.14 (t, J1,2 = 5.6, J2,3 = 
6.8 Hz, 1H, H-2), 4.35 (dd, J5,6 = 4.8, J6,6’ = 12 Hz, 1H, H-6), 4.17 (dd, J5,6’ = 6.4, J6,6’ = 12 Hz, 
1H, H-6’), 4.13 (dd, J3,4 = 6, J4,5 = 4.4 Hz, 1H, H-4), 2.13 (s, 3H, OAc), 2.10 (s, 3H, OAc), 2.08 
α-D-galactofuranosyl azide 
1H-NMR (400 MHz, CD3OD, 25°C) 
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(s, 3H, OAc), 2.05 (s, 3H, OAc). 13C-NMR (100 MHz, CDCl3, 25°C): δ = 170.6, 170.2, 170.1, 
169.9, 88.8 (C-1), 79.1 (C-4), 75.9 (C-2), 73.6 (C-3), 69.6 (C-5), 62.4 (C-6) 20.9-20.6 (4xOAc). 
NOESY (400 MHz, CDCl3, 25°C): contact between H-1/H-4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tetra-O-acetyl-α-D-galactofuranosyl azide 
1H-NMR (400 MHz, CDCl3, 25°C) 
 
Chapter 6 
 189 
6.7 References 
                                                 
1
  Angyal, S. J. Carbohydr. Res. 1994, 263, 1-11. 
2
  Györgydeák, Z.; Szitagyi, L.; Paulsen H. J. Carb. Chem. 1993, 12, 139-163. 
3
  Norrild, J. Chr.; Eggert, H. J. Am. Chem. Soc. 1995, 117, 1479-1484. 
4
  Nisic, F.; Bernardi, A. Carbohydr. Res 2008, 343, 1636-1643. 
5
  Nisic, F.; Andreini, M.; Bernardi, A. Eur. J. Org.Chem, 2009, 5744-5751. 
6
  Chittenden, G. J. F. Carbohydr. Res 1972, 25, 35-41. 
7
  Owen, D. J.; Davis, C. B.; Hartnell, R. D.; Madge, P. D.; Thomson, R. J.; Chong, A. K. J.; Coppel, R. L.; M. von 
Itzstein Carbohydr. Res. 2007, 342, 1773-1780. 
8
  Owen, D. J.; Davis, C. B.; Hartnell, R. D.; Madge, P. D.; Thomson, R. J.; Chong, A. K. J.; Coppel, R. L.; M. von 
Itzstein Bioorg. Med. Chem. Lett. 2007, 17, 2274-2277. 
9
  Bianchi, A.; Bernardi, A. J. Org. Chem. 2006, 71, 4565-4577. 
10
  Baldoni, L.; Marino, C. J. Org. Chem. 2009, 74, 1994-2003. 
11
  Brandstrom, A.; Lamm, B.; Palmertz, I. Acta Chem. Scand. (B), 1974, 28, 699-701. 
12
  Corey, E. J.; Venkateswarlu, A. J. Am. Chem. Soc. 1972, 94, 6190-6191. 
13
  World Health Organization. Fact Sheet No. 104; World Health Organization: Geneva, 2002 
14
  Duncan, K. Curr. Pharm. Des. 2004, 10, 3185-3194. 
15
  Scherman, M. S.; Winans, K. A.; Bertozzi, C. R. Antimicrob. Agents Chemother. 2003, 378-382. 
16
  Kremer, L.; Dover, L.G.; Morehouse, C.; Hitchin, P.; Everett, M.; Morris, H. R.; Dell, A.;Brennan, P. J.;Besra, 
G. S. J. Biol. Chem. 2001, 276, 26430-26440. 
17
  Rose, N. L.; Completo, G. C.; Lin, S. J.; McNeil, M.; Palcic, M. M.; Lowary, T. L. J. Am. Chem. Soc. 2006, 128, 
6721-6729. 
18
  Richards, R. M.; Lowary, T. L. ChemBioChem 2009, 10, 1920-1938. 
19
  Lee, R. E.; Smith, M. D.; Nash, R. J.; Griffiths, R. C.; McNeil, M.; Grewal, R. K.; Yan, W. X.; Besra, G. S.; 
Brennan, P. J.; Fleet, G. W. J. Tethrahedron Lett. 1997, 38, 6733-6736.  
20
 Itoh, K.; Huang, Z. S.; Liu, H. W. Org. Lett. 2007, 9, 879-882. 
21
  Kovensky, J.; McNeil, M.; Sinaÿ, P. J. Org. Chem. 1999, 64, 6202-6205; (b) Caravano, A.; Vincent, S. P.; Sinaÿ, 
P. Chem. Commun. 2004, 1216-1217. (c) Caravano, A.; Mengin-Lecreuix, D.; Brondello, J. M.; Vincent, S. P.; 
Sinaÿ, P. Chemistry-Eur. J. 2003, 9, 5888-5898. (d) Pan, W. D.; Ansiaux, C.; Vincent, S. P. Tetrahedron Lett. 
2007, 48, 4353-4356. 
22
  Tangallapally, R. P.; Yendapally, R.; Lee, R. E.; Hevener, K.; Jones, V. C.;Lenaerts, A. J. M.; McNeil, M. R.; 
Wang, Y. H.; Franzblau, S.; Lee, R. E. J. Med. Chem. 2004, 47, 5276-5283. 
23
  Soltero-Higgin, M.; Carlson, E. E.; Phillips, J. H.; Kiessling, L. L. J. Am. Chem. Soc. 2004, 126, 10532-10533. 
24
  Carlson, E. E.; May, J. F.; Kiessling, L. L. Chem. Biol. 2006, 13, 825-837; Dykhuizen, E. C.; May, J. F.; 
Tongpenay, A.; Kiessling, L. L. J. Am. Chem. Soc. 2008, 130, 6706-6707; Dykhuizen, E. C.; Kiessling, L. L. 
Org. Lett. 2009, 11, 193-196. 
25
  Veerapen, N.; Yuan, Y.; Sanders, D. A. R.; Pinto, B. M. Carbohydr. Res. 2004, 339, 2205-2217. 
26
  Frigell, J.; Cumpstey, I. Tethrahedron Lett. 2007, 48, 9073-9076. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 
Summary, discussion, perspectives 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 
 191 
 
7.1 Mechanistic considerations 
 
Although the Staudinger reaction has been known from 1919, and was actually described before 
the Wittig counterpart, the mechanism of this reaction is still poorly understood. The number of 
the intermediates and of the possible reaction pathways connecting them to each other and to the 
starting and final products is high and the potential energy surface extremely complex. 
The mechanism of the Staudinger reaction has been extensively studied by using computational1, 
2, 3
 and experimental methods. 4, 5  
Kinetic studies of the classical Staudinger reaction have shown that the process can be first- or 
second-order overall depending on the exact nature of the reactants. For example, the rate-
limiting step in the reaction between triphenylphosphine and benzenesulfonyl azide (R’ = -
SO2Ph) is the unimolecular decomposition (k2, Scheme 1) of the phosphazide complex 130.6 
In contrast, the reaction of benzoyl azide (R’ = -COPh) with triphenylphosphine follows second 
order kinetics, indicating that the bimolecular step leading to the formation of the phosphazide 
130 (k1, Scheme 1) is rate-limiting.7 In reactions between substituted phenyl azides and 
substituted triphenylphosphines, deviations from second-order kinetics are observed, presumably 
due to the reversibility of formation of the phosphazide intermediate 130 (k
-1, Scheme 1).7 
 
 
 
Scheme 1. Schematic mechanism of the classical Staudinger reaction 
 
Phosphotriazadienes have been isolated from Staudinger azide reductions: these intermediates 
are stabilised by electron-donating groups on the phosphine, or electron-withdrawing groups on 
the azide, or sterically hindering groups on both phosphine and azide.1 Some 
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phosphotriazadienes have been characterised by X-ray crystallography and other techniques:1, 4, 8, 
9, 10
 they all have been found to be consistent with a zwitterionic structure corresponding to 130 
(Scheme 1) displaying a partial double bond character of the central N-N linkage. The E 
configuration of the N-N double bond (Scheme 1, 130-E) is generally observed,8 while the cis-
configuration has rarely been isolated.8a 
In the reaction mixture 130-E can isomerise to the Z isomer 130-Z, which spontaneously 
decomposes to afford N2 and the aza-ylide 131.  
Iminophosphoranes 131 are relatively stable species and have been isolated in a number of 
instances.1 In particular, glycosyl iminophosphoranes from O-acetyl protected sugars are rather 
stable, and many have been isolated and characterised by NMR spectroscopy.9, 11, 12 
Mechanistic investigations of the traceless Staudinger ligation with phosphine 132 (Scheme 2) 
were recently reported by the Bertozzi group.13 They determined the kinetic parameters of the 
Staudinger ligation of phosphine 132 and benzyl azide 133 using 31P-NMR spectroscopy. When 
132 (0.041 M) and 133 (0.41 M) were combined in CD3CN with 5 % water (v/v) (2.78 M), 
consumption of 132 followed pseudo-first-order kinetics. Under these conditions, the only 
species detectable by 31P-NMR were the starting material 132 and the ligation product 134.  
 
 
 
 
Scheme 2. Mechanistic investigations of the traceless Staudinger ligation 13 
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For this reaction the results can be summarised as follows: 
 
1. The reaction proceeded faster in solvents with higher dielectric constants. These 
observations suggest that the rate-limiting step involves a polar transition state that can be 
stabilised by polar solvents. 
2. The kinetic studies suggest that the rate-limiting step of the reaction occurs prior to the 
intramolecular reaction of the aza-ylide group with the ester functionality and consists of 
the initial bimolecular reaction between the phosphine and the benzyl azide. The acyl 
transfer step, however, competes with the hydrolysis of the aza-ylide if the ester leaving 
group is bulky (R = t-Bu). 
3. The overall rate of the reaction increases when the phosphine is substituted with electron-
donating groups. 
 
Different conclusions can be drawn from the reaction between 132 and phenyl azide. In this 
instance, a stable aza-ylide intermediate (31P-NMR signal +13 ppm) is formed and only slowly 
converted to the ligation product. Thus, the rate-determining step in the Staudinger ligation of 
aryl azides appears to be the intramolecular amide bond formation. This difference is likely 
associated to the lower basicity / nucleophilicity of the N atom in the iminophosphorane 
intermediate.13 
More recently, Raines and coworkers discussed the mechanistic aspects of the Staudinger 
ligation of peptides mediated by (diphenylphosphino)methanethiol.14, 15 
The mechanism proposed by Raines and co-workers (Scheme 3)15 for the ligation mediated by 
(diphenylphosphino)methanethiol 99, show that the imminophosphorane 100 can form a 
tetrahedral intermediate 101, which collapses to give an amidophosphonium salt 102 that is 
hydrolyzed in aqueous solution, to afford the final amide.  
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Scheme 3. Mechanism for the Traceless Staudinger ligation mediated by 
(diphenylphosphino)methanthiol  
 
To obtain insight on the ability of nonpolar solvents to provide higher yields of the desired 
peptide product, the author performed DFT calculations on the effect of solvent on the electron 
density on phosphorus in tetrahedral intermediate 101 (R = R’ = CH3). The calculation indicated 
that this electron density increases in nonpolar solvents (Table 1), presumably due to the 
dispersal of charge into the phenyl groups.  
 
Table 1. Effect of solvent polarity on the calculated electron density on P and N in 101 
Parameter H2O ΤΗF 
P, charge + 0.082 + 0.028 
N, charge - 0.348 - 0.335 
 
All of the experimental and theoretical results from reactions with different phenyl substituents 
and in solvents of different polarity are consistent. These results indicate that increasing the 
electron density on phosphorus leads to a higher yield of amide products. This finding can be 
depicted by the dissection of tetrahedral intermediate 101 into resonance forms 101p+ (which has 
less charge dispersal) and 101pδ+. To emphasize the importance of 101p+ and 101pδ+ to the 
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product distribution, Raines refined the mechanism of the Staudinger ligation as reported in 
Scheme 4. 
 
 
 
Scheme 4. Refined mechanism including the resonance form 101pδ+ 
 
Previous studies from our laboratory 16 examined the mechanism of  the reaction of the α-tetra-
O-benzyl glucosyl azide 8 with phosphines 81 (Scheme 5). The accepted mechanism for the 
Staudinger reduction of azides with phosphines 81 requires the formation of two sequential 
intermediates. The initial nucleophilic attack of the phosphine on the azide is expected to 
proceed through a phosphotriazadiene 135 (often called phosphotriazene or phosphazene or 
phosphazide), which should be present as an equilibrating Z-E mixture of zwitterions (136-Z and 
136-E). This intermediate is stabilized by electron-donating groups on the phosphine, electron-
withdrawing groups on the azide, or sterically hindering groups on both the phosphine and the 
azide.17 
In the course of reactions performed in solvents of low polarity (toluene, CCl4, CHCl3) and 
starting from α-tetra-O-benzyl glucosyl azide 8, intermediates that are consistent with the 
structures 136 were indeed isolated,16 with a ratio that probably depends on the steric hindrance 
of the acyl group that is transferred (86:14 ratio from 81b, and 50:50 from 81j).  
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Scheme 5. Proposed mechanism for the traceless Staudinger ligation of 81 with α-tetra-O-
benzyl-glucosyl azide 8 
 
The configuration of the two intermediates was not fully assigned, but it could be clearly 
differentiated analysing the coupling constant between the anomeric proton and the phosphorous 
atom. Unfortunately, these compounds, once isolated from the reaction mixture by 
chromatography, rapidly undergo nitrogen extrusion and are not stable enough to allow a 
complete characterisation. Furthermore, in apolar solvents, sunlamp irradiation appeared to 
accelerate the decomposition of some, but not all, of the intermediates. In any case, acyl transfer 
appeared to occur with retention of configuration at the anomeric carbon, leading to the 
formation of the corresponding α-tetra-O-benzyl-glucosyl amides.  
Acceleration of the acyl transfer was obtained more reliably using aprotic dipolar solvents. The 
intermediates were isolated only for the reaction of 8 with 81j, and found to be identical to those 
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isolated from toluene. The α/β selectivity was also improved in these solvents, but phosphine 81j 
represents one exception, because the reaction became non-stereoconservative.  
Finally, upon reaction of the α-tetra-O-acetyl glucosyl azide 2 with 81j in N,N-
dimethylacetamide at 40 °C formation of the phosphotriazadiene could not be characterized, but 
the corresponding aza-ylide (iminophosphorane) intermediate 139 was directly isolated and fully 
characterised by NMR spectroscopy (1H NMR, CDCl3, 400 MHz: H1, 5.29 ppm, dd, J1-2 = 3.7 
Hz, J1-P = 22.6 Hz, Scheme 6).17 This is in agreement with previous reports on the Staudinger 
reaction of O-acetyl glycosyl azides.9, 18, 19  
 
 
 
Scheme 6. Staudinger ligation of azide 2 with phosphine 81j 
 
Interestingly, upon water work up at 40 °C or 70 °C, this intermediate afforded the β-glucosyl 
amide 104j only. This behavior is not limited to phosphine 81j, but is a general feature of the 
ligation reaction of α-tetra-O-acetl-glycopyranosyl azides. 
 In general, the anomeric iminophosphoranes of O-acetyl pyranoses appear to react more 
sluggishly than the corresponding O-benzyl derivatives with acylating agents and to allow α to β 
anomerization to occur prior to acyl transfer. Unlike the ligation of tetra-O-benzyl-
glycopyranosyl azides, the reduction-acylation of tetra-O-acetyl-glycopyranosyl azides is a 
nonstereoconservative process, and acyl transfer occurs more slowly than iminophosphorane 
anomerisation.  
These results are in agreement with recent literature reports obtained by the Kiessling group 
using dialkylphosphino-(borane)methanethioesters. 20 
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We speculated that tetra-O-acetyl-glycopyranosyl iminophosphoranes may be deactivated 
toward acyl transfer by the electron-withdrawing effect of the acetates, which delocalize the 
negative charge on the nitrogen atom and allow anomeric equilibration to occur before the acyl 
transfer step. On the contrary, the stereoconservative process obtained with tetra-O-benzyl and 
unprotected glycopyranoses was interpreted as the result of a stronger localization of the 
negative charge on the anomeric nitrogen, leading to faster acyl transfer and blocking the ring-
opening anomerization process (Scheme 7). 
 
 
 
Scheme 7. Stereochemical course of the staudinger ligation of tetra-O-acetyl-, tetra-O-benzyl- 
and unprotected α-glucopyranosyl azides 2, 8, and 7 with phosphines 81 
 
However, closer inspection of the results from unprotected α-glycopiranosyl azides and 
furanosyl azides revealed a more complex picture. 
Indeed, formation of variable quantities of glucofuranosyl amide by-products from unprotected 
α-glucopyranosyl azide 7 both in the reaction with 81 and 83 (Scheme 8) suggests that the 
Staudinger intermediates must, also in these cases, undergo a ring-opening process, at least to 
some extent. This however, is not leading to α-β equilibration, but rather to a ring-contraction, 
which is most unusual for pyranoses particularly in the gluco configuration.  
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Scheme 8. Formation of α-glucofuranosyl amide 95 from α-glucopyranosyl azide 7  
 
Other elements are gathered from the ligation reactions of β-glucopyranosyl azide 10  and β-
galactopyranosyl azide 43 with phosphines 83j-m (Scheme 9). β-glucopyranosyl azide 10 reacts 
with 83 to afford β-pyranosyl amides 94 only and no ring contraction products are identified in 
the crude reaction mixtures. However, α-galactofuranosyl amides 111 are formed as by-products 
in the ligation of the β-galactopyranosyl amide 43 with 83. Again, the unusual and unstable α-
anomer is the only furanose form isolated. 
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Scheme 9. β-glucopyranosyl amide 10 does not afford ring contraction products in the reaction 
with 83; β-galactopyranosyl azide 43 does  
 
Finally, and perhaps more strikingly, the reaction of pyranosyl and furanosyl azides appear, at 
first sight, to follow opposite stereochemical pathways. In fact 1,2-trans O-acetyl-furanosyl 
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azides of the galacto-, ribo- and arabino- series (36, 41 and 40) do not isomerize upon ligation 
with 81b, whereas the same 1,2-trans furanosyl azides do when they are unprotected 
(compounds 37, 53 and 49, respectively). This behaviour, exemplified in Scheme 10 for  the β-
galactofuranosyl azides 36 and 37, is exactly the opposite as that described for 2 and 7 in 
Scheme 7. 
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Scheme 10. Stereochemical course of the Staudinger ligation of tetra-O-acetyl and unprotected 
β-glycofuranosyl azides 36 and 37 with phopshines 81b 
 
The remaining sections of this chapter will be dedicated to a full discussion of the reaction 
selectivity for unprotected and O-acetyl-glycosyl azides in the context of a common mechanistic 
framework. 
 
7.2 Mechanism of the ligation of unprotected glycosyl azides  
 
We have shown in this thesis that the behavior of the unprotected furanosyl azides may be traced 
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to ring opening of the intermediate iminophosphorane, leading to a phosphinimine 123 which 
allows coordination of the phosphorous atom by the hydroxy group in position 2 of the sugar to 
afford the oxaphospholane 124, which leads to the 1,2-cis  isomer after closure of the furanose 
ring (Scheme 11). 
 
 
Scheme 11. Proposed mechanism for the anomeric epimerization of 37 
 
This hypothesis was confirmed by the observation that the unprotected 1,2-cis galactofuranosyl 
azide 46 reacted with 81b with total retention of configuration (Scheme 12), thus showing that 
1,2-cis compounds are formed from furanosyl azides regardless of the configuration of the 
starting material.  
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Scheme 12. Synthesis of α-galactofuranosyl amide 111b by ligation of 46 with 81b 
 
The mechanistic path shown in Scheme 11 can be used to reconcile the apparently opposite 
behaviors of pyranosyl and furanosyl azides in the ligation process. The full mechanistic picture 
is shown in Scheme 13, using unprotected galactosyl azides as substrates.  
The reaction course is dominated by the competition between acyl transfer and ring opening 
process, as discussed in the opening sections of this thesis. However, for unprotected sugars the 
behavior of the intermediated phosphinimine is more complex than previously discussed. In fact, 
once the phosphinimine is formed, the phosphorous atom is probably trapped by the 2 hydroxy 
group of the sugar in a 5-membered oxazaphospholane ring, exemplified in 124. Once this cycle 
is formed, the ring closure process can no longer revert to β-isomers of the iminophosphorane 
and only the left half side of the Scheme 13 is still available. In particular 124 can cyclize by 
attack of O4 to the anomeric carbon and form the α-furanosyl iminophosphorane 125, which, 
upon acyl transfer leads to the α-furanosyl amides 111. An alternative pathway for 124 is 
represented by O5 attack to the anomeric carbon, leading to the α-pyranosyl iminophosphorane 
140, from which acyl transfer would generate the α-galactopyranosyl amides 142. This pathway 
does not appear to be followed, since no α-pyranosyl azide is observed in the ligation of the 
furanosyl azides 46 and 37.  But the reverse pathway, leading from 140 to 124, is the source of 
α-furanosyl amide formation in the ligation of the α-pyranosyl azide 47 and of the corresponding 
azide in the gluco-series (7). Acyl transfer in the α-pyranosyl iminophosphoranes 140 is 
relatively slow, allowing for ring opening and phosphorous coordination by the 2 hydroxy group. 
The latter event prevents α-β isomerization of the pyranose ring to β-pyranosyl 
iminophosphorane 141, and rather redirects the open sugar through the furanose pathway. Hence, 
O4 attack on the anomeric carbon, leads to 125 and thus to the α-furanosyl amide by-products 
both in the galacto- (111) and gluco- series. 
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When the ligation is performed starting from β-pyranosyl azides, a more facile acyl transfer is 
expected. Thus, in the gluco series, β-pyranosyl amides are the only reaction product. However, 
if ring opening of the β-pyranosyl iminophosphorane 141 can occur, the reaction can again be 
funnelled through the cyclic oxazaphospholane 124, thus providing a path for pyranose to α-
furanose isomerization. This appears to be the case with β-galactopyranosyl azide 43 (Scheme 
13). Finally, the β-furanosyl iminophosphorane 122 must initially be formed upon reduction of 
β-galacto furanosyl azide 37. This, however, appears to be unable of direct acyl transfer but  
undergoes fast ring opening leading through 124 and 125 to the α-furanosyl amides 111.  
In this rather complex framework, the mechanistic scheme shown in Chapter 4 for the reaction of 
α-gluco pyranosyl azide 7 with 9 (Scheme 4, Chapter 4) can be riformulated  as shown in 
Scheme 14.  The iminophosphorane 96, formed in the first steps of the ligation can either 
transfer the acyl group to the anomeric N leading to α-glucopyranosyl amide 93, or can undergo 
ring opening to 97. This is probably not an equilibrium reaction, because the resulting 
phosphinimine 97 is blocked in the oxazaphospholane which strongly favors the formation of 5-
5-fused bicyclic systems and hence of the furanosyl amide 95.  
 
 
 Scheme 14. Mechanism for the formation of furanosyl amide 95 in the ligation of 7 with 81 
Chapter 7 
 205 
Indirect proof of this is the absence of pyranosyl amides in the ligation products of furanosyl 
azides. The amount of 95 formed in this reaction increases with the reaction temperature because 
higher temperatures favour ring opening of 96 and reduce the acyl transfer selectivity.  
 
7.3 Mechanism of the ligation of O-acetyl-glycosyl azides  
 
The results obtained in the ligation of tetra-O-acetyl-glycosyl azides 1, 2, 31, 36 and 129 with the 
pentanoyl phosphine 81b are summarized in Scheme 15. 
Ligation of tetra-O-acetyl-β-glucopyranosyl azide 1 procedes uneventfully to afford the β-amide 
104b (Scheme 15, eq. 1). The same product is form by ligation of α-tetra-O-acetyl-
glucopyranosyl azide 2 (Scheme 15, eq 2) As seen in Chapter 1 and previously reported 17 the 
complete inversion of configuration observed in this reaction can be explained by ring opening 
of the intermediate iminophosphorane, facilitated by the electron-withdrawing effect of the 
acetyl groups, which favors phosphinimine formation. (Ring contraction paths are not available 
to these O-acetyl substrates). A similar behaviour is observed for the α-tetra-O-acetyl-
galactopyranosyl azide 31 (Scheme 15, eq 3), although the anomeric inversion is not complete 
and a 4:1 β:α mixture of anomeric amides 108b and 143b is formed. This suggests that either the 
acyl transfer is faster for the α-galactopyranosyl iminophosphorane than for the corresponding 
gluco- derivative, or that the anomeric equilibrium in the galactopyranose series is less shifted 
toward the β-isomer. 
Given the propensity of acetylated glycosyl iminophosphoranes to undergo ring opening upon 
formation of the iminophosphorane, it is rather surprising to observe a totally stereoconservative 
process in the ligation of β-tetra-O-acetyl-galactofuranosyl azide 36 (Scheme 15, eq 4). Indeed, 
all literature data support small energetic differences for the α and β isomers of furanoses.21 Ring 
opening would be expected to produce a mixture of isomer iminophosphoranes and there is no 
reason why 36 should be stabilized against it. Indeed, ligation of the α-tetra-O-acetyl-
galactofuranosyl azide 129 (Scheme 15, eq 5) affords a 4:1 mixture of β- and α- isomers 112b 
and 114b, which must originate from a ring opening event. The partial inversion of the anomeric 
configuration observed in this reaction suggests that when ring opening occurs for these 
galactofuranose substrates, the subsequent ring closure is biased towards the formation of 1,2-
trans-amides, presumably for steric reasons.  
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Scheme 15. Ligation of tetra-O-acetyl-glycosyl azides 1, 2, 31, 36 and 129 
 
With these observations we think we have now begun to clarify the mechanistic picture of these 
ligation processes to the point where  predictions can be made concerning the stereochemistry of 
the reaction on new substrates and with new combinations of reagents. Work is in progress in our 
laboratory to test hypotheses generated by the models described above. 
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